Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
42529215	p-fsh	u/l (u/l)	5866	7717	0.00%
42529215	p-fsh	— (—)	1547	1860	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Female infertility

1018

1578

4.17

307.98

1.3

13.54

31.07

u/l

50.43

905

1277

Hypopituitarism

284

248

12.64

279.44

1.8

1.3

14.23

21.70

u/l

2.59

232

207

Disorders of other endocrine glands

953

2708

3.57

273.32

1.6

1.3

16.86

26.00

u/l

17.13

824

2221

Exclusions for E4_PCOS_BROAD

509

1029

5.23

238.00

1.9

1.3

17.09

24.70

u/l

6.29

431

858

Female infertility, cervigal, vaginal, other or unspecified origin

829

1555

3.72

222.77

1.3

14.84

31.51

u/l

40.91

727

1256

Female infertility, associated with anovulation

403

720

6.14

218.52

1.4

1.3

9.29

25.51

u/l

27.39

360

581

General examination and investigation of persons without complaint and reported diagnosis

1100

1897

3.14

216.71

1.4

1.3

25.82

25.78

u/l

0.01

907

1617

Depression

1702

5084

2.34

208.82

1.4

1.3

22.20

26.23

u/l

5.14

1331

4282

Medical observation and evaluation for suspected diseases and conditions

1108

1897

3.04

204.69

1.4

1.3

22.96

25.78

u/l

1.64

860

1617

Mood [affective] disorders

1755

5104

2.30

203.69

1.4

1.3

22.35

26.18

u/l

4.85

1375

4297

Mood disorders

1756

5104

2.29

203.33

1.4

1.3

22.32

26.19

u/l

4.96

1375

4297

Anxiety disorders, excluding more controls

1476

4030

2.47

201.11

1.4

1.3

25.06

27.06

u/l

1.31

1186

3414

Examination and observation for other reasons

962

1895

3.14

198.65

1.4

1.3

22.18

25.80

u/l

2.39

772

1615

Mood disorders, excluding more controls

1578

4074

2.39

196.78

1.4

1.3

23.19

26.94

u/l

4.04

1244

3447

Irregular menses

1336

4468

2.50

193.17

1.5

1.3

20.23

28.77

u/l

19.11

1139

3660

Recurrent or chronic depression

870

2071

3.11

185.29

1.4

1.3

24.48

28.22

u/l

2.23

687

1779

Anxiety disorders

1608

5176

2.24

178.71

1.4

1.3

23.82

25.85

u/l

1.52

1295

4317

Neurotic, stress-related and somatoform disorders

1603

5175

2.24

178.35

1.4

1.3

23.88

25.80

u/l

1.40

1291

4316

Polycystic ovarian syndrome, consortium definition

1636

4577

2.20

167.11

1.5

1.3

20.40

29.00

u/l

21.40

1390

3752

Amenorrhoea

288

487

6.39

164.79

1.8

1.3

12.72

24.19

u/l

8.81

267

400

Polycystic ovarian syndrome, broad definition

520

1455

3.87

160.89

1.4

1.3

9.00

20.22

u/l

27.99

467

1198

L02BG Aromatase inhibitors

465

1190

4.02

160.08

1.4

1.3

40.07

40.75

u/l

0.13

434

942

Noninflammatory disorders of female genital tract

946

1720

2.83

153.29

1.4

1.3

17.67

29.60

u/l

20.28

817

1396

Medicines for HER+ breast cancer

642

2024

3.18

153.10

1.4

1.3

37.22

38.21

u/l

0.26

599

1598

Hypothyroidism (congenital or acquired)

668

1187

3.32

146.45

1.5

1.2

17.62

19.89

u/l

1.05

560

997

Endocrine, nutritional and metabolic diseases

1485

3477

2.20

146.35

1.4

1.3

18.81

26.41

u/l

15.84

1250

2895

Hypothyroidism, levothyroxine purchases

664

1186

3.30

144.75

1.5

1.2

17.75

19.91

u/l

0.97

557

996

Hypothyroidism and >3 levothyroxin purchases

664

1186

3.30

144.75

1.5

1.2

17.75

19.91

u/l

0.97

557

996

Disorders of the thyroid gland

1546

4929

2.08

140.70

1.4

1.3

23.61

25.55

u/l

1.42

1257

4087

Hypothyroidism, other/unspecified

1489

4814

2.07

134.51

1.5

1.3

24.41

25.90

u/l

0.91

1220

3992

Excessive, frequent and irregular menstruation

809

1683

2.73

127.55

1.4

1.3

21.39

30.12

u/l

9.33

667

1365

Hypothyreosis and Thyroxine purchase for inclusion criteria

1512

5033

2.01

126.11

1.5

1.3

24.57

26.01

u/l

0.88

1236

4167

Anxiety (asthma-related co-morbidities)

1155

4301

2.15

119.80

1.4

1.3

20.14

26.01

u/l

8.15

926

3631

Depression or dysthymia

953

2237

2.41

119.00

1.4

1.3

24.86

27.64

u/l

1.48

737

1923

Ovarian dysfunction

346

902

4.17

118.91

1.6

1.3

14.23

19.50

u/l

3.21

316

763

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

158

187

8.13

114.32

1.3

26.53

35.82

u/l

1.97

153

128

Oxycodone

400

1115

3.53

114.28

1.5

1.3

28.34

31.33

u/l

0.93

353

903

Lung cancer and mesothelioma

184

234

6.85

110.19

1.3

1.2

26.11

34.92

u/l

2.31

176

185

Other antidepressants

1428

3782

1.99

110.04

1.4

1.3

22.99

25.67

u/l

2.14

1128

3201

Other special examinations and investigations of persons without complaint or reported diagnosis

898

1898

2.42

109.69

1.4

1.3

23.28

25.78

u/l

1.27

738

1617

Hypothyroidism, strict autoimmune

1220

3988

2.05

108.09

1.4

1.3

24.82

26.20

u/l

0.71

993

3315

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

405

1056

3.42

107.66

1.6

1.3

33.63

31.37

u/l

0.60

384

796

Non-small cell lung cancer

158

221

7.30

106.95

1.3

1.4

26.53

34.35

u/l

1.88

153

176

Malignant neoplasm of breast, HER-positive

527

1863

2.86

105.01

1.4

1.3

43.00

40.54

u/l

0.76

498

1453

Polycystic ovarian syndrome

277

675

4.52

104.81

1.5

1.3

7.50

17.83

u/l

15.71

249

577

All anxiety disorders

1170

4735

2.02

103.19

1.4

1.3

19.92

24.72

u/l

5.92

940

3944

Pain in joint

880

2581

2.29

102.18

1.4

1.3

25.37

25.63

u/l

0.08

699

2174

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

200

293

5.81

101.84

1.4

1.3

25.72

32.68

u/l

1.71

191

201

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

177

233

6.44

99.26

1.3

26.79

35.88

u/l

2.22

170

162

Other nutritional deficiencies

1090

5366

2.02

99.04

1.4

1.3

17.37

26.88

u/l

27.18

888

4440

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

576

2257

2.61

96.76

1.7

1.3

21.47

29.68

u/l

7.37

477

1846

Benzodiazepine use

1397

5393

1.86

95.43

1.4

1.3

24.42

25.85

u/l

0.82

1081

4519

Exclusions for E4_PCOS_CONSORTIUM

1398

4736

1.88

94.62

1.5

1.3

23.43

26.97

u/l

3.67

1178

3862

Special screening examination for infectious and parasitic diseases

521

1426

2.79

93.33

1.3

16.64

22.51

u/l

3.61

368

1213

Parasetamol

1230

3203

1.98

93.08

1.4

1.3

21.77

22.79

u/l

0.49

1037

2660

Obesity and other hyperalimentation

1044

5252

2.00

92.73

1.4

1.3

17.15

27.21

u/l

30.05

848

4344

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

236

547

4.40

92.69

1.7

1.3

32.56

32.64

u/l

0.01

227

396

Obesity

1041

5238

2.00

92.61

1.4

1.3

17.15

27.13

u/l

29.52

846

4331

Psychiatric diseases

1493

4077

1.85

92.33

1.4

1.3

25.15

26.88

u/l

1.08

1185

3448

Any mental disorder

1496

4088

1.85

92.27

1.4

1.3

25.06

26.89

u/l

1.17

1184

3458

Obesity due to excess calories

810

3761

2.20

92.25

1.4

1.3

17.69

27.11

u/l

19.53

649

3091

Headache

1047

4427

2.00

91.21

1.4

1.3

23.39

25.04

u/l

0.85

860

3635

Follow-up examination after treatment for conditions other than malignant neoplasms

654

1759

2.47

89.69

1.3

29.24

27.17

u/l

0.73

534

1496

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

532

1675

2.64

87.09

1.4

1.3

43.03

38.19

u/l

2.07

500

1269

Pain and other conditions associated with female genital organs and menstrual cycle

440

1543

2.81

84.35

1.3

19.16

29.16

u/l

7.47

363

1243

Male infertility

12.72

83.38

1.5

1.3

10.51

9.65

u/l

0.17

Ovarian cyst

663

1619

2.41

83.20

1.4

1.3

24.70

30.94

u/l

4.52

566

1313

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1279

4122

1.85

82.76

1.4

1.3

35.54

26.53

u/l

14.58

1154

3240

General symptoms and signs

1585

4567

1.75

82.57

1.4

1.3

25.48

24.55

u/l

0.48

1308

3753

Malignant neoplasm, wide definition for exclusion

1278

4124

1.85

82.36

1.4

1.3

35.49

26.53

u/l

14.41

1152

3241

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1278

4124

1.85

82.35

1.4

1.3

35.49

26.53

u/l

14.41

1152

3241

Other soft tissue disorders, not elsewhere classified

1308

4458

1.83

82.27

1.4

1.3

23.23

23.65

u/l

0.18

1054

3733

Malignant neoplasm

1241

3984

1.87

82.22

1.4

1.3

36.02

27.73

u/l

12.14

1128

3133

Any event in cancer register

1376

4599

1.79

80.12

1.4

1.3

33.86

24.45

u/l

17.50

1220

3671

Dermatitis and eczema

1467

5567

1.74

79.50

1.4

1.3

23.33

25.31

u/l

1.48

1197

4616

GASTRO-related operations

1267

3458

1.86

79.20

1.4

1.3

22.59

22.87

u/l

0.11

1074

2821

Any gastric operation

1267

3458

1.86

79.20

1.4

1.3

22.59

22.87

u/l

0.11

1074

2821

Depression medications

607

1241

2.50

78.91

1.4

1.3

18.93

19.38

u/l

0.13

503

1047

Genitourinary diseases

672

1442

2.36

77.83

1.4

1.3

18.05

24.04

u/l

4.95

571

1180

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

173

366

4.84

76.33

1.5

1.4

33.93

28.59

u/l

1.06

163

272

Other specific joint derangements/joint disorders

1185

4410

1.82

74.66

1.4

1.3

25.56

23.11

u/l

1.62

956

3688

Neurological diseases

1322

3740

1.80

74.61

1.4

1.3

20.94

24.09

u/l

2.97

1098

3135

Neoplasms

1238

3685

1.82

73.84

1.4

1.3

20.31

19.20

u/l

0.64

1067

2967

Selective serotonin reuptake inhibitors

1280

3788

1.79

72.86

1.4

1.3

22.23

25.64

u/l

3.08

1024

3206

Persons encountering health services for examination and investigation

795

1898

2.12

71.88

1.4

1.3

22.48

25.78

u/l

1.91

649

1617

Used for control exclusion in common control thyroid runs

1422

4218

1.72

69.98

1.5

1.3

21.07

24.72

u/l

4.01

1161

3529

Testicular dysfunction

15.54

69.42

1.4

1.2

18.44

7.59

u/l

3.09

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

169

379

4.54

69.36

1.5

1.3

34.36

31.75

u/l

0.40

160

271

Other anxiety disorders

847

3933

1.94

67.96

1.4

1.3

19.51

22.45

u/l

2.08

688

3278

Hypothyroidism, strict autoimmune, 3 medication purchases required

1247

4934

1.74

67.87

1.4

1.3

25.65

26.44

u/l

0.35

1010

4079

Malignant neoplasm of breast

735

2617

2.06

67.00

1.4

1.3

41.21

37.64

u/l

1.71

689

2040

Anaemias

417

1062

2.66

66.53

1.4

1.2

24.40

21.49

u/l

0.93

343

887

Dysplasia of cervi uteri

469

1526

2.43

64.34

1.3

24.34

31.50

u/l

4.42

369

1236

Malignant neoplasm of respiratory system and intrathoracic organs

148

285

4.84

64.21

1.4

26.34

31.69

u/l

1.08

140

227

Continuous positive airway pressure

207

482

3.76

63.40

1.3

1.4

24.48

34.18

u/l

3.47

165

399

Malignant neoplasm of breast, HER2-negative

695

2527

2.05

63.17

1.4

1.3

41.61

38.22

u/l

1.50

654

1966

Low back pain

1009

4372

1.80

62.50

1.4

1.3

24.42

24.86

u/l

0.16

795

3649

Procreative management

555

2163

2.20

62.19

1.4

19.01

27.77

u/l

9.09

480

1714

Testicular hypofunction

15.67

61.70

1.4

1.2

20.02

8.04

u/l

3.11

Malignant neoplasm of bronchus and lung

127

227

5.30

61.47

1.3

1.4

27.90

33.25

u/l

0.98

121

183

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

746

2488

1.99

60.72

1.4

1.3

41.10

35.24

u/l

3.85

699

1907

Episodal and paroxysmal disorders

1511

4788

1.63

60.71

1.4

1.3

21.43

25.27

u/l

4.66

1229

3984

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

746

2490

1.99

60.58

1.4

1.3

41.10

35.25

u/l

3.84

699

1909

Menorrhagia

582

1470

2.23

60.55

1.3

26.77

33.51

u/l

4.09

482

1193

Diseases of pulp and periapical tissues

454

1976

2.33

60.54

1.4

1.3

24.56

27.91

u/l

1.37

361

1663

Migraine

924

4387

1.82

60.26

1.5

1.3

21.54

25.78

u/l

3.79

768

3641

Dorsalgia

1377

4535

1.66

59.88

1.4

1.3

23.66

24.18

u/l

0.23

1114

3796

Benign neoplasm: Pituitary gland, craniopharyngeal duct

119

227

5.52

59.79

2.2

1.3

16.09

22.24

u/l

1.52

110

177

Other diseases of hard tissues of teeth

854

3446

1.87

59.69

1.4

1.3

25.51

26.11

u/l

0.19

677

2892

Lower back pain or/and sciatica

1324

5617

1.65

59.32

1.4

1.3

25.27

25.14

u/l

0.05

1066

4666

Neurological diseases, wide definition

585

1356

2.19

57.50

1.4

1.3

19.39

22.83

u/l

1.66

485

1148

Nerve, nerve root and plexus disorders

1315

5067

1.64

57.14

1.4

1.3

27.17

26.61

u/l

0.23

1054

4190

Symptoms and signs involving the circulatory and respiratory systems

1485

4672

1.61

56.01

1.4

1.3

23.54

24.27

u/l

0.35

1221

3873

Soft tissue disorders

1398

4513

1.62

55.30

1.4

1.3

22.18

23.42

u/l

0.73

1140

3785

Acute upper respiratory infections

1330

5172

1.62

55.08

1.4

1.3

24.89

26.18

u/l

0.70

1072

4288

Other menopausal disorders

473

1199

2.32

54.57

1.5

1.3

36.27

38.34

u/l

0.53

380

984

Chronic laryngitis and laryngotracheitis

211

658

3.29

54.27

1.3

32.92

31.71

u/l

0.16

160

558

Opioids

1397

4598

1.61

53.55

1.4

1.3

22.99

24.04

u/l

0.57

1146

3810

Chronic diseases of tonsils and adenoids

1123

4284

1.67

52.48

1.4

1.3

25.26

25.25

u/l

0.00

914

3585

Myalgia

384

1669

2.35

51.73

1.5

1.4

23.68

27.38

u/l

1.36

303

1376

Dentinal caries

292

1111

2.66

51.63

1.5

1.3

20.53

23.51

u/l

0.92

238

948

Endometriosis

547

1565

2.11

51.15

1.4

1.3

25.61

31.66

u/l

3.45

465

1272

Other dorsopathies, not elsewhere classified

1365

4549

1.59

50.76

1.4

1.3

23.08

24.12

u/l

0.56

1105

3808

Other reaction to severe stress, and adjustment disorders

651

3486

1.90

50.03

1.4

1.3

24.74

24.43

u/l

0.09

534

2889

Other problems related to primary support group, including family circumstances

289

1097

2.66

49.70

1.5

1.4

20.56

20.80

u/l

0.05

257

928

Benign neoplasm: Pituitary gland, craniopharyngeal duct

119

267

4.68

49.49

2.2

1.4

16.09

24.17

u/l

2.50

110

222

Carpal tunnel syndrome

748

3765

1.81

49.31

1.4

1.3

29.42

32.10

u/l

1.33

612

3086

Dental caries

320

1296

2.48

49.14

1.4

1.3

21.03

23.81

u/l

0.85

264

1099

Mental and behavioural disorders due to tobacco

144

382

3.90

47.67

1.4

1.3

26.32

26.44

u/l

0.01

109

312

Abnormal findings on diagnostic imaging of lung

326

1328

2.41

47.25

1.4

1.3

29.49

33.03

u/l

1.15

292

1064

Smoking dependency

144

386

3.86

46.97

1.4

26.32

26.47

u/l

0.02

109

313

Benign neoplasms

1101

3822

1.64

46.93

1.4

1.3

21.11

19.44

u/l

1.03

924

3072

Dorsopathies

1385

4562

1.56

46.69

1.4

1.3

22.19

24.06

u/l

1.35

1134

3820

Substance abuse, excluding more controls

587

2705

1.92

46.10

1.4

1.3

23.02

25.33

u/l

0.92

451

2284

Other disorders of teeth and supporting structures

252

954

2.68

45.59

1.5

1.3

27.25

27.74

u/l

0.08

209

806

Hyperfunction of pituitary gland

137

365

3.95

45.47

1.9

1.4

14.25

24.24

u/l

4.49

124

309

Chronic periapical parodontitis

244

914

2.71

45.09

1.4

1.3

28.29

27.57

u/l

0.11

189

771

Other symptoms and signs involving the digestive system and abdomen

251

956

2.68

45.02

1.4

30.46

33.51

u/l

0.64

201

783

Pain, not elsewhere classified

386

1781

2.20

44.96

1.6

1.3

24.95

26.03

u/l

0.26

335

1460

Oligomenorrhoea

209

5.00

44.44

1.3

1.4

9.47

26.17

u/l

9.75

178

Personality disorders, excluding more controls

430

2115

2.07

42.47

1.5

1.3

21.48

23.40

u/l

0.63

336

1794

Migraine, single triptan purchase ok & required. ICD-code if available is included

1160

5059

1.57

42.06

1.4

1.3

24.47

26.16

u/l

0.94

960

4171

Triptan medication for migraine, single purchase ok

1160

5059

1.57

42.06

1.4

1.3

24.47

26.16

u/l

0.94

960

4171

Unspecified urinary incontinence

127

340

3.84

41.47

1.5

1.3

31.58

32.77

u/l

0.12

280

Malignant melanoma, excluding all cancers (controls excluding all cancers)

152

464

3.33

40.44

1.5

1.3

32.81

32.07

u/l

0.09

143

337

Codeine

1255

4517

1.54

40.41

1.4

1.3

23.04

24.36

u/l

0.74

1020

3742

Hypertrichosis

101

238

4.69

40.30

1.5

1.4

6.70

19.63

u/l

9.13

200

Hyperprolactinaemia

116

301

4.11

40.23

1.8

1.4

14.44

25.81

u/l

4.66

104

251

Substance use, excluding alcohol

286

1222

2.38

40.18

1.4

22.65

22.43

u/l

0.04

222

1019

Benign neoplasm of other and unspecified endocrine glands

159

504

3.22

39.92

2.0

1.3

19.69

28.73

u/l

3.09

145

387

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

525

2602

1.88

39.76

1.4

1.3

27.67

31.33

u/l

1.74

449

2108

Sciatica+with lumbago

617

3301

1.79

39.72

1.4

1.3

27.77

29.99

u/l

0.88

515

2726

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

157

5.23

39.65

1.3

34.55

31.47

u/l

0.26

112

Dental caries 2

1098

5623

1.55

38.82

1.4

1.3

22.46

25.57

u/l

2.52

880

4675

First line medication for Crohn's disease

1402

5174

1.49

38.63

1.4

1.3

25.59

23.81

u/l

1.17

1172

4258

Hirsutism in women

214

4.84

38.34

1.6

1.4

6.05

19.78

u/l

9.62

180

Dental caries 2, only avohilmo

1091

5617

1.55

38.34

1.4

1.3

22.46

25.50

u/l

2.44

873

4667

Unknown and unspecified causes of morbidity

122

337

3.72

38.11

1.3

26.53

25.17

u/l

0.16

117

276

Dental caries 2 and operation codes

1086

5636

1.54

38.09

1.4

1.3

22.55

25.47

u/l

2.27

871

4683

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

133

393

3.44

37.33

1.6

1.3

32.93

31.74

u/l

0.13

125

287

Other and unspecified disorders of skin and subcutaneous tissue

104

262

4.10

37.09

1.4

29.12

28.18

u/l

0.09

213

Persons encountering health services in other circumstances

503

2730

1.86

37.00

1.4

22.65

24.21

u/l

0.52

437

2227

Other joint disorders

1254

4457

1.51

36.86

1.4

1.3

21.98

22.93

u/l

0.46

1013

3729

Sleep disorders (combined)

1150

4985

1.52

36.73

1.4

1.3

23.87

28.18

u/l

4.71

939

4093

Abnormalities of heart beat

413

2090

1.98

36.57

1.4

1.3

22.94

26.90

u/l

1.58

338

1715

Any reimbursement code in KELA

984

3114

1.60

36.53

1.5

1.3

23.20

20.97

u/l

1.30

830

2527

Fever of other and unknown origin

591

3121

1.77

36.52

1.5

1.3

27.55

24.65

u/l

1.32

518

2572

Symptoms and signs involving the skin and subcutaneous tissue

814

5052

1.62

36.13

1.4

1.3

25.58

27.07

u/l

0.64

679

4154

Fibromyalgia

202

781

2.68

35.63

1.4

28.00

30.02

u/l

0.33

160

651

Non-selective monoamine reuptake inhibitors

369

1774

2.04

35.37

1.4

1.3

31.67

36.23

u/l

1.57

283

1463

Certain infectious and parasitic diseases

1311

4448

1.48

35.31

1.4

1.3

25.59

25.48

u/l

0.04

1063

3688

Dermatitis

677

4057

1.68

35.25

1.5

1.3

24.52

27.81

u/l

1.91

558

3350

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

453

2438

1.88

34.46

1.4

1.3

19.11

24.06

u/l

3.06

347

2062

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

140

5.14

34.14

1.3

34.77

29.84

u/l

0.44

102

Generalized anxiety disorder

296

1378

2.20

34.11

1.5

1.3

19.42

18.72

u/l

0.15

231

1149

Substance abuse

587

3261

1.73

33.97

1.4

1.3

23.02

23.85

u/l

0.25

451

2699

Codeine or tramadol medication

1391

5360

1.45

33.43

1.4

1.3

24.21

25.40

u/l

0.68

1138

4435

Autoimmune diseases

1345

4742

1.46

33.08

1.4

1.3

22.79

24.24

u/l

0.88

1086

3955

Gastro-oesophageal reflux disease

708

3854

1.64

32.81

1.4

1.3

27.57

30.02

u/l

1.08

548

3176

Other diseases of intestines

1347

5446

1.45

32.76

1.4

1.3

26.03

24.35

u/l

1.03

1091

4524

Abnormalities of breathing

1157

4657

1.49

32.41

1.4

1.3

25.36

24.33

u/l

0.46

954

3859

Panic disorder

287

1349

2.17

32.30

1.5

1.3

19.12

19.19

u/l

0.01

225

1120

Sleep apnoea, including avohilmo

1055

4586

1.50

31.75

1.4

1.3

25.08

30.41

u/l

6.04

855

3762

Pain in limb

901

4240

1.55

31.69

1.5

1.3

24.45

24.55

u/l

0.03

722

3546

Benign neoplasm of other and unspecified endocrine glands

159

576

2.82

31.62

2.0

1.4

19.69

29.63

u/l

3.87

145

470

Mental and behavioural disorders due to psychoactive substance use

601

3383

1.69

31.60

1.4

1.3

22.98

23.92

u/l

0.29

462

2802

Other diseases of upper respiratory tract

1225

4375

1.47

31.55

1.4

1.3

25.54

25.10

u/l

0.17

993

3657

Malignant melanoma

132

432

3.10

31.43

1.5

1.4

32.20

32.79

u/l

0.07

124

350

Somatoform disorder

246

1103

2.27

31.07

1.5

1.3

28.49

26.87

u/l

0.29

198

911

Other intervertebral disc disorders

960

3870

1.53

31.00

1.4

1.3

28.07

27.34

u/l

0.26

763

3203

Excluding asthma or asthma-COPD overlap

1008

3331

1.52

30.92

1.4

1.3

24.64

26.64

u/l

1.08

811

2795

Cervicobrachial syndrome

296

1429

2.10

30.90

1.4

1.3

31.68

32.80

u/l

0.21

244

1152

1341

4964

1.43

30.69

1.4

1.3

25.94

26.16

u/l

0.08

1083

4117

Other and unspecified dermatitis

574

3427

1.69

30.46

1.5

1.3

24.25

28.55

u/l

2.59

471

2806

Bronchitis

1252

5748

1.44

30.12

1.4

1.3

22.39

25.52

u/l

2.90

1024

4763

Obesity, other/unspecified

512

2980

1.74

30.04

1.5

1.3

15.33

29.33

u/l

32.96

428

2425

Inflammatory diseases of female pelvic organs

1010

5151

1.49

29.99

1.4

1.3

25.46

27.26

u/l

0.90

807

4282

Other pulmonary diagnosis

1001

3331

1.51

29.75

1.4

1.3

25.05

26.64

u/l

0.76

801

2795

Complications of procedures, not elsewhere classified

910

5232

1.51

29.75

1.4

1.3

27.92

26.65

u/l

0.52

775

4265

Other disorders of skin and subcutaneous tissue, not elsewhere classified

153

561

2.77

29.70

1.5

1.4

28.08

27.89

u/l

0.02

130

463

Malignant melanoma of skin

109

331

3.35

29.44

1.6

1.4

31.24

33.31

u/l

0.25

102

272

Benign neoplasms

1224

4761

1.44

29.34

1.4

1.3

22.63

22.90

u/l

0.11

1030

3921

Diseases of the skin and subcutaneous tissue

1235

4314

1.44

28.97

1.4

1.3

23.76

25.14

u/l

0.73

1008

3572

Other headache syndromes

587

3575

1.66

28.97

1.4

1.3

26.11

28.54

u/l

0.98

469

2949

ILD medications: prednisolone, methylprednisolone, prednisone

1312

5248

1.42

28.89

1.4

1.3

26.14

24.73

u/l

0.80

1087

4334

Complications of surgical and medical care, not elsewhere classified

1089

5399

1.45

28.52

1.4

1.3

28.87

26.04

u/l

1.87

927

4416

COPD differential diagnosis

998

3350

1.50

28.49

1.4

1.3

24.70

26.58

u/l

0.98

804

2809

ILD differential diagnosis

997

3349

1.50

28.36

1.4

1.3

24.72

26.58

u/l

0.96

803

2809

Impingement syndrome of shoulder

234

1069

2.21

28.11

1.4

1.3

35.87

35.45

u/l

0.06

179

866

Acute upper respiratory infections of multiple and unspecified sites

961

4881

1.49

28.11

1.4

1.3

21.95

25.13

u/l

2.43

778

4043

Arthropathies

1247

4458

1.43

28.10

1.4

1.3

20.98

22.93

u/l

1.38

1029

3730

Symptoms and signs involving the digestive system and abdomen

1119

3857

1.46

28.03

1.4

1.3

23.85

25.32

u/l

0.76

923

3213

Use of hypnotics and sedatives

1224

4996

1.42

27.55

1.4

1.3

27.05

26.96

u/l

0.03

967

4140

L01XE Protein kinase inhibitors

152

4.53

27.45

1.5

1.4

35.33

33.29

u/l

0.16

120

Follow-up care involving plastic surgery

227

3.86

27.41

1.2

1.3

35.93

30.48

u/l

0.59

185

Gastrointestinal diseases

887

2932

1.53

27.35

1.4

1.3

21.52

23.14

u/l

0.78

740

2464

Migraine without aura

414

2340

1.80

27.18

1.5

1.3

21.65

25.29

u/l

1.63

343

1939

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1249

5077

1.41

26.51

1.4

1.3

25.28

25.77

u/l

0.20

1053

4163

Endometriosis of pelvic peritoneum

272

1335

2.05

26.33

1.3

29.45

32.83

u/l

0.79

233

1082

Persons encountering health services in other circumstances, wide

1357

5082

1.39

26.31

1.4

1.3

24.68

25.74

u/l

0.55

1136

4168

Persistent mood disorders

240

1139

2.14

26.29

1.4

1.3

24.60

27.15

u/l

0.59

185

953

Disorders of thyroid, IBD co-morbidities

290

1053

2.03

26.27

1.4

1.3

29.13

27.34

u/l

0.34

234

886

Fentanyl

200

3.90

26.23

1.4

37.21

31.70

u/l

0.55

157

Sleep apnoea

934

4317

1.48

26.16

1.4

1.3

24.56

31.91

u/l

10.32

762

3516

Bipolar affective disorders

299

1544

1.97

26.03

1.5

1.3

18.06

23.28

u/l

2.72

238

1291

Diseases of the ear and mastoid process

1461

5408

1.37

26.01

1.4

1.3

24.62

24.95

u/l

0.13

1182

4497

Irritable bowel syndrome

379

2111

1.82

25.96

1.4

1.3

24.13

27.22

u/l

1.09

313

1753

Abdominal and pelvic pain

1100

3857

1.44

25.70

1.4

1.3

23.91

25.32

u/l

0.72

908

3213

Other/unspecified dorsalgia

417

2382

1.76

25.63

1.4

1.3

22.61

28.69

u/l

3.60

333

1956

Antihypertensive medication - note that there are other indications

1027

3893

1.45

25.48

1.4

1.3

19.69

22.01

u/l

1.63

848

3254

Temporomandibular joint disorders

251

1229

2.08

25.39

1.6

1.3

27.83

29.69

u/l

0.39

206

1013

Contraceptive management

554

2385

1.65

25.33

1.3

1.4

30.52

29.42

u/l

0.30

448

1894

Polyp of the female genital tract

419

1368

1.80

25.26

1.4

1.3

31.26

35.18

u/l

1.38

344

1117

Oxicams

231

596

2.22

24.88

1.4

23.05

27.05

u/l

1.01

188

489

Bacterial infection, other or unspecified

370

1857

1.81

24.83

1.4

1.3

28.51

28.35

u/l

0.03

316

1534

Vasomotor and allergic rhinitis

542

3320

1.62

24.69

1.4

1.3

23.96

24.71

u/l

0.20

423

2772

COPD/asthma related infections

1271

4590

1.39

24.64

1.3

26.11

26.18

u/l

0.03

1029

3807

COPD/asthma/ILD related infections

1271

4590

1.39

24.64

1.3

26.11

26.18

u/l

0.03

1029

3807

Personality disorders

430

2528

1.72

24.49

1.5

1.3

21.48

22.58

u/l

0.31

336

2103

Oedema, not elsewhere classified

273

1386

1.98

24.41

1.5

1.3

27.28

28.99

u/l

0.38

225

1136

Disorders of skin appendages

607

3888

1.57

24.32

1.4

1.3

20.34

24.89

u/l

3.48

509

3205

Behavioural syndromes associated with physiological disturbances and physical factors

494

3016

1.66

24.28

1.5

1.3

17.43

21.61

u/l

2.76

418

2508

TMD related pain

283

3.38

24.13

1.7

1.4

27.57

22.89

u/l

0.63

242

Malignant neoplasm of urinary organs

151

4.23

23.98

1.3

37.58

28.25

u/l

1.02

118

Melanocytic naevi, other sites/unspecified

116

415

2.86

23.83

1.5

1.4

26.20

23.70

u/l

0.36

329

Diseases of male genital organs

218

489

2.26

23.82

1.4

1.3

10.02

10.34

u/l

0.12

170

414

Tonsillectomy and adenotomy

1001

4916

1.43

23.78

1.4

20.37

23.45

u/l

2.51

837

4066

KRA_PSY_EATING, excluding more controls

196

896

2.24

23.75

1.5

1.4

13.34

15.83

u/l

0.83

171

775

Hyperhidrosis

189

3.92

23.74

1.6

1.3

29.07

21.78

u/l

0.92

159

Lumbar disc prolapse

684

3570

1.53

23.64

1.4

1.3

27.94

29.04

u/l

0.37

550

2947

Opening and dilatation of root channel of tooth

111

391

2.92

23.53

1.4

21.18

22.36

u/l

0.15

331

ILD medications

1331

5373

1.37

23.36

1.4

1.3

25.41

24.27

u/l

0.62

1102

4444

Coxibs

293

792

1.98

23.28

1.3

1.4

17.48

21.69

u/l

1.58

243

660

Medical treatment for female infertility

549

3483

1.61

23.27

1.3

1.4

15.83

24.91

u/l

13.85

476

2850

Tramadol

853

3756

1.47

23.14

1.4

1.3

28.08

28.12

u/l

0.01

696

3074

Missing teeth due to accident, extraction or parodontitis

109

382

2.90

23.14

1.5

1.3

34.01

29.30

u/l

0.66

325

L02BA Anti-estrogens

241

1208

2.03

22.97

1.5

1.3

35.36

37.42

u/l

0.40

226

962

Tobacco use

265

3.35

22.96

1.4

13.44

19.86

u/l

1.66

219

Cervicalgia

225

1099

2.07

22.89

1.4

1.3

28.25

31.43

u/l

0.70

184

908

Poisoning by drugs, medicaments and biological substances

361

2061

1.78

22.87

1.4

20.27

23.26

u/l

1.07

273

1710

Complications of medical and surgical care

757

4891

1.48

22.62

1.4

1.3

27.31

28.20

u/l

0.30

625

3995

Cystitis

1112

4905

1.39

22.49

1.4

1.3

26.18

25.90

u/l

0.10

911

4077

Diseases of the respiratory system

795

2680

1.49

22.44

1.4

1.3

25.60

26.51

u/l

0.30

638

2245

Shoulder lesions

764

3149

1.49

22.42

1.4

1.3

31.48

30.52

u/l

0.30

603

2607

Disorders of adult personality and behaviour

450

2743

1.66

22.39

1.5

1.3

21.47

22.63

u/l

0.34

352

2288

Chronic periodontitis

121

456

2.69

22.36

1.3

35.08

29.97

u/l

0.82

100

377

Unspecified/other endometriosis

175

788

2.27

22.15

1.3

20.10

28.59

u/l

3.00

155

643

Pain (limb, back, neck, head abdominally)

772

2594

1.50

22.10

1.4

1.3

22.36

25.48

u/l

1.79

632

2187

Diseases of oesophagus, stomach and duodenum

1182

5254

1.37

21.88

1.4

1.3

26.72

26.40

u/l

0.12

932

4371

Malignant neoplasm of kidney, except renal pelvis

145

4.12

21.76

1.3

37.06

28.53

u/l

0.86

114

Disorders of synovium and tendon

600

3530

1.54

21.75

1.3

27.92

27.77

u/l

0.03

479

2936

Diseases of oral cavity, salivary glands and jaws

958

3467

1.42

21.26

1.4

1.3

25.75

26.13

u/l

0.12

771

2911

Diseases of the musculoskeletal system and connective tissue

756

2556

1.49

21.24

1.4

1.3

19.41

22.50

u/l

1.93

629

2170

Other maternal disorders predominantly related to pregnancy

990

4460

1.41

21.20

1.4

1.3

25.38

28.86

u/l

2.68

837

3657

Triptan medication for migraine, min. 3 purchases

944

5330

1.41

21.15

1.4

1.3

22.33

26.31

u/l

3.59

798

4378

Asthma (mode)

875

3349

1.44

21.09

1.4

1.3

23.29

26.58

u/l

2.31

723

2809

Other diseases of urinary system

1225

5094

1.36

21.03

1.4

1.3

25.29

25.30

u/l

0.00

997

4235

Supervision of high-risk pregnancy

506

1917

1.62

20.93

1.4

23.13

29.69

u/l

4.16

431

1512

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

221

1067

2.01

20.68

1.3

37.11

36.58

u/l

0.07

205

815

Adenomyosis (Endometriosis of uterus)

162

727

2.26

20.59

1.4

1.3

21.11

37.60

u/l

8.79

143

600

Persons encountering health services in circumstances related to reproduction

605

2693

1.53

20.44

1.4

25.22

27.84

u/l

1.13

508

2157

Nonorganic sleeping disorders, excluding more controls

247

1301

1.92

20.38

1.5

1.3

20.14

23.72

u/l

1.05

203

1085

Specific personality disorders

376

2245

1.70

20.35

1.5

1.3

20.90

22.22

u/l

0.36

295

1859

Symptoms and signs involving the urinary system

622

3196

1.51

20.27

1.4

1.3

26.14

28.18

u/l

0.80

500

2632

Infections with a predominantly sexual mode of transmission

521

3368

1.56

20.26

1.3

1.4

21.12

21.94

u/l

0.24

409

2817

Other functional intestinal disorders

408

2371

1.65

19.95

1.5

1.3

22.61

28.37

u/l

3.22

335

1971

Hernia of abdominal wall, postoperative

144

623

2.33

19.87

1.3

28.10

29.56

u/l

0.19

117

503

Asthma, excluding more controls

870

3267

1.43

19.70

1.4

1.3

23.41

26.49

u/l

2.05

718

2741

Schizophrenia or delusion, excluding more controls

328

1885

1.74

19.69

1.5

1.3

21.66

25.37

u/l

1.36

255

1583

Asthma (only as main-diagnosis)

787

3301

1.45

19.62

1.4

1.3

23.82

26.57

u/l

1.57

647

2769

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

315

1818

1.76

19.45

1.4

1.3

17.74

22.61

u/l

2.32

240

1526

Poisoning by medicine

321

1859

1.75

19.45

1.4

19.79

23.42

u/l

1.32

249

1541

Asthma

871

3301

1.42

19.43

1.4

1.3

23.39

26.57

u/l

2.17

719

2769

Rotator cuff syndrome

528

2543

1.55

19.22

1.3

31.93

33.57

u/l

0.48

422

2087

Spinal instabilities

142

4.02

19.21

1.5

1.4

30.00

29.80

u/l

0.01

115

Asthma (only as main-diagnosis), excluding more controls

786

3267

1.44

19.20

1.4

1.3

23.86

26.49

u/l

1.46

646

2741

Malaise and fatigue

413

2117

1.64

19.18

1.4

1.3

25.34

26.59

u/l

0.33

352

1728

Phobic anxiety disorders

222

1155

1.95

19.09

1.5

1.3

18.61

18.36

u/l

0.04

181

968

Endometriosis of ovary

235

1242

1.91

19.07

1.3

23.99

33.87

u/l

4.43

207

1004

Localized swelling, mass and lump of skin and subcutaneous tissue

307

1766

1.75

18.95

1.4

1.3

25.77

28.59

u/l

0.79

256

1443

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

478

1497

1.61

18.90

1.4

1.3

22.52

23.01

u/l

0.11

405

1258

Symptoms and signs concerning food and fluid intake

362

2.74

18.89

1.5

1.3

21.60

22.95

u/l

0.16

308

Problems related to lifestyle

143

633

2.30

18.86

1.5

1.3

13.64

20.35

u/l

3.01

122

533

Deposits [accretions] on teeth

240

3.15

18.84

1.4

1.3

24.35

23.74

u/l

0.06

204

Hypothyroidism, drug reimbursement

218

791

1.99

18.84

1.5

1.2

30.22

26.95

u/l

0.66

172

644

Endometriosis of intestine

132

4.20

18.78

1.3

27.74

25.98

u/l

0.12

120

Melanocytic naevi, other sites/unspecified

116

470

2.52

18.72

1.5

1.4

26.20

25.87

u/l

0.04

390

Pain associated with micturition

131

560

2.38

18.71

1.3

1.4

25.03

26.60

u/l

0.21

103

474

Dental pulpitis 4

1203

4682

1.34

18.63

1.4

1.3

22.87

24.57

u/l

1.06

956

3923

Dental pulpitis 1

1201

4684

1.34

18.38

1.4

1.3

22.90

24.58

u/l

1.04

954

3925

Functional dyspepsia

295

1694

1.76

18.37

1.4

1.3

24.50

30.19

u/l

2.17

224

1413

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

509

3271

1.53

18.36

1.4

1.3

24.82

27.44

u/l

0.97

412

2703

Acute sinusitis

676

4382

1.45

18.20

1.3

23.65

25.24

u/l

0.64

543

3622

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

261

1453

1.82

18.19

1.4

20.60

22.80

u/l

0.54

195

1212

Correction of physiology of bite - demanding therapy visit

129

558

2.37

18.11

1.6

1.4

24.35

25.23

u/l

0.11

111

468

Obesity related asthma

346

2083

1.68

18.11

1.4

1.3

20.24

30.78

u/l

9.67

279

1696

Diseases of pulp and periapical tissues, including avohilmo

1198

4682

1.33

18.07

1.4

1.3

22.88

24.58

u/l

1.05

951

3924

Dental caries 2 and operation codes, only avohilmo

914

4119

1.39

18.04

1.5

1.3

24.88

24.28

u/l

0.21

731

3417

Convalescence

284

2.96

18.01

1.4

23.81

28.33

u/l

0.58

235

Other predominantly sexually transmitted diseases, not elsewhere classified

311

1829

1.73

17.96

1.3

1.4

20.85

20.81

u/l

0.01

244

1528

Factors influencing health status and contact with health services

231

591

1.97

17.95

1.4

21.42

27.29

u/l

1.93

185

500

Other disorders of lacrimal gland

350

2122

1.66

17.84

1.5

1.3

30.66

31.08

u/l

0.08

283

1740

Visual disturbances and blindness

469

3047

1.55

17.82

1.5

1.4

26.99

26.58

u/l

0.09

391

2492

Pain in thoracic spine

188

946

2.01

17.80

1.4

1.3

24.02

29.83

u/l

1.70

160

783

Haemorrhoids and perianal venous thrombosis

200

1026

1.96

17.75

1.4

1.3

27.91

28.72

u/l

0.12

164

853

Other enthesopathies

325

1937

1.69

17.68

1.4

1.3

27.32

33.33

u/l

2.50

256

1588

Seborrhoeic dermatitis

353

2.70

17.64

1.5

1.4

21.08

25.68

u/l

0.81

288

Disturbances of skin sensation

377

2340

1.63

17.58

1.4

1.3

23.12

26.35

u/l

1.18

306

1917

Complications of labour and delivery

934

3802

1.38

17.56

1.3

1.4

27.37

27.99

u/l

0.21

784

3112

Migraine without aura and triptan purchases

333

2013

1.68

17.42

1.5

1.4

22.40

23.82

u/l

0.37

273

1663

Gastroduodenal ulcer

135

601

2.25

17.33

1.4

1.3

27.46

30.98

u/l

0.64

111

495

Any operation in hilmo

4.55

17.29

1.5

1.3

17.44

26.02

u/l

0.82

Diseases of external ear

310

1839

1.70

17.17

1.4

21.74

26.29

u/l

1.73

226

1531

Disorders of lacrimal system

413

2639

1.58

16.96

1.5

1.3

29.09

31.17

u/l

0.57

335

2154

Gastric ulcer

100

395

2.55

16.89

1.3

1.4

28.53

31.22

u/l

0.36

326

Postpartum care and examination

385

1526

1.64

16.86

1.4

22.63

24.36

u/l

0.45

322

1216

Other disorders of skin and subcutaneous tissue

577

3617

1.47

16.85

1.4

1.3

26.73

29.95

u/l

1.59

479

2951

Allergic rhinitis

473

3092

1.53

16.84

1.4

23.13

23.32

u/l

0.04

372

2565

Other abnormal uterine and vaginal bleeding

225

856

1.89

16.83

1.4

1.3

28.30

37.01

u/l

3.37

191

698

Other disorders of adrenal gland

185

3.38

16.78

1.8

1.3

27.55

26.25

u/l

0.10

151

Dysphagia

186

951

1.97

16.77

1.4

1.3

31.76

30.49

u/l

0.19

151

780

Oral corticosteroids

1162

5352

1.32

16.68

1.4

1.3

26.29

25.59

u/l

0.30

972

4393

Trochanteric bursitis

142

662

2.17

16.52

1.4

31.35

36.33

u/l

0.93

114

542

TMD related operations

238

1329

1.82

16.48

1.6

1.3

24.84

26.39

u/l

0.33

204

1096

Other diseases of jaws

326

2.72

16.48

1.4

1.3

27.76

25.23

u/l

0.22

278

Cardiovascular diseases

1008

4096

1.35

16.43

1.4

1.3

22.10

21.48

u/l

0.25

846

3407

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

453

2985

1.53

16.32

1.4

19.11

22.84

u/l

1.99

347

2487

Concussion

524

3062

1.49

16.28

1.4

1.3

22.17

25.10

u/l

1.32

423

2571

Suicide or other Intentional self-harm

327

2000

1.65

16.21

1.4

21.20

25.01

u/l

1.41

239

1655

Dentofacial anomalies [including malocclusion]

366

2278

1.60

16.11

1.5

1.3

24.33

26.74

u/l

0.78

300

1913

Visual disturbances

442

2907

1.53

15.95

1.5

1.3

26.88

26.49

u/l

0.09

370

2382

Otitis externa

240

1359

1.78

15.80

1.4

1.3

21.65

25.55

u/l

1.13

178

1135

Polyuria

159

787

2.04

15.75

1.4

22.17

26.66

u/l

1.00

121

656

Dental pulpitis 4, only avohilmo

1200

4813

1.31

15.72

1.4

1.3

22.35

24.74

u/l

1.82

951

4025

Premenstrual syndrome

5.10

15.69

1.4

1.3

7.02

28.53

u/l

5.72

Inflammatory bowel disease treatment related agents

1273

5623

1.29

15.48

1.4

1.3

25.46

24.64

u/l

0.40

1072

4630

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

571

3960

1.44

15.47

1.4

1.3

27.23

28.80

u/l

0.52

467

3227

Hypo-osmolality and hyponatraemia

405

2.46

15.46

1.6

1.4

39.74

32.68

u/l

0.90

333

Lateral epicondylitis

171

877

1.98

15.43

1.4

26.63

34.92

u/l

2.54

134

716

Adrenocortical insufficiency

146

3.59

15.38

1.8

1.3

28.48

28.84

u/l

0.02

118

Kela-code for severe mental illness

414

2709

1.54

15.35

1.5

1.3

20.54

24.83

u/l

2.20

320

2236

Atopic dermatitis

797

5004

1.37

15.34

1.4

1.3

20.79

24.77

u/l

3.15

645

4146

Cervical disc disorders

299

1811

1.66

15.33

1.5

1.3

32.05

34.61

u/l

0.61

236

1475

Alcohol use disorder, ICD-based

333

2075

1.61

15.24

1.4

22.77

24.43

u/l

0.41

257

1721

Deforming dorsopathies

273

1626

1.69

14.98

1.4

28.01

28.71

u/l

0.12

215

1340

FESS (DNB20)

146

717

2.07

14.90

1.4

24.76

26.70

u/l

0.28

118

591

Autoimmune diseases related-to ILD

891

5893

1.34

14.85

1.4

1.3

25.54

25.61

u/l

0.02

724

4870

Soft tissue disorders related to use, overuse and pressure

220

1238

1.79

14.78

1.4

29.79

32.58

u/l

0.56

181

1020

Other shoulder lesions

118

536

2.24

14.74

1.5

1.4

25.45

29.78

u/l

0.74

448

Spondylolisthesis/Spondylolysis

160

815

1.98

14.68

1.4

1.3

32.23

34.69

u/l

0.39

127

663

Other disorders of fluid, electrolyte and acid-base balance

180

917

1.90

14.68

1.6

1.4

31.88

29.80

u/l

0.28

142

750

Complications associated with artificial fertilization

142

3.63

14.67

1.4

1.3

8.96

26.20

u/l

6.34

122

Benign neoplasm: Sigmoid colon

369

2.48

14.62

1.5

1.3

28.32

33.49

u/l

0.76

259

Cough

379

2361

1.55

14.48

1.4

1.3

28.11

29.49

u/l

0.33

311

1945

Artrosis, including avohilmo

945

3905

1.33

14.47

1.4

1.3

28.57

28.50

u/l

0.02

742

3233

Mental and behavioural disorders due to alcohol, excluding acute intoxication

347

2210

1.58

14.43

1.4

23.02

24.61

u/l

0.39

264

1831

Benign neoplasm: Colon

262

1181

1.71

14.36

1.5

1.3

32.20

33.47

u/l

0.22

209

881

Emotionally unstable personality disorder

228

1314

1.77

14.32

1.5

1.3

20.04

20.39

u/l

0.06

174

1102

Dental pulpitis 1, only avohilmo

1191

4843

1.29

14.14

1.4

1.3

22.47

24.74

u/l

1.67

944

4050

Acetic acid derivatives and related substances

259

777

1.75

14.14

1.4

17.73

21.98

u/l

1.47

218

647

Cerebral cysts

306

2.64

14.11

1.4

19.42

20.38

u/l

0.09

257

Pleural effusion

288

2.66

14.05

1.3

1.4

23.72

28.30

u/l

0.66

232

Migraine with aura

380

2495

1.54

14.02

1.5

1.3

19.17

25.04

u/l

3.52

315

2072

Ethmoidectomy

147

741

2.01

13.99

1.4

24.60

26.70

u/l

0.32

119

612

Chronic rhinitis, nasopharyngitis and pharyngitis

349

2248

1.56

13.97

1.4

1.3

24.81

29.32

u/l

1.82

274

1851

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

834

5129

1.34

13.71

1.4

1.3

25.33

27.21

u/l

0.88

690

4215

Malignant neoplasm of breast, HER-negative

168

891

1.90

13.68

1.3

1.4

37.17

38.58

u/l

0.19

156

692

Other diseases of the digestive system

179

970

1.86

13.61

1.4

1.3

20.09

26.65

u/l

2.43

147

794

COPD (mode)

121

446

2.16

13.58

1.3

24.92

31.71

u/l

1.49

368

Eating disorder

196

1100

1.82

13.53

1.5

1.4

13.34

16.20

u/l

1.02

171

946

Primary ovarian failure

176

3.24

13.48

2.0

1.4

43.95

24.43

u/l

3.92

148

Covid-19 suspected case

305

1924

1.60

13.47

1.3

1.4

24.74

22.21

u/l

0.68

252

1602

Primary_lymphoid and hematopoietic malignant neoplasms

116

542

2.15

13.42

1.4

1.3

31.56

27.84

u/l

0.52

100

402

Mouth breathing

334

2148

1.56

13.39

1.3

1.4

22.81

28.51

u/l

2.69

282

1766

Dental caries 3 and operation codes

854

3285

1.34

13.34

1.4

1.3

25.70

26.26

u/l

0.19

701

2737

Assault

166

887

1.90

13.32

1.4

19.67

20.63

u/l

0.16

126

750

Other postsurgical states

246

2.77

13.27

1.4

24.25

27.00

u/l

0.30

205

Preterm labour and delivery

400

2690

1.50

13.21

1.3

1.4

30.31

32.16

u/l

0.48

328

2165

Other medical care

284

1723

1.62

13.18

1.5

1.3

27.37

26.34

u/l

0.21

248

1403

Hyperkinetic disorders, excluding more controls

160

825

1.92

13.16

1.5

1.3

12.13

14.52

u/l

0.61

118

718

Personal history of malignant neoplasm

167

3.20

13.13

1.7

1.4

31.93

29.53

u/l

0.19

139

Other otitis externa (chronic)

294

2.60

13.08

1.5

1.4

21.90

25.94

u/l

0.48

243

Nausea and vomiting

228

1321

1.71

13.05

1.5

1.4

21.25

24.65

u/l

0.93

194

1097

Temporomandibular joint disorders, including avohilmo

623

4544

1.38

12.99

1.5

1.3

25.45

24.32

u/l

0.38

519

3740

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

100

449

2.26

12.91

1.3

1.4

27.36

27.04

u/l

0.03

374

Mental and behavioural disorders due to alcohol

405

2665

1.49

12.83

1.4

22.35

24.17

u/l

0.54

308

2210

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

523

3712

1.42

12.81

1.4

1.3

26.38

29.23

u/l

1.15

425

3020

Assault by bodily force

103

472

2.22

12.69

1.5

1.4

19.33

20.16

u/l

0.10

400

Finngen Rheumatological endpoints

1158

5209

1.27

12.67

1.4

1.3

25.73

24.58

u/l

0.55

931

4333

Postmenopausal bleeding

250

813

1.70

12.66

1.4

1.3

43.46

46.30

u/l

0.61

205

671

Dyshidrosis [pompholyx]

112

3.76

12.64

1.3

1.4

25.67

19.34

u/l

0.54

Mental and behavioural disorders due to sedatives or hypnotics

360

2.40

12.59

1.3

1.4

22.94

21.77

u/l

0.11

299

Diseases of the digestive system

319

2056

1.56

12.59

1.4

23.08

26.60

u/l

1.14

262

1692

Pollen allergy

300

1898

1.58

12.54

1.4

18.63

19.79

u/l

0.27

232

1592

Unspecified mental disorder

460

3208

1.44

12.51

1.5

1.3

21.42

24.41

u/l

1.26

354

2640

Alcohol use disorder, Swedish definition

427

2725

1.46

12.37

1.4

22.12

25.10

u/l

1.15

328

2244

Urticaria and erythema

445

3094

1.45

12.35

1.4

1.3

22.89

26.28

u/l

1.34

366

2536

Exposure to other specified factors

769

5471

1.32

12.28

1.4

21.97

24.94

u/l

1.97

606

4536

Sleep disorders

269

1685

1.61

12.27

1.5

1.4

20.12

23.34

u/l

1.01

223

1389

Dissociative [conversion] disorders

281

2.60

12.25

1.3

21.27

17.16

u/l

0.46

243

Dental operations

506

1811

1.44

12.24

1.4

1.3

27.53

27.98

u/l

0.10

414

1511

Early lumbar disc prolapse, operated

160

872

1.86

12.17

1.6

1.4

17.72

24.91

u/l

2.63

133

727

Dental caries 1 and operation codes

781

3008

1.34

12.14

1.4

1.3

27.13

26.68

u/l

0.13

636

2506

Viral hepatitis, IBD co-morbidity

264

2.62

12.11

1.4

1.3

16.26

26.77

u/l

1.78

227

Migraine with aura and triptan purchases

279

1774

1.60

12.05

1.5

1.4

19.36

23.19

u/l

1.34

225

1475

Eating disorders

202

1183

1.74

12.04

1.5

1.4

13.15

16.67

u/l

1.49

176

1018

Obsessive-compulsive disorder

108

516

2.13

12.03

1.3

13.19

15.73

u/l

0.49

450

Other and unspecified polyneuropathies, also in other diseases

104

488

2.15

11.99

1.5

1.4

36.41

28.25

u/l

1.27

404

Spinal stenosis

255

1228

1.63

11.98

1.4

1.3

32.99

37.31

u/l

1.20

208

985

Allergic contact dermatitis

194

1127

1.75

11.89

1.4

1.3

27.25

28.61

u/l

0.22

155

942

Lesion of ulnar nerve

121

604

2.02

11.88

1.5

1.4

26.99

31.00

u/l

0.70

495

Benign neoplasm: Colon

264

1620

1.60

11.88

1.5

1.3

32.07

34.18

u/l

0.43

210

1313

Cardiovascular diseases (excluding rheumatic etc)

1004

4540

1.28

11.82

1.4

1.3

24.86

23.25

u/l

0.85

834

3770

Elevated blood glucose level

327

2.42

11.82

1.4

17.02

24.08

u/l

1.26

267

Otitis externa, unspecified

129

661

1.98

11.81

1.4

20.28

24.19

u/l

0.80

105

554

False labour

693

3257

1.35

11.77

1.4

23.19

26.63

u/l

1.94

574

2691

Family history of malignant neoplasm

167

933

1.82

11.76

1.4

30.95

27.04

u/l

0.68

152

776

Inflammatory disease of uterus

253

1582

1.62

11.75

1.4

22.41

24.86

u/l

0.59

199

1318

Osteopathies and chondropathies

443

2941

1.44

11.73

1.5

1.3

28.86

28.76

u/l

0.02

361

2404

Spontaneous abortion

719

3683

1.34

11.70

1.3

25.58

27.45

u/l

0.76

594

3053

All influenza

195

1137

1.73

11.68

1.3

24.66

23.48

u/l

0.19

166

945

Other pleural conditions

189

2.88

11.68

1.5

1.4

22.42

27.97

u/l

0.76

152

Mental and behavioural disorders due to opioids

235

2.71

11.67

1.5

1.4

15.76

14.62

u/l

0.13

200

Arthrosis

737

3044

1.34

11.62

1.4

1.3

30.03

30.33

u/l

0.08

585

2512

Polyneuropathies and other disorders of the peripheral nervous system

123

622

1.99

11.61

1.5

1.4

36.04

28.41

u/l

1.31

101

511

Benign neoplasm: Caecum

180

2.92

11.48

1.3

27.34

32.87

u/l

0.55

130

Disorders of mineral metabolism

295

2.47

11.47

1.4

34.75

28.30

u/l

0.60

241

Other noninflammatory disorders of uterus, except cervix

179

687

1.79

11.40

1.4

1.3

32.44

43.46

u/l

3.74

150

569

Vocal cord dysfunction

148

743

1.87

11.37

1.5

1.3

27.48

32.23

u/l

0.87

117

618

Corns and callosities

249

2.61

11.37

1.3

22.91

29.30

u/l

0.76

203

Other symptoms and signs involving cognitive functions and awareness

261

1545

1.59

11.36

1.4

25.44

30.27

u/l

1.52

198

1272

Preparation and fitting of bite rail to mouth

182

1054

1.75

11.30

1.6

1.4

23.94

26.74

u/l

0.62

158

876

Fenamates

166

617

1.83

11.28

1.4

1.3

24.74

25.92

u/l

0.16

132

506

Nonorganic sleeping disorders

247

1549

1.61

11.27

1.5

1.4

20.14

22.99

u/l

0.77

203

1285

Rheumatism, unspecified

145

785

1.87

11.24

1.4

27.29

36.50

u/l

2.60

114

646

Endometriosis diagnosis and infertility diagnosis occurring together

219

1339

1.67

11.23

1.4

18.87

26.75

u/l

3.89

193

1100

Asthma, including avohilmo

1242

5827

1.24

11.22

1.4

1.3

22.58

25.22

u/l

2.33

1016

4830

Inflammatory disease of cervix uteri

348

2.34

11.22

1.3

1.4

28.12

33.98

u/l

0.81

293

Other disorders of the genitourinary system

102

489

2.11

11.20

1.5

1.4

32.60

37.24

u/l

0.61

396

Alcohol dependence

183

1063

1.73

11.14

1.4

23.10

24.88

u/l

0.33

144

884

Use of disulfiram, acamprosate or naltrexone

374

2.28

11.11

1.3

1.4

24.10

25.20

u/l

0.11

299

Other and unspecified drugs and medicaments

407

2.22

11.06

1.3

1.4

28.59

26.37

u/l

0.23

336

Benign neoplasm of colon, rectum, anus and anal canal

317

1491

1.52

10.96

1.5

1.3

32.67

32.90

u/l

0.04

255

1127

Misadventures to patients during surgical and medical care

135

721

1.89

10.93

1.4

26.08

28.70

u/l

0.43

118

587

Wide developmental disorders, excluding more controls

147

3.10

10.87

1.4

9.22

11.97

u/l

0.35

135

Gingivitis and periodontal diseases

866

3464

1.29

10.83

1.4

1.3

26.94

26.15

u/l

0.27

687

2908

Urticaria

379

2627

1.45

10.80

1.4

1.3

21.97

25.74

u/l

1.44

309

2170

Persons encountering health services for specific procedures and health care

1140

5682

1.25

10.77

1.4

1.3

28.27

24.81

u/l

2.84

957

4674

Dyspnoea

817

4860

1.29

10.73

1.4

1.3

28.11

27.08

u/l

0.37

673

3996

Excessive attrition of teeth

507

1977

1.40

10.69

1.4

1.3

22.72

23.83

u/l

0.31

394

1659

Superficial injury of head

195

1170

1.68

10.57

1.4

21.23

25.10

u/l

1.13

156

978

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

210

1285

1.65

10.57

1.4

21.08

33.32

u/l

8.52

165

1038

Follow-up examination after treatment for malignant neoplasms

217

2.65

10.55

1.5

1.3

31.45

35.59

u/l

0.32

193

Postpartum haemorrhage due to anatomy

243

1550

1.60

10.53

1.3

1.4

17.33

19.87

u/l

0.72

200

1300

Early onset COPD, excluding more controls

110

554

2.00

10.52

1.3

24.71

32.45

u/l

1.63

462

Implicit Sepsis

518

2938

1.37

10.51

1.3

1.4

24.98

27.07

u/l

0.72

416

2425

Subjective visual disturbances

230

1442

1.61

10.50

1.5

1.4

27.70

26.22

u/l

0.26

188

1191

Autism spe, excluding more controls

121

3.32

10.50

1.4

10.44

12.31

u/l

0.18

112

Hypertrophic scar

372

2.25

10.48

1.5

1.4

19.25

21.99

u/l

0.42

316

Chronic sinusitis

439

3138

1.41

10.46

1.4

1.3

27.73

28.23

u/l

0.11

354

2591

Other follicular disorders

470

2.10

10.46

1.4

22.86

22.97

u/l

0.01

402

Other complications of surgical and medical care, not elsewhere classified

106

530

2.03

10.46

1.3

1.4

34.19

27.01

u/l

1.16

443

Leiomyoma of uterus

704

3016

1.32

10.42

1.3

31.01

29.04

u/l

0.78

587

2358

Special screening examination for other diseases and disorders

315

2.34

10.39

1.4

1.3

21.62

24.29

u/l

0.32

280

Other and unspecified urticaria

248

1589

1.58

10.37

1.4

22.25

25.35

u/l

0.78

202

1322

Endometriosis of rectovaginal septum and vagina

425

2.15

10.35

1.5

1.3

33.05

32.18

u/l

0.07

354

Disorders of calcium metabolism

214

2.66

10.35

1.4

33.30

28.98

u/l

0.30

179

Weight loss

335

2.29

10.32

1.5

1.4

24.68

24.03

u/l

0.06

279

Propionic acid derivatives

267

851

1.58

10.20

1.4

16.71

20.67

u/l

1.54

232

716

Infections of the skin and subcutaneous tissue

548

4060

1.35

10.20

1.5

1.3

22.92

24.08

u/l

0.40

455

3351

Post-traumatic stress disorder

146

820

1.81

10.19

1.5

1.3

18.05

18.57

u/l

0.08

125

697

Hypertrophic disorders of skin

403

2.18

10.15

1.5

1.4

20.05

22.43

u/l

0.35

343

Other disorders of patella

234

1488

1.59

10.12

1.4

1.3

28.89

27.89

u/l

0.15

182

1228

Other sexually transmitted chlamydial diseases

125

672

1.90

10.07

1.2

1.4

12.03

13.98

u/l

0.45

583

Other skin changes

121

641

1.90

10.06

1.6

1.3

28.88

28.85

u/l

0.00

109

529

Flat foot [pes planus] (acquired)

464

2.07

10.00

1.5

1.3

32.83

36.68

u/l

0.46

391

Injuries to the ankle and foot

811

5807

1.28

9.99

1.4

22.40

24.07

u/l

0.78

658

4813

Disorders of vestibular function (Vertigo)

343

2350

1.46

9.99

1.4

1.3

30.75

32.38

u/l

0.37

282

1908

Schizophrenia, schizotypal and delusional disorders

329

2254

1.47

9.98

1.5

1.4

21.63

24.23

u/l

0.82

254

1864

Deviated nasal septum

226

1427

1.59

9.97

1.3

22.88

26.84

u/l

1.08

187

1184

GI-bleeding

163

947

1.73

9.95

1.4

19.32

26.35

u/l

2.94

133

777

Other disorders of optic [2nd] nerve and visual pathways

291

2.38

9.94

1.8

1.4

17.64

23.34

u/l

0.99

239

Psychotic depression

285

2.38

9.90

1.6

1.3

17.45

25.28

u/l

1.40

243

Atypical facial pain

286

2.39

9.88

1.5

1.4

27.49

30.78

u/l

0.36

241

Other diseases of anus and rectum

203

1252

1.63

9.86

1.4

1.3

27.50

28.78

u/l

0.20

162

1045

Chronic periodontitis, complicated

273

2.41

9.86

1.3

1.4

32.10

29.51

u/l

0.25

215

Social phobias

126

684

1.87

9.81

1.4

1.3

18.86

17.04

u/l

0.27

587

Abnormal findings in secretions and smears from cervix uteri vagina vulva

805

4975

1.28

9.79

1.4

1.3

25.48

27.63

u/l

1.05

668

4089

Schizophrenia or delusion

328

2255

1.46

9.78

1.5

1.4

21.66

24.20

u/l

0.80

255

1862

Dental caries 3

738

2904

1.30

9.74

1.4

1.3

25.80

27.12

u/l

0.50

610

2446

Haemorrhage in early pregnancy

484

3481

1.37

9.73

1.4

1.3

23.71

28.04

u/l

2.42

415

2840

Postprocedural disorders of nervous system

131

724

1.85

9.69

1.5

1.4

19.02

23.45

u/l

1.04

111

609

Monoamine oxidase A inhibitors

105

538

1.97

9.67

1.4

1.3

25.51

31.66

u/l

1.04

436

Diaphragmatic hernia

228

1455

1.57

9.65

1.5

1.3

34.23

33.51

u/l

0.10

185

1192

Use of pramipexole

143

809

1.78

9.63

1.3

28.33

32.58

u/l

0.83

118

651

Diseases of the eye and adnexa

1088

4403

1.24

9.63

1.4

1.3

22.90

23.56

u/l

0.27

896

3672

Sacroiliitis, not elsewhere classified

386

2.17

9.61

1.3

1.4

19.82

22.62

u/l

0.37

329

Non-invasive ventilation

1068

0.39

9.50

1.2

1.3

29.25

29.05

u/l

0.01

890

Parodontitis and operation codes

739

4481

1.29

9.48

1.3

1.4

30.47

30.03

u/l

0.12

568

3669

Other noninflammatory disorders of vulva and perineum

102

522

1.98

9.47

1.3

28.76

35.22

u/l

1.27

427

Pain in throat and chest

878

4258

1.26

9.45

1.4

1.3

26.33

26.03

u/l

0.10

717

3515

Direct fill therapy

130

720

1.82

9.44

1.5

1.4

24.25

24.37

u/l

0.01

105

609

Intracranial trauma

573

3230

1.33

9.37

1.4

1.3

21.92

25.22

u/l

1.67

460

2710

Anorexia (incl.atypical)

107

561

1.94

9.32

1.7

1.4

9.05

17.09

u/l

5.02

486

479

3166

1.36

9.31

1.4

1.3

21.91

24.26

u/l

0.91

368

2618

Intracranial injury

467

3329

1.36

9.20

1.4

18.92

23.50

u/l

3.04

373

2760

Benign neoplasm of colon, rectum, anus and anal canal

321

2002

1.45

9.16

1.5

1.3

32.73

34.07

u/l

0.27

257

1623

Acute suppurative otitis media

369

2452

1.42

9.10

1.4

14.26

16.34

u/l

1.00

301

2072

Benign neoplasm: Rectum, anus and anal canal

426

2.05

9.08

1.5

1.3

35.55

33.83

u/l

0.15

303

Hypertensive diseases (excluding secondary)

734

3329

1.29

9.05

1.4

29.28

29.27

u/l

0.00

581

2727

Benign neoplasm of mouth and pharynx

362

2.15

8.98

1.3

1.4

24.22

27.26

u/l

0.36

270

Maternal care related to the fetus and amniotic cavity and possible delivery problems

773

3582

1.28

8.98

1.4

1.3

26.64

28.48

u/l

0.76

639

2961

Thyroiditis, ILD-related definition

152

896

1.72

8.97

1.5

1.4

27.81

25.19

u/l

0.41

123

742

Ovarian hyperstimulation (induction)

185

2.72

8.96

1.4

1.5

9.13

23.03

u/l

4.90

157

Maltreatment syndromes

404

2.10

8.94

1.6

1.4

14.84

19.63

u/l

0.99

348

Epilepsy

249

1646

1.52

8.92

1.4

1.3

22.83

27.22

u/l

1.49

203

1366

Ganglion

244

1615

1.52

8.86

1.3

1.4

27.12

29.47

u/l

0.51

196

1333

Insomnia

199

1261

1.59

8.82

1.5

1.4

20.07

23.95

u/l

1.10

172

1042

Spondylosis

363

2214

1.41

8.82

1.4

1.3

34.37

35.77

u/l

0.32

282

1798

436

2940

1.37

8.81

1.4

22.04

24.12

u/l

0.70

335

2429

Torsion of ovary, ovarian pedicle and fallopian tube

146

2.89

8.80

1.6

1.3

24.24

28.77

u/l

0.37

126

Deep endometriosis

145

850

1.73

8.78

1.4

27.39

24.20

u/l

0.51

121

726

Single delivery by caesarean section

385

1589

1.42

8.78

1.4

20.81

22.37

u/l

0.45

337

1310

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

478

3568

1.35

8.76

1.4

22.05

22.80

u/l

0.20

386

2961

Perineal laceration during delivery

339

2137

1.43

8.75

1.3

1.4

16.34

18.51

u/l

0.77

290

1768

Failed induction of labour

132

757

1.79

8.75

1.3

1.4

14.38

19.52

u/l

1.35

109

628

Benign lipomatous neoplasm

202

1285

1.58

8.74

1.4

1.3

30.96

30.77

u/l

0.03

166

985

Dental operations, only avohilmo

524

2001

1.35

8.72

1.4

1.3

27.83

28.22

u/l

0.09

422

1679

Internal derangement of knee

349

2475

1.41

8.70

1.4

1.3

28.88

27.66

u/l

0.26

278

2045

Abnormal weight loss

283

2.29

8.69

1.6

1.4

27.32

24.49

u/l

0.28

235

Other and unspecified nerve root and plexus disorders, also in other diseases

169

1032

1.65

8.69

1.4

1.3

25.65

30.53

u/l

1.14

131

853

Benign neoplasm: Sigmoid colon

461

1.99

8.68

1.5

1.3

28.32

34.37

u/l

1.02

372

Dermatitis due to substances taken internally

265

2.34

8.67

1.3

1.4

29.44

24.38

u/l

0.50

218

Fitting and adjustment of other devices

160

893

1.67

8.65

1.3

26.63

30.88

u/l

0.94

139

708

Hypertrophy of breast in women and men

277

1894

1.48

8.64

1.3

1.4

28.67

32.83

u/l

1.27

227

1530

Brachial plexus disorders

136

788

1.75

8.59

1.5

1.4

24.49

28.92

u/l

0.84

114

649

Codes for special purposes

494

3721

1.33

8.59

1.3

1.4

24.19

22.96

u/l

0.36

416

3080

Anomalies of dental arch relationship, including avohilmo

244

1458

1.52

8.56

1.5

1.4

19.08

21.02

u/l

0.49

193

1237

Iron deficiency anaemia

329

2300

1.42

8.54

1.3

1.4

26.82

27.72

u/l

0.17

268

1897

Autism

143

2.87

8.52

1.4

10.23

11.83

u/l

0.16

125

Provisional assignment of new diseases of uncertain etiology

493

3718

1.33

8.50

1.3

1.4

24.19

22.97

u/l

0.35

416

3077

Other specified/unspecified soft tissue disorders

165

2.70

8.50

1.6

1.4

25.49

30.44

u/l

0.41

140

Other eating disorders

103

552

1.91

8.48

1.6

1.4

13.32

15.62

u/l

0.45

482

Disorders of puberty, all

101

3.27

8.45

2.3

1.4

8.80

11.02

u/l

0.34

Benign neoplasm: Transverse colon

171

2.65

8.44

1.2

1.3

33.90

31.26

u/l

0.20

122

Diseases of inner ear

384

2732

1.38

8.39

1.4

1.3

30.38

32.19

u/l

0.48

317

2222

Benign neoplasm: Rectum

367

2.08

8.28

1.5

1.3

34.86

33.68

u/l

0.09

259

Unspecified misadventure during surgical and medical care

215

2.46

8.26

1.5

1.4

26.47

26.00

u/l

0.03

175

Mycoses

220

1447

1.53

8.25

1.4

24.30

25.75

u/l

0.27

169

1201

Other diseases of pleura

187

1045

1.59

8.24

1.4

1.3

23.63

28.82

u/l

1.56

155

839

Melanocytic naevi

291

2026

1.45

8.22

1.4

1.3

24.16

24.10

u/l

0.01

247

1607

Fibroblastic disorders

148

886

1.68

8.21

1.4

30.04

33.07

u/l

0.48

113

729

Syncope and collapse

287

1762

1.45

8.13

1.3

23.56

24.47

u/l

0.18

233

1457

All influenza (not pneumonia)

122

695

1.77

8.12

1.3

1.4

22.57

21.27

u/l

0.17

106

585

Other and unspecified local infections of skin and subcutaneous tissue

425

2.00

8.11

1.4

21.41

24.17

u/l

0.38

351

Disturbance of activity and attention

157

948

1.66

8.10

1.5

1.4

12.10

14.63

u/l

0.64

115

828

Other systemic involvement of connective tissue (FG)

229

1516

1.51

8.07

1.4

26.76

29.72

u/l

0.66

199

1263

Benign neoplasm: Caecum

217

2.42

8.06

1.3

1.4

27.34

32.96

u/l

0.60

177

Osteoporosis

109

573

1.82

8.01

1.6

1.3

42.91

36.94

u/l

0.66

457

Lesion of lateral popliteal nerve

159

2.68

7.99

1.3

1.4

21.36

27.61

u/l

0.56

128

Dizziness and giddiness

648

4134

1.28

7.97

1.4

1.3

25.28

28.83

u/l

2.02

532

3403

Dental pulpitis 2

583

2292

1.31

7.96

1.4

1.3

25.56

27.16

u/l

0.53

481

1953

Early lumbar disc prolapse operation

162

1005

1.63

7.94

1.6

1.4

17.77

23.10

u/l

1.71

134

835

Car occupant injured in other and unspecified transport accidents

216

1429

1.52

7.93

1.3

1.4

18.62

21.94

u/l

1.02

171

1191

Convulsions, not elsewhere classified

196

1252

1.55

7.92

1.4

1.3

19.74

20.06

u/l

0.06

154

1041

Uterine polyps

103

563

1.85

7.91

1.4

34.47

41.56

u/l

1.26

464

Nutritional anaemias

359

2537

1.38

7.89

1.3

26.72

28.19

u/l

0.33

292

2080

Other benign neoplasms of skin

247

1647

1.48

7.87

1.4

1.3

31.57

29.47

u/l

0.40

194

1284

Other local infections of skin and subcutaneous tissue

451

1.95

7.85

1.4

22.51

24.43

u/l

0.23

372

Abnormal results of function studies

376

2.04

7.83

1.4

19.86

26.91

u/l

1.11

309

Hernia of abdominal wall

315

2244

1.41

7.82

1.3

1.4

23.64

27.75

u/l

1.56

253

1863

Wide developmental disorders

179

2.57

7.80

1.4

9.22

11.69

u/l

0.31

157

Thyrotoxicosis, other and/or unspecified

206

1354

1.53

7.80

1.4

1.3

29.57

29.72

u/l

0.02

168

1115

Hyperkinetic disorders

161

988

1.63

7.80

1.5

1.4

12.03

14.49

u/l

0.65

119

862

Impotence

3.80

7.80

1.3

1.2

12.10

13.47

u/l

0.12

Implicit viral Sepsis

118

675

1.76

7.75

1.4

24.88

24.23

u/l

0.07

100

567

Diseases of salivary glands

168

1056

1.60

7.73

1.3

30.89

29.78

u/l

0.16

137

896

Dental pulpitis 2, only avohilmo

593

2346

1.30

7.71

1.3

25.59

27.34

u/l

0.61

488

1995

Asthma, hospital admission 2, infections

525

3985

1.30

7.69

1.4

21.44

25.85

u/l

3.03

434

3287

Asthma-related infections

525

3985

1.30

7.69

1.4

21.44

25.85

u/l

3.03

434

3287

Benign neoplasm of other and ill-defined parts of digestive system

105

582

1.82

7.68

1.5

1.3

31.79

31.41

u/l

0.04

431

Other peripheral vertigo

359

2.06

7.65

1.5

1.4

33.51

32.19

u/l

0.10

302

Viral Sepsis

118

678

1.75

7.64

1.4

24.88

24.24

u/l

0.07

100

570

Dental caries 3, only avohilmo

733

2981

1.26

7.61

1.4

1.3

25.97

26.94

u/l

0.34

605

2507

Other noninfective gastroenteritis and colitis

213

1416

1.51

7.60

1.5

1.3

26.90

24.76

u/l

0.42

172

1172

Benign neoplasm: Stomach

261

2.24

7.60

1.4

33.15

34.86

u/l

0.14

190

Other specified/unspecified dorsopathies

152

2.68

7.59

1.4

1.3

34.41

30.38

u/l

0.25

131

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

285

1826

1.43

7.57

1.4

12.19

13.59

u/l

0.46

221

1583

Correction of physiology of bite - very demanding therapy visit

213

2.41

7.55

1.8

1.4

24.88

23.91

u/l

0.08

179

Open wound of wrist and hand

381

2790

1.36

7.54

1.4

22.72

22.59

u/l

0.03

311

2307

Unspecified haematuria

197

1100

1.54

7.53

1.4

1.3

26.50

26.32

u/l

0.02

167

904

Vitamin deficiency

194

2.46

7.53

1.6

1.3

25.39

24.93

u/l

0.03

157

Vitamin deficiency, wide

194

2.46

7.53

1.6

1.3

25.39

24.93

u/l

0.03

157

Benign neoplasm: Ascending colon

231

2.31

7.47

1.6

1.3

37.13

34.85

u/l

0.15

161

Fissure and fistula of anal and rectal regions

199

1314

1.52

7.38

1.4

1.3

27.86

28.18

u/l

0.04

159

1101

Dental caries, including avohilmo

647

2602

1.27

7.36

1.3

26.55

27.68

u/l

0.36

532

2193

Other disorders of urethra and urinary system

759

4596

1.24

7.33

1.4

1.3

26.37

27.22

u/l

0.29

606

3811

Chronic periodontitis, including avohilmo

768

4596

1.24

7.32

1.3

30.36

29.70

u/l

0.21

589

3773

Injuries to the neck

241

1659

1.46

7.30

1.4

20.62

22.09

u/l

0.34

202

1380

Benign neoplasm of other and unspecified female genital organs

185

2.47

7.29

1.4

1.3

28.57

28.61

u/l

0.00

140

Plantar fascial fibromatosis

102

571

1.81

7.29

1.4

32.46

35.18

u/l

0.33

470

Other epidermal thickening

173

2.53

7.28

1.5

1.4

26.25

24.19

u/l

0.14

143

Postpartum haemorrhage

483

3235

1.31

7.28

1.3

1.4

22.03

26.46

u/l

2.34

399

2628

Dental caries 1

647

2606

1.27

7.27

1.3

26.55

27.66

u/l

0.36

532

2197

Anti-inflammatory and antirheumatic products, non-steroids

250

851

1.48

7.26

1.4

16.69

20.67

u/l

1.50

218

716

Parodontitis or operation codes

772

4607

1.24

7.24

1.3

30.20

29.69

u/l

0.15

593

3781

Parodontitis

771

4605

1.24

7.23

1.3

30.23

29.70

u/l

0.16

592

3779

Primary_lymphoid and hematopoietic malignant neoplasms

116

675

1.73

7.20

1.4

31.56

28.04

u/l

0.51

100

558

Focal epilepsy, strict definition

147

912

1.62

7.16

1.4

21.87

25.29

u/l

0.75

122

766

Transport accidents

498

3413

1.30

7.15

1.4

18.57

23.93

u/l

4.20

401

2872

Focal epilepsy, mode (most common among epilepsy diagnosis)

145

898

1.63

7.13

1.4

22.64

25.32

u/l

0.52

120

749

Alcohol abuse, main dg, excluding more controls

112

648

1.74

7.12

1.3

21.51

21.19

u/l

0.03

550

Other and unspecified iron deficiency

258

1806

1.44

7.12

1.3

26.20

27.09

u/l

0.15

212

1492

Autism spe

152

2.63

7.10

1.4

10.44

11.38

u/l

0.09

132

Spondylopathies

648

3125

1.26

7.07

1.4

1.3

30.27

31.25

u/l

0.30

522

2570

Enthesopathies of lower limb, excluding foot

200

1336

1.51

7.05

1.5

1.4

30.03

32.17

u/l

0.36

162

1084

Falls/tendency to fall

1272

5396

1.18

7.05

1.4

1.3

24.22

24.58

u/l

0.14

1003

4527

Other abnormal products of conception

649

3451

1.26

7.03

1.3

23.04

26.40

u/l

1.80

550

2849

Stomatitis and related lesions

427

1.92

7.01

1.4

1.3

21.59

23.73

u/l

0.27

364

Superficial injury of wrist and hand

211

1429

1.49

6.98

1.3

1.4

21.46

21.90

u/l

0.08

171

1196

Dislocation, sprain and strain of joints and ligaments at neck level

191

1269

1.52

6.96

1.4

1.3

20.54

21.55

u/l

0.19

159

1050

Diseases of middle ear and mastoid

671

4416

1.25

6.96

1.4

1.3

15.89

20.29

u/l

4.55

547

3698

Radial styloid tenosynovitis [de Quervain]

387

1.97

6.95

1.3

1.4

23.17

29.83

u/l

0.94

323

Radiculopathy

105

601

1.76

6.94

1.6

1.3

34.55

32.15

u/l

0.32

495

Other septicaemia

180

1156

1.53

6.94

1.5

1.3

33.88

26.79

u/l

1.65

144

944

Gonarthrosis

558

2500

1.28

6.92

1.4

1.3

34.12

33.81

u/l

0.07

435

2053

Infections, IBD-co-morbidities

133

584

1.67

6.91

1.4

1.3

28.36

32.19

u/l

0.56

110

490

Injury, poisoning and certain other consequences of external causes

668

2668

1.26

6.86

1.3

23.76

24.44

u/l

0.20

550

2238

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

417

1.92

6.83

1.4

14.55

17.38

u/l

0.56

355

Systemic connective tissue disorders

291

2098

1.39

6.82

1.4

27.72

29.58

u/l

0.40

244

1724

Agranulocytosis

488

1.84

6.82

1.4

32.63

29.35

u/l

0.41

401

Schizoaffective disorder

489

1.84

6.81

1.4

19.61

24.51

u/l

0.81

404

Cellulitis

165

1066

1.56

6.80

1.5

1.3

24.09

24.92

u/l

0.13

133

878

Candidiasis

135

835

1.63

6.73

1.3

1.4

26.51

25.76

u/l

0.08

101

703

Injuries to the wrist and hand

999

6064

1.20

6.72

1.4

1.3

23.24

25.06

u/l

1.02

817

5022

Algoneurodystrophy

231

2.26

6.71

1.7

1.4

29.40

24.60

u/l

0.47

189

In situ neoplasms

262

1773

1.42

6.70

1.4

1.3

26.67

26.65

u/l

0.00

216

1396

Nontoxic single thyroid nodule

351

1.99

6.66

1.2

1.4

23.46

32.25

u/l

1.15

293

Dental caries 1, only avohilmo

657

2685

1.25

6.61

1.3

26.44

27.50

u/l

0.34

543

2260

437

3339

1.30

6.59

1.4

21.90

24.79

u/l

1.29

364

2765

Focal epilepsy

166

1082

1.54

6.58

1.4

1.3

21.64

25.01

u/l

0.81

138

901

Diplopia

552

1.77

6.58

1.4

28.27

26.38

u/l

0.21

456

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

238

2.20

6.58

1.4

1.3

32.34

30.91

u/l

0.11

169

Care involving use of rehabilitation procedures

541

4062

1.27

6.57

1.5

1.3

27.86

28.68

u/l

0.23

454

3281

Acne

148

943

1.59

6.55

1.4

10.26

14.85

u/l

2.27

130

817

Other diseases of lip and oral mucosa

111

657

1.70

6.54

1.4

1.3

35.45

30.51

u/l

0.76

550

Congenital malformations, deformations and chromosomal abnormalities

706

5517

1.23

6.52

1.4

1.3

22.52

23.56

u/l

0.41

592

4554

Symptoms and signs involving cognition, perception, emotional state and behaviour

922

5387

1.20

6.52

1.4

1.3

25.64

27.05

u/l

0.64

747

4447

Other systemic involvement of connective tissue

232

1622

1.44

6.52

1.4

26.53

28.99

u/l

0.52

201

1335

Disorders of psychological development

132

757

1.63

6.51

1.5

1.4

10.04

12.37

u/l

0.69

107

667

Additional codes for the location of defect, injury or illness

253

2.16

6.50

1.3

1.4

27.52

24.17

u/l

0.27

208

Salpingitis and oophoritis

205

1403

1.47

6.49

1.5

1.3

36.11

36.03

u/l

0.01

157

1149

Disorders of optic nerve and visual pathways

107

630

1.72

6.48

1.6

1.4

19.80

24.42

u/l

1.01

524

Sequelae of injuries of head

221

2.25

6.47

1.1

1.4

18.59

22.44

u/l

0.45

181

Other diseases of blood and blood-forming organs, wide

157

1016

1.55

6.45

1.4

1.3

28.15

28.51

u/l

0.05

137

827

External causes of morbidity and mortality

808

3318

1.22

6.45

1.3

23.53

24.78

u/l

0.50

653

2809

Bell's palsy

541

1.77

6.44

1.5

1.4

28.38

28.87

u/l

0.05

449

Suppurative and unspecified otitis media

449

3083

1.30

6.43

1.4

14.38

17.60

u/l

2.25

366

2593

Hidradenitis suppurativa

275

2.12

6.42

1.3

1.4

23.89

23.01

u/l

0.09

230

Paracetamol of NSAID medication

167

537

1.57

6.42

1.5

1.4

16.19

19.91

u/l

0.97

147

450

Other and unspecified mononeuropathies, also in other diseases

3.02

6.41

1.3

46.37

29.91

u/l

0.71

Constipation

718

4192

1.23

6.40

1.5

1.3

27.09

30.39

u/l

1.78

559

3445

Other chronic obstructive pulmonary disease, including avohilmo

208

1183

1.47

6.36

1.3

27.41

32.41

u/l

1.47

171

947

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

309

2.03

6.34

1.1

1.4

30.92

31.86

u/l

0.08

226

Hypermobility syndrome

576

1.75

6.34

1.5

1.4

27.21

22.25

u/l

0.65

494

Other disorders of breast

165

1087

1.53

6.33

1.5

1.4

27.25

28.72

u/l

0.22

141

895

Disorders of tooth development and eruption

288

2.06

6.31

1.5

1.3

15.85

16.23

u/l

0.04

255

Mixed and other personality disorders

105

622

1.71

6.25

1.3

23.35

23.79

u/l

0.05

528

Disturbances of smell and taste

168

2.42

6.23

1.4

38.13

31.54

u/l

0.43

145

Other and unspecified tonsillitis

405

2636

1.31

6.21

1.4

15.65

17.22

u/l

0.60

333

2225

Trigger finger

119

730

1.64

6.16

1.3

1.4

33.67

34.27

u/l

0.06

602

Pediculosis, acariasis and other infestations

286

2.05

6.13

1.5

1.3

16.14

20.57

u/l

0.83

237

Benign neoplasm of mouth and pharynx

418

1.86

6.13

1.3

1.4

24.22

29.36

u/l

0.74

341

Septicaemia

202

1338

1.46

6.10

1.5

1.3

31.52

26.44

u/l

1.15

163

1099

Intestinal infectious diseases

903

5896

1.19

6.08

1.4

1.3

21.09

24.49

u/l

2.69

759

4872

Haemorrhage from respiratory passages

162

991

1.52

6.05

1.5

1.3

25.60

26.83

u/l

0.20

142

823

Other disorders of penis

122

2.64

6.05

1.4

1.3

7.90

11.40

u/l

0.77

Spontaneous rupture of synovium and tendon

267

2.08

6.04

1.3

1.4

31.50

35.16

u/l

0.33

222

Other bacterial diseases

735

4177

1.22

6.04

1.4

1.3

28.23

28.52

u/l

0.08

609

3402

Melanocytic naevi of trunk

107

643

1.68

6.02

1.4

1.3

22.00

23.53

u/l

0.20

509

Iron deficiency anaemia secondary to blood loss (chronic)

104

620

1.69

6.01

1.4

26.76

29.68

u/l

0.33

511

Impacted teeth

261

1760

1.39

6.00

1.4

12.28

12.68

u/l

0.13

234

1527

Ocular pain

517

1.76

5.99

1.3

1.4

22.46

24.52

u/l

0.22

439

Asthma, unspecified (mode), excluding more controls

472

2913

1.28

5.94

1.4

1.3

24.58

28.45

u/l

1.91

379

2434

Colonic or urogenital fistula

211

1477

1.44

5.93

1.4

1.3

28.30

28.22

u/l

0.01

169

1217

Disorders of continuity of bone

511

1.76

5.92

1.4

22.81

27.02

u/l

0.59

418

Other sleep disorders

474

1.79

5.91

1.4

19.38

25.74

u/l

1.33

407

Asthma, unspecified (mode)

472

2943

1.28

5.91

1.4

1.3

24.58

28.56

u/l

1.99

379

2458

Vulvovaginal ulceration/inflammation in other diseases

107

649

1.68

5.90

1.3

1.4

21.50

21.79

u/l

0.03

558

Implicit bacterial Sepsis

157

948

1.52

5.90

1.4

1.3

26.52

27.23

u/l

0.08

122

769

Other noninflammatory disorders of vagina

424

1.84

5.89

1.3

25.42

35.58

u/l

1.82

352

Scabies

237

2.14

5.89

1.5

1.4

15.83

18.82

u/l

0.47

198

Acne vulgaris

117

725

1.63

5.88

1.5

1.4

10.41

14.09

u/l

1.24

103

627

Pulmonary heart disease

144

935

1.55

5.85

1.5

1.4

27.87

31.11

u/l

0.65

132

758

Erysipelas

292

1969

1.36

5.84

1.4

1.3

26.76

29.70

u/l

0.89

236

1600

Pulmonary embolism

144

936

1.54

5.82

1.5

1.4

27.87

31.11

u/l

0.65

132

758

Mixed hyperlipidaemia

3.03

5.81

1.1

1.3

15.36

27.74

u/l

1.24

Other arthrosis

386

2120

1.31

5.76

1.4

1.3

31.69

34.43

u/l

0.78

305

1735

Trigeminal neuralgia

273

2.04

5.74

1.4

23.46

31.27

u/l

0.89

224

Bulimia nervosa (incl. atypical)

409

1.85

5.70

1.4

14.19

16.60

u/l

0.42

357

Embedded and impacted teeth

354

2298

1.32

5.69

1.3

1.4

12.48

14.20

u/l

0.93

314

1946

Thyroiditis

444

1.80

5.69

1.6

1.4

30.78

27.84

u/l

0.29

372

Bruxism

164

2.39

5.68

1.6

1.4

22.47

21.64

u/l

0.05

136

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

300

2244

1.34

5.68

1.4

23.20

24.68

u/l

0.35

247

1862

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

3.75

5.66

1.6

1.3

41.14

32.49

u/l

0.37

Acute generalized exanthematous pustulosis

208

2.20

5.66

1.4

25.27

24.89

u/l

0.03

172

Cervicocranial syndrome

594

1.68

5.63

1.6

1.3

25.39

31.65

u/l

1.10

487

Benign neoplasm: Lip

3.59

5.63

1.6

1.4

13.91

28.88

u/l

1.16

LSIL lesion of the cervix uteri, vagina or vulva

249

1817

1.39

5.62

1.4

28.00

25.48

u/l

0.60

206

1505

Papilloedema, unspecified

134

2.52

5.60

1.8

1.4

8.39

19.66

u/l

3.81

115

Collagenous colitis

410

1.82

5.57

1.4

24.13

27.74

u/l

0.46

342

Maternal care for other known or suspected fetal problems

553

2862

1.25

5.56

1.4

19.14

24.20

u/l

3.66

453

2384

Enlarged lymph nodes

124

789

1.58

5.56

1.4

1.3

22.67

25.24

u/l

0.44

109

646

Sequelae of external causes of morbidity and mortality

171

1166

1.47

5.55

1.4

1.3

30.32

28.05

u/l

0.36

151

961

Metatarsalgia

514

1.73

5.54

1.5

1.4

27.99

31.88

u/l

0.48

427

Noninfective enteritis and colitis

419

3286

1.28

5.53

1.4

25.28

25.23

u/l

0.01

345

2706

Heartburn

529

1.72

5.53

1.4

24.99

27.80

u/l

0.31

431

Volume depletion

190

2.22

5.53

1.5

1.4

26.95

23.22

u/l

0.21

158

Benign neoplasm: Colon, unspecified

459

1.76

5.52

1.5

1.3

27.48

34.04

u/l

0.89

329

Drug-induced neutropenia

277

2.01

5.52

1.4

41.31

29.67

u/l

1.56

228

Pruritus

105

644

1.65

5.51

1.5

1.4

19.75

26.99

u/l

2.06

544

Spondylopathies (FG)

146

968

1.52

5.47

1.3

1.4

22.14

24.47

u/l

0.43

123

808

Acute bronchitis

296

2176

1.34

5.46

1.4

23.12

24.69

u/l

0.39

252

1789

Otalgia

450

1.78

5.45

1.5

1.4

24.60

24.14

u/l

0.04

377

Viral hepatitis

415

1.80

5.38

1.4

1.3

19.22

20.94

u/l

0.15

340

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

4.18

5.38

1.6

1.4

45.04

28.55

u/l

0.71

Nontoxic multinodular goitre

131

851

1.55

5.37

1.3

29.42

34.98

u/l

1.02

701

Abnormal findings on examination of urine, without diagnosis

174

2.27

5.35

1.3

1.4

33.39

21.97

u/l

0.91

143

Abnormal findings on examination of blood, without diagnosis

248

1699

1.37

5.34

1.4

23.62

24.96

u/l

0.25

208

1397

Early onset COPD

110

688

1.61

5.31

1.3

24.71

32.03

u/l

1.53

548

Speech and linguistic disorders, excluding more controls

419

1.77

5.31

1.6

1.3

10.94

12.60

u/l

0.31

370

Extrapyramidal and movement disorders

201

1425

1.42

5.30

1.3

1.4

31.03

29.91

u/l

0.17

159

1165

Agoraphobia

248

2.06

5.30

1.5

1.3

19.60

17.27

u/l

0.23

214

Other chronic obstructive pulmonary disease

151

838

1.50

5.29

1.3

25.17

31.66

u/l

1.74

123

669

Other female pelvic inflammatory diseases

183

1281

1.44

5.24

1.5

1.3

29.94

30.17

u/l

0.03

144

1066

Open wound of head

315

2364

1.32

5.23

1.3

1.4

25.80

25.05

u/l

0.16

248

1955

Other disorders of conjunctiva

455

1.75

5.23

1.3

1.4

32.75

31.28

u/l

0.13

375

COPD, early/later onset

151

854

1.50

5.22

1.3

25.17

31.64

u/l

1.73

123

681

Umbilical hernia

190

1340

1.42

5.18

1.3

19.82

23.79

u/l

1.28

148

1120

Familial hypercholesterolemia

304

1.92

5.18

1.4

30.81

29.37

u/l

0.10

253

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

3.24

5.17

1.3

1.2

19.45

30.82

u/l

0.75

Benign neoplasm: Stomach

305

1.92

5.15

1.4

33.15

34.36

u/l

0.10

245

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

594

1.64

5.13

1.4

1.3

33.41

29.53

u/l

0.53

450

Diseases of the myoneural junction and muscle

385

1.80

5.09

1.4

1.3

24.00

25.62

u/l

0.16

312

Oter anti-inflammatory and antirheumatic agents, non-steroids

128

454

1.57

5.09

1.5

1.4

30.23

32.85

u/l

0.34

373

Sequelae of other external causes

224

2.08

5.09

1.5

1.4

28.66

25.70

u/l

0.22

181

COPD

157

879

1.48

5.08

1.3

25.03

31.48

u/l

1.76

127

705

Benign neoplasm: Descending colon

122

2.48

5.04

1.5

1.3

30.68

31.85

u/l

0.06

LSIL lesion of the cervix uteri

204

1470

1.40

5.03

1.3

1.4

26.42

23.67

u/l

0.62

172

1216

Accidents

961

4109

1.17

5.03

1.3

23.63

25.45

u/l

0.98

782

3475

Thyrotoxicosis

241

1780

1.36

5.02

1.3

1.4

30.29

30.07

u/l

0.03

198

1462

Heart failure, not strict

413

2246

1.27

5.01

1.5

1.3

28.87

33.43

u/l

1.91

337

1823

Female infertility, tubal origin

418

1.77

5.01

1.4

20.27

37.51

u/l

4.30

346

Contusion of ankle

226

2.07

5.00

1.6

1.4

24.20

18.20

u/l

0.61

197

Congenital iodine-deficiency syndrome/hypothyroidism

117

2.52

4.98

1.6

1.3

23.95

22.92

u/l

0.07

Diseases of liver

226

1654

1.37

4.97

1.4

25.12

30.14

u/l

1.38

171

1346

Inflammatory diseases of prostate (prostatitis)

160

2.26

4.97

1.3

10.98

12.65

u/l

0.30

128

Erosion of teeth, including avohilmo

240

1714

1.36

4.96

1.5

1.3

22.46

23.28

u/l

0.15

187

1439

Acute alcohol intoxication

162

1119

1.45

4.96

1.4

21.59

22.33

u/l

0.11

120

937

Transplanted organ and tissue status

345

1.84

4.96

1.4

34.91

24.67

u/l

1.40

284

Premature rupture of membranes

443

2605

1.26

4.95

1.4

16.22

24.04

u/l

7.58

353

2172

Benign neoplasm of other and unspecified female genital organs

220

2.08

4.95

1.4

28.57

30.97

u/l

0.17

186

Diabetes mellitus in pregnancy

712

3869

1.20

4.95

1.4

17.57

25.98

u/l

14.01

605

3177

COPD, hospital admissions

149

853

1.48

4.94

1.3

25.25

31.68

u/l

1.70

122

680

Fracture of skull and facial bones

153

1047

1.47

4.93

1.5

1.4

23.68

23.87

u/l

0.02

132

869

Symptoms and signs involving the nervous and musculoskeletal systems

469

3785

1.24

4.92

1.4

1.3

27.54

27.30

u/l

0.05

402

3094

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

339

1.85

4.92

1.1

1.4

30.92

32.61

u/l

0.15

276

Other and unspecified myopathies

207

2.09

4.90

1.4

1.3

22.64

24.33

u/l

0.12

168

Injuries to the thorax

269

2026

1.33

4.89

1.3

1.4

22.10

25.82

u/l

1.29

201

1681

Other extrapyramidal and movement disorders in other diseases

141

951

1.49

4.89

1.3

29.39

29.49

u/l

0.01

105

771

Bacterial Sepsis

196

1246

1.40

4.89

1.4

1.3

25.59

26.97

u/l

0.21

156

1028

Hypertrophy of breast

248

1852

1.35

4.87

1.3

1.4

30.07

33.23

u/l

0.78

205

1499

Recurrent dislocation of patella

543

1.66

4.86

1.3

19.56

20.13

u/l

0.07

469

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

371

1.80

4.80

1.4

24.96

28.28

u/l

0.38

303

Dermatophytosis

437

1.73

4.80

1.5

1.4

23.80

26.80

u/l

0.38

359

Other specified and unspecified personality disorders

109

700

1.57

4.80

1.5

1.3

21.24

22.86

u/l

0.21

587

Other symptoms and signs involving the urinary system

349

1.82

4.79

1.4

1.3

23.82

23.48

u/l

0.03

288

Other enthesopathy of foot (+metatarsalgia)

567

1.64

4.79

1.5

1.4

27.86

32.47

u/l

0.63

476

Toxic effects of substances chiefly nonmedicinal as to source

614

1.61

4.77

1.5

1.4

19.69

21.38

u/l

0.27

516

Benign neoplasm: Transverse colon

223

2.03

4.75

1.2

1.3

33.90

31.40

u/l

0.20

182

Abnormal involuntary movements

607

1.61

4.74

1.4

25.55

26.80

u/l

0.14

502

Other and unspecified visual disturbances

432

1.73

4.73

1.4

28.01

26.94

u/l

0.10

359

Cholecystectomy

627

4623

1.20

4.72

1.4

1.3

26.97

31.47

u/l

3.07

508

3779

Unspecified event, undetermined intent

133

2.38

4.71

1.3

1.4

17.20

19.20

u/l

0.18

114

Cerebral palsy and other paralytic syndromes

562

1.63

4.70

1.7

1.4

24.72

26.85

u/l

0.25

462

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

421

3345

1.25

4.69

1.4

21.45

21.63

u/l

0.04

370

2778

Benign neoplasm: Rectum, anus and anal canal

531

1.65

4.68

1.5

1.4

35.55

33.64

u/l

0.18

432

Acute alcohol intoxication, ICD10

144

986

1.47

4.66

1.3

1.4

21.01

21.55

u/l

0.07

103

827

Cutaneous abscess, furuncle and carbuncle

217

1598

1.36

4.64

1.5

1.4

21.00

23.76

u/l

0.77

192

1327

Sequelae of injuries, of poisoning and of other consequences of external causes

189

1361

1.40

4.64

1.3

1.4

23.88

27.23

u/l

0.73

149

1124

COPD, hospital admission 2, with asthma infections

100

537

1.59

4.63

1.2

1.3

26.80

31.93

u/l

0.91

428

Retention of urine

137

782

1.48

4.62

1.4

24.49

24.24

u/l

0.03

108

651

Acute and transient psychotic disorders

114

746

1.54

4.61

1.5

1.3

24.86

26.61

u/l

0.24

610

Disorders of parathyroid gland

595

1.60

4.61

1.7

1.3

33.16

36.85

u/l

0.42

470

TMD muscular pain linked with fibromyalgia

2.77

4.59

1.4

1.5

30.23

29.04

u/l

0.05

Endometriosis ASRM stages 3,4

302

2340

1.30

4.57

1.4

25.16

27.77

u/l

0.70

260

1934

Benign neoplasm of other and ill-defined parts of digestive system

105

676

1.56

4.56

1.5

1.3

31.79

33.54

u/l

0.20

542

Spondyloarthritis

157

1098

1.44

4.55

1.3

1.4

24.08

24.91

u/l

0.12

132

910

Anankastic personality disorder

284

1.90

4.55

1.5

1.3

25.43

22.52

u/l

0.22

241

Pregnancy with abortive outcome

875

3918

1.17

4.52

1.4

1.3

25.33

26.52

u/l

0.48

723

3254

Ventral hernia

152

1058

1.44

4.52

1.3

1.4

28.61

30.03

u/l

0.20

124

874

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

245

1251

1.34

4.48

1.5

1.3

35.69

34.89

u/l

0.13

219

931

Chronic viral hepatitis

321

1.83

4.48

1.4

11.01

19.85

u/l

3.32

265

Other neurological diseases

453

2954

1.24

4.47

1.4

1.3

26.62

29.73

u/l

1.19

377

2409

Disorders of breast

611

4743

1.20

4.47

1.4

1.3

27.92

30.01

u/l

0.85

520

3879

Hypokalaemia

394

1.74

4.47

1.5

1.4

21.38

30.72

u/l

1.33

325

Other contact dermatitis

493

1.66

4.46

1.3

1.4

27.18

27.00

u/l

0.02

414

All dysplastic lesions of the cervix uteri, vagina or vulva

512

4200

1.22

4.46

1.4

25.18

25.42

u/l

0.06

405

3464

Benign neoplasm: Lip

3.05

4.42

1.6

1.5

13.91

29.13

u/l

1.26

Other external causes of accidental injury

951

4109

1.16

4.42

1.4

1.3

24.73

25.45

u/l

0.27

779

3475

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

419

1.71

4.41

1.4

19.77

19.92

u/l

0.01

356

Explicit Sepsis

249

1807

1.32

4.40

1.4

27.37

25.44

u/l

0.38

203

1496

Sicca syndrome [Sjögren]

434

1.70

4.40

1.5

1.4

27.93

31.33

u/l

0.39

359

Scoliosis

503

1.64

4.39

1.3

1.4

19.35

19.21

u/l

0.01

438

Postmenopausal atrophic vaginitis

202

884

1.38

4.36

1.3

47.66

44.61

u/l

0.52

169

728

Emotional disorders starting during childhood or adolecense, excluding more controls

317

1.81

4.35

1.5

1.4

5.69

9.89

u/l

4.38

286

Oral leukoplakia and related diseases, including avohilmo

266

1.89

4.35

1.3

1.4

30.60

33.08

u/l

0.17

214

Other viral hepatitis

376

1.75

4.34

1.4

1.3

15.78

19.78

u/l

0.43

310

Event of undetermined intent

332

1.80

4.32

1.3

1.4

23.96

19.45

u/l

0.47

278

Postpartum hemorraghe, all women as controls

483

3964

1.22

4.30

1.3

1.4

22.03

24.41

u/l

0.93

399

3260

COPD related to multimorbidity

110

607

1.53

4.30

1.3

25.44

31.95

u/l

1.42

481

Benign leiomyoma with endometriosis

121

815

1.49

4.29

1.3

31.85

34.11

u/l

0.29

634

Use of interferon beta-1a

227

1.99

4.28

1.3

1.4

26.62

24.54

u/l

0.16

189

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

290

1.85

4.27

1.2

1.4

31.66

31.62

u/l

0.00

239

Alcoholic liver disease

219

1.97

4.25

1.3

25.15

27.05

u/l

0.11

175

Nontoxic goitre/thyroid nodule

215

1605

1.35

4.24

1.3

29.09

34.56

u/l

1.43

172

1317

Asthma, hospital admissions , main diagnosis only

794

6110

1.17

4.24

1.4

1.3

23.67

25.37

u/l

0.84

652

5056

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

167

1.90

4.24

1.4

1.2

11.40

11.04

u/l

0.05

111

Osteoporosis with pathological fracture (FG)

102

2.47

4.21

1.6

1.3

63.20

48.65

u/l

0.57

Ménière disease

364

1.74

4.21

1.5

1.4

31.83

32.41

u/l

0.04

303

Melanocytic naevi

291

2269

1.29

4.21

1.4

24.16

26.33

u/l

0.57

247

1871

Medical abortion

831

3879

1.17

4.20

1.3

27.81

26.74

u/l

0.39

658

3219

Other acute lower respiratory infections

402

3103

1.24

4.20

1.4

21.17

23.23

u/l

0.73

339

2562

Pulmonary heart disease, diseases of pulmonary circulation

145

1015

1.43

4.20

1.5

1.3

27.69

30.83

u/l

0.64

133

819

Hypertension

847

4123

1.16

4.19

1.4

1.3

30.13

30.62

u/l

0.15

672

3383

Episcleritis

321

1.80

4.19

1.4

23.22

27.69

u/l

0.46

266

Asthma-related pneumonia

219

1640

1.34

4.19

1.4

1.3

22.40

27.46

u/l

1.78

181

1354

Hypertensive diseases

848

4130

1.16

4.18

1.4

1.3

30.13

30.58

u/l

0.14

672

3388

Diarrhoea and gastroenteritis of presumed infectious origin

663

5112

1.18

4.16

1.4

1.3

21.09

23.24

u/l

1.06

561

4223

Family history of certain disabilities and chronic diseases leading to disablement

389

1.72

4.16

1.4

12.13

19.84

u/l

3.02

336

Other CVD

410

1.69

4.15

1.4

1.3

36.76

29.23

u/l

0.75

337

Autoimmune diseases excluding thyroid diseases

969

4675

1.15

4.15

1.4

1.3

25.12

24.36

u/l

0.30

794

3899

Benign neoplasm: Rectum

464

1.64

4.14

1.5

1.4

34.86

32.62

u/l

0.20

377

Female genital prolapse

269

1188

1.31

4.14

1.4

1.3

35.35

38.37

u/l

0.65

203

974

Asthma, hospital admissions 3, pneumonia

219

1643

1.34

4.14

1.4

1.3

22.40

27.41

u/l

1.75

181

1357

Asthma-related pneumonia or sepsis

219

1643

1.34

4.14

1.4

1.3

22.40

27.41

u/l

1.75

181

1357

Undetermined asthma, excluding more controls

100

652

1.54

4.13

1.3

28.32

27.53

u/l

0.08

551

Benign paroxysmal vertigo

184

1347

1.37

4.13

1.3

28.56

31.61

u/l

0.63

149

1103

SLE (Finngen)

188

2.05

4.11

1.3

25.00

22.91

u/l

0.12

157

Chronic lower respiratory diseases

1220

5828

1.13

4.11

1.4

1.3

22.58

25.14

u/l

2.18

1009

4824

Gluteal tendinitis

188

2.05

4.11

1.4

29.09

34.02

u/l

0.35

159

Undetermined asthma

100

653

1.54

4.11

1.3

28.32

27.80

u/l

0.05

554

Schizophrenia

138

963

1.44

4.10

1.4

21.06

24.83

u/l

0.75

110

789

Other and unspecified effects of external causes

293

2295

1.28

4.10

1.4

19.58

23.48

u/l

1.48

247

1903

Dependent personality disorder

104

2.45

4.09

1.4

23.04

27.12

u/l

0.27

Carcinoma in situ of breast, intraductal

360

1.74

4.09

1.3

36.29

37.54

u/l

0.09

264

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

258

1.88

4.09

1.2

1.4

22.78

27.00

u/l

0.35

220

Other disorders starting during childhood or adolecense, excluding more controls

276

1.84

4.09

1.4

9.28

10.29

u/l

0.19

247

Superficial injury of ankle and foot

128

882

1.46

4.09

1.5

1.4

16.68

20.66

u/l

1.01

109

749

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

681

5079

1.18

4.09

1.3

1.4

23.39

28.17

u/l

3.83

578

4168

Glucagon-like peptide-1 (GLP-1) analogues

232

1443

1.33

4.08

1.3

1.4

25.49

35.98

u/l

5.23

176

1169

Type 2 diabetes

948

4897

1.15

4.07

1.4

1.3

21.52

29.53

u/l

13.84

760

4038

Benign neoplasm of ovary

123

841

1.47

4.07

1.3

40.06

34.70

u/l

0.96

112

645

Noninfectious colitis NAS

113

762

1.49

4.02

1.6

1.4

27.93

24.90

u/l

0.39

637

Ovarian dysfunction, other/unspecified

3.29

4.01

1.8

1.5

29.17

22.20

u/l

0.36

All dysplastic lesions of the cervix uteri

463

3822

1.22

4.01

1.3

1.4

23.55

24.43

u/l

0.25

365

3167

Vestibular neuronitis

340

1.75

4.00

1.4

33.73

29.26

u/l

0.48

285

Lesion of radial nerve

124

2.28

3.98

1.4

1.3

36.10

28.59

u/l

0.55

100

Other and unspecified nonorganic psychotic disorders

202

1511

1.34

3.98

1.5

1.4

19.46

21.64

u/l

0.52

160

1252

Other/unspecified synovitis and tenosynovitis

603

1.55

3.98

1.4

25.10

30.11

u/l

0.66

502

Atopic dermatitis, strict definition with reimbursement

400

3160

1.23

3.97

1.4

1.3

20.43

22.28

u/l

0.59

321

2642

Neuromuscular dysfunction of bladder

356

1.73

3.96

1.4

22.89

27.48

u/l

0.59

296

Sudden idiopathic hearing loss

341

1.74

3.96

1.6

1.4

22.65

27.90

u/l

0.53

283

Disorders of eyelid, lacrimal system and orbit

731

4920

1.17

3.95

1.5

1.3

27.84

28.91

u/l

0.37

593

4047

Abnormal findings on diagnostic imaging of central nervous system

247

1.89

3.95

1.4

23.81

24.67

u/l

0.06

203

Familial hypercholesterolemia, with ischemic heart disease

118

2.30

3.94

1.1

1.3

24.91

27.53

u/l

0.15

Vasomotor rhinitis (mode)

365

1.71

3.92

1.4

27.84

28.12

u/l

0.02

300

Outcome of delivery

215

1752

0.75

3.90

1.4

34.36

27.82

u/l

1.89

197

1387

Melanocytic naevi of trunk

107

719

1.50

3.89

1.4

22.00

24.98

u/l

0.47

602

Restless leg syndrome

559

1.57

3.88

1.2

1.4

26.24

29.33

u/l

0.30

456

Foreign body in alimentary tract

213

1.94

3.88

1.4

1.3

28.21

20.14

u/l

0.77

173

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

412

1.66

3.86

1.6

1.4

32.76

26.24

u/l

0.77

340

Puerperal sepsis

131

918

1.44

3.85

1.4

1.3

30.90

33.90

u/l

0.49

106

756

Effects of foreign body entering through natural orifice

164

1195

1.38

3.82

1.4

22.16

21.40

u/l

0.12

134

1001

Conductive hearing loss, unspecified

391

1.68

3.80

1.4

32.83

25.12

u/l

1.03

328

Androgenic alopecia

3.02

3.80

1.8

1.5

32.34

23.15

u/l

0.51

Neuralgia and neuritis, unspecified

236

1.88

3.80

1.6

1.4

37.32

29.94

u/l

0.58

196

Polyarthrosis

591

1.53

3.80

1.4

38.17

43.84

u/l

0.84

488

Benign neoplasm: Skin of eyelid, including canthus

499

1.59

3.79

1.4

1.3

32.58

31.88

u/l

0.06

373

Complications of internal orthopaedic prosthetic devices, implants and grafts

538

1.57

3.79

1.3

33.88

34.55

u/l

0.05

431

Benign neoplasm: Ascending colon

301

1.77

3.79

1.6

1.3

37.13

33.75

u/l

0.25

244

Scleritis and episcleritis

377

1.69

3.77

1.4

21.63

27.67

u/l

0.80

311

Disorders of sclera, cornea, iris and ciliary body

454

3767

1.21

3.77

1.4

1.3

27.92

27.01

u/l

0.23

384

3069

In situ neoplasms

262

2047

1.28

3.77

1.4

26.67

28.96

u/l

0.54

216

1681

Benign lipomatous neoplasm

202

1524

1.33

3.76

1.4

30.96

31.51

u/l

0.08

166

1245

Fistulae involving female genital tract

2.96

3.76

1.4

31.80

33.89

u/l

0.09

Unspecified kidney failure

160

2.07

3.76

2.0

1.3

24.68

26.62

u/l

0.12

128

Ectopic pregnancy

237

1832

1.30

3.75

1.4

1.3

27.80

31.87

u/l

1.18

201

1496

Mental retardation, excluding more controls

151

2.11

3.75

1.6

1.3

13.55

19.26

u/l

0.80

133

Other mental disorders due to brain damage and dysfunction and to physical disease

244

1.85

3.74

1.4

1.3

31.75

29.98

u/l

0.12

199

Cardiac murmurs and other cardiac sounds

527

1.57

3.72

1.3

1.4

19.88

19.74

u/l

0.01

451

Hypoglycaemia, other or unspecified

296

1.77

3.71

1.4

15.34

20.95

u/l

0.84

244

Specific development disorders of scholastic skills

286

1.78

3.69

1.7

1.4

11.36

12.45

u/l

0.14

254

Dystonia

260

1.83

3.69

1.3

1.4

34.25

26.46

u/l

0.73

213

Injury of muscle and tendon at wrist and hand level

550

1.55

3.69

1.3

1.4

26.86

24.66

u/l

0.23

454

Speech therapy

1347

0.67

3.67

1.4

1.3

33.59

30.26

u/l

0.41

1097

Endometriosis ASRM stages 1,2

274

2168

1.27

3.63

1.3

1.4

29.51

27.29

u/l

0.48

235

1795

Maternal care for known or suspected fetal abnormality and damage

195

2275

0.76

3.63

1.3

1.4

17.15

23.74

u/l

2.98

152

1891

Abnormalities of forces of labour

189

1426

1.34

3.61

1.3

1.4

30.75

32.63

u/l

0.34

154

1134

Gestational diabetes (for exclusion)

749

4595

1.16

3.61

1.4

16.29

25.65

u/l

20.37

630

3782

Alcohol abuse, main dg

112

772

1.46

3.61

1.3

1.4

21.51

21.59

u/l

0.01

650

Other and unspecified nail disorders

2.39

3.61

1.3

27.58

23.69

u/l

0.20

Other symptoms and signs involving the circulatory and respiratory systems

262

1.81

3.60

1.2

1.3

34.27

23.40

u/l

1.12

214

Leisure time condition

133

947

1.41

3.59

1.3

1.4

19.69

23.72

u/l

0.72

102

800

Disorder of lipoprotein metabolism, unspecified

262

1.80

3.58

1.4

18.57

30.94

u/l

2.31

217

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

184

1.97

3.58

1.4

27.31

27.89

u/l

0.03

140

Burn and corrosion of wrist and hand

199

1.93

3.55

1.3

1.4

14.44

17.73

u/l

0.33

167

Hyperparathyroidism

486

1.57

3.54

1.6

1.3

33.24

38.24

u/l

0.56

386

Congenital malformations and deformations of the musculoskeletal system

659

1.49

3.51

1.3

1.4

22.40

19.23

u/l

0.42

575

Other symptoms and signs involving the nervous and musculoskeletal systems

364

2980

1.23

3.50

1.5

1.4

28.02

26.73

u/l

0.29

314

2426

Condition for Implicit Sepsis (Organ dysfunction codes)

624

3880

1.17

3.50

1.3

25.27

27.49

u/l

0.90

500

3198

Tinnitus

155

1138

1.37

3.49

1.4

25.90

30.00

u/l

0.78

122

929

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

101

675

1.48

3.48

1.4

1.3

45.60

33.76

u/l

2.53

519

Nonalcoholic fatty liver disease

456

1.59

3.47

1.3

1.4

26.14

28.45

u/l

0.20

368

Burns and corrosions of external body surface, specified by site

543

1.54

3.46

1.4

20.02

20.82

u/l

0.09

457

Invasive ventilation

226

0.31

3.45

1.6

1.4

27.66

22.65

u/l

—

185

Parodontitis, under 40 years

132

948

1.40

3.44

1.4

13.87

11.09

u/l

0.83

117

815

Allergic urticaria

578

1.52

3.41

1.5

1.4

20.71

23.10

u/l

0.26

493

Disorders of ocular muscles, binocular movement, accommodation and refraction

479

4003

1.19

3.40

1.4

1.3

24.07

24.92

u/l

0.22

392

3297

Other benign neoplasms of skin

247

1943

1.28

3.40

1.4

31.57

30.82

u/l

0.12

194

1604

Moderate visual impairment, binocular

2.68

3.40

1.9

1.5

13.22

23.13

u/l

0.87

Parodontitis, under 40 years, or operation codes

132

950

1.40

3.40

1.4

13.87

11.08

u/l

0.84

117

816

Nummular dermatitis

260

1.78

3.38

1.6

1.3

24.14

27.23

u/l

0.29

210

Parodontitis, under 40 years and operation codes

126

901

1.41

3.38

1.4

14.24

11.15

u/l

0.91

112

773

Nail disorders

374

1.64

3.36

1.2

1.4

23.45

24.45

u/l

0.09

307

Other and unspecified mood [affective] disorders

564

1.52

3.36

1.4

16.15

20.32

u/l

0.73

483

Parodontitis, operation under 40 years and operation codes

126

903

1.41

3.34

1.4

14.24

11.14

u/l

0.92

112

775

Chronic gastritis

120

851

1.41

3.33

1.6

1.4

33.67

33.35

u/l

0.03

700

Autoimmune diseases excluding thyroid diseases, strict definition

913

4481

1.14

3.32

1.4

1.3

25.11

24.42

u/l

0.26

746

3730

Tooth agenesis EXCLUDE clefts and syndromes

300

1.72

3.31

1.5

1.4

17.62

14.45

u/l

0.36

261

Other disorders of amniotic fluid and membranes

266

2105

1.26

3.31

1.3

1.4

22.24

23.51

u/l

0.29

219

1755

Benign neoplasm: Skin of other and unspecified parts of face

360

1.65

3.31

1.3

1.4

29.04

27.53

u/l

0.12

278

Viral infections characterized by skin and mucous membrane lesions

328

2673

1.23

3.30

1.5

1.3

20.38

25.33

u/l

2.31

272

2213

Other other unspecified disorders of the circulatory system

115

2.20

3.30

1.4

42.10

32.61

u/l

0.54

Abrasion of teeth

286

1685

1.25

3.27

1.5

1.3

32.66

26.94

u/l

1.72

228

1395

Prolonged pregnancy

190

2246

0.77

3.27

1.3

22.35

22.66

u/l

0.05

158

1880

DVT of lower extremities and pulmonary embolism

205

1578

1.30

3.27

1.5

1.4

26.74

30.30

u/l

0.97

183

1279

Hypoparathyroidism

109

2.22

3.26

1.8

1.3

37.84

31.20

u/l

0.32

Conduction disorders

121

714

1.41

3.26

1.3

20.57

27.16

u/l

1.46

582

Aplastic and other anaemias

203

1484

1.30

3.26

1.4

1.3

28.51

29.11

u/l

0.09

168

1216

Benign neoplasm of urinary organs

116

2.17

3.23

1.2

1.3

31.89

29.59

u/l

0.09

Hyperlipidaemia, other/unspecified

125

850

1.39

3.20

1.3

1.4

32.24

31.28

u/l

0.12

699

Polyhydramnios

621

1.49

3.20

1.4

23.78

21.57

u/l

0.23

520

Other noninflammatory disorders of cervix uteri

178

1.93

3.20

1.4

1.3

44.93

42.17

u/l

0.16

155

Injuries to the knee and lower leg

1153

5913

1.12

3.19

1.4

1.3

25.56

24.65

u/l

0.42

943

4901

Superficial injury of shoulder and upper arm

554

1.51

3.19

1.2

1.4

20.12

23.53

u/l

0.50

464

Lichen planus

434

1.57

3.19

1.4

1.3

40.21

34.47

u/l

0.60

353

Duodenal ulcer

185

1.90

3.18

1.4

24.11

31.06

u/l

0.76

144

Superficial injury of abdomen, lower back and pelvis

127

919

1.39

3.17

1.3

1.4

17.14

21.05

u/l

1.00

105

777

Persistent delusional disorders

288

1.71

3.17

1.5

1.4

32.46

28.04

u/l

0.33

230

Other anaemias

183

1349

1.31

3.16

1.4

1.3

27.82

29.04

u/l

0.18

151

1112

Other and unspecified anaemias

181

1336

1.31

3.16

1.4

1.3

28.10

28.93

u/l

0.12

149

1101

Lichen planus, including avohilmo

100

694

1.45

3.15

1.4

37.22

32.83

u/l

0.57

554

Other abnormal findings in urine

3.00

3.15

1.5

1.4

41.99

24.37

u/l

—

Other bursopathies

451

1.56

3.15

1.4

35.99

32.91

u/l

0.28

378

Other diseases of peritoneum

201

1.86

3.13

1.2

1.4

30.09

30.65

u/l

0.03

165

Benign neoplasm: Cerebral meninges

282

1.71

3.12

1.7

1.4

30.52

35.67

u/l

0.46

207

Assault by unspecified means

112

2.18

3.09

1.3

1.5

22.52

20.36

u/l

0.12

Injury of muscle and tendon at shoulder and upper arm level

158

1188

1.33

3.08

1.3

1.4

30.54

29.94

u/l

0.08

130

966

Seborrhoeic keratosis

681

1.44

3.07

1.4

1.3

33.51

35.78

u/l

0.27

542

Obstructed labour due to maternal pelvic abnormality

167

1269

1.32

3.07

1.3

1.4

32.73

38.62

u/l

1.30

138

1003

Crohn disease

123

892

1.39

3.06

1.3

1.4

22.75

u/l

0.00

106

744

Allergic asthma (mode), excluding more controls

263

2076

1.25

3.05

1.4

1.3

19.37

24.30

u/l

2.19

227

1742

Benign neoplasm of eye and adnexa

322

1.65

3.05

1.3

1.4

37.07

29.11

u/l

0.75

247

Benign neoplasm: Descending colon

153

1.97

3.04

1.5

1.4

30.68

33.33

u/l

0.14

120

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

106

751

1.42

3.04

1.2

1.4

22.19

28.78

u/l

1.41

622

Lichen sclerosus et atrophicus

416

1.57

3.04

1.3

1.4

28.45

35.92

u/l

1.22

341

Benign neoplasm of meninges

315

1.66

3.03

1.7

1.3

32.39

33.73

u/l

0.10

234

Supplementary factors related to causes of morbidity and mortality classified elsewhere

238

1895

1.26

3.02

1.4

21.25

23.92

u/l

0.61

193

1571

Disorders of refraction and accommodation

271

2182

1.24

3.02

1.4

25.34

24.65

u/l

0.11

219

1815

Spirochaetal infections, other/unspecified

331

1.64

3.01

1.5

1.4

26.03

30.06

u/l

0.33

275

Abnormal findings on diagnostic imaging of other body structures

578

1.48

3.00

1.5

1.3

26.08

32.79

u/l

0.98

466

Postpartum hemorraghe, parous women as controls

483

3611

1.18

3.00

1.3

22.03

26.28

u/l

2.23

399

2972

Foreign body on external eye

521

1.50

3.00

1.4

19.66

18.00

u/l

0.20

430

Other disorders of central nervous system

2.69

2.99

1.1

1.5

33.68

27.80

u/l

0.32

Allergic asthma (mode)

263

2083

1.24

2.98

1.4

1.3

19.37

24.48

u/l

2.31

227

1748

Type 2 diabetes, wide definition

494

2743

1.18

2.96

1.3

24.07

34.69

u/l

10.57

379

2233

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

679

1.44

2.96

1.4

33.41

31.19

u/l

0.26

552

Carcinoma in situ of cervix uteri, exocervix

2.53

2.94

1.2

1.4

13.75

28.67

u/l

1.55

Other peripheral vascular diseases

404

1.57

2.93

1.3

1.4

17.85

25.31

u/l

1.20

336

Labour and delivery complicated by umbilical cord complications

542

1.50

2.93

1.4

24.05

27.51

u/l

0.45

446

Benign neoplasm of breast

102

722

1.42

2.93

1.3

28.58

28.57

u/l

0.00

565

Hordeolum and other deep inflammation of eyelid

288

1.68

2.92

1.5

1.4

28.21

23.22

u/l

0.49

241

Thyrotoxicosis with diffuse goitre

145

1088

1.34

2.92

1.3

26.93

29.20

u/l

0.35

117

901

Hypertension, essential

787

3958

1.14

2.92

1.4

1.3

29.81

31.31

u/l

0.57

617

3240

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

206

1.81

2.90

1.4

1.3

24.63

28.23

u/l

0.29

168

SLE, ICD10

214

1.80

2.90

1.3

1.4

25.00

26.90

u/l

0.11

180

SLE, strict definition

214

1.80

2.90

1.3

1.4

25.00

26.90

u/l

0.11

180

Presbyopia

406

1.57

2.89

1.3

1.4

40.94

33.27

u/l

0.55

322

Crohn disease (strict definition, require KELA)

406

1.57

2.89

1.4

21.41

19.83

u/l

0.17

346

Stenosis and insufficiency of lacrimal passages

374

1.59

2.89

1.5

1.4

22.05

29.90

u/l

1.15

311

Conjunctivitis (acute, non atopic)

260

2097

1.24

2.88

1.5

1.3

24.50

25.20

u/l

0.13

216

1739

Postprocedural musculoskeletal disorders, not elsewhere classified

192

1.83

2.88

1.5

1.3

38.70

33.57

u/l

0.33

153

Malignant neoplasm of tongue

2.96

2.87

1.6

1.5

43.27

33.08

u/l

0.34

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

2.95

2.86

1.5

1.3

25.78

38.73

u/l

0.87

Contact with machinery

274

1.69

2.86

1.3

1.4

24.48

18.23

u/l

0.74

224

Other disorders of glucose regulation and pancreatic internal secretion

367

1.59

2.86

1.4

15.21

21.92

u/l

1.22

306

Graves disease, strict definition

117

853

1.38

2.86

1.3

1.4

27.05

27.29

u/l

0.03

712

Examination and encounter for administrative purposes

109

2.13

2.85

1.3

1.2

38.49

20.44

u/l

1.07

101

Viral and other specified intestinal infections

209

1614

1.27

2.84

1.5

1.4

13.99

14.79

u/l

0.20

185

1376

Peritonsillar abscess

210

1663

1.27

2.83

1.4

20.72

22.77

u/l

0.47

182

1397

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

3.11

2.82

1.7

1.4

38.55

38.05

u/l

0.02

Diabetes mellitus

1004

5373

1.12

2.81

1.4

1.3

21.57

27.51

u/l

8.50

809

4459

Viral infections of the central nervous system

393

1.56

2.80

1.5

1.4

18.33

23.73

u/l

0.90

326

Type 2 diabetes, definitions combined, including avohilmo

860

4527

1.13

2.79

1.4

1.3

22.30

30.82

u/l

13.88

693

3724

Other inflammation of eyelid

629

1.44

2.79

1.5

1.3

20.77

28.87

u/l

1.85

514

Other gastritis (incl. Duodenitis)

110

796

1.39

2.78

1.4

29.59

29.71

u/l

0.01

657

Systemic lupus erythematosus

217

1.77

2.78

1.3

1.4

25.00

25.11

u/l

0.01

184

Other disorders of eye and adnexa

125

925

1.36

2.78

1.4

1.3

22.10

25.65

u/l

0.61

103

767

Acute laryngitis and tracheitis

127

927

1.36

2.78

1.5

1.4

13.16

18.01

u/l

1.59

114

798

Procedures for purposes other than remedying health state

152

1.94

2.77

1.1

1.3

36.67

27.78

u/l

0.63

126

Ankylosing spondylitis

458

1.52

2.77

1.3

23.50

26.07

u/l

0.31

385

L02BB Anti-androgens

0.00

2.75

0.0

1.4

—

16.57

—

Palmar fascial fibromatosis [Dupuytren]

262

1.68

2.75

1.5

1.3

24.62

30.67

u/l

0.52

222

Type 2 diabetes, definitions combined

836

4434

1.13

2.75

1.4

1.3

21.83

31.17

u/l

16.27

674

3642

Pneumothorax

188

1.82

2.74

1.5

1.4

26.58

21.65

u/l

0.38

150

Paralytic strabismus

240

1.72

2.74

1.2

1.3

18.20

25.29

u/l

1.25

194

Injuries to the abdomen, lower back, lumbar spine and pelvis

255

2057

1.23

2.74

1.4

1.3

21.16

23.51

u/l

0.61

206

1700

Zoster [herpes zoster]

623

1.43

2.73

1.6

1.4

28.78

30.11

u/l

0.12

510

Dislocation, sprain and strain of joints and ligaments of thorax

153

1.92

2.72

1.2

1.4

18.74

22.62

u/l

0.38

126

Left ventricular outflow tract obstruction (LVOTO), broad definition

404

1.54

2.71

1.3

28.66

26.20

u/l

0.25

330

Disorders of conjunctiva

816

6088

1.12

2.70

1.4

1.3

24.85

25.10

u/l

0.08

661

5046

Speech and linguistic disorders

520

1.47

2.70

1.6

1.4

10.79

11.47

u/l

0.12

459

Crohn disease (strict definition, require KELA, min 2 HDR)

397

1.55

2.70

1.4

21.52

19.58

u/l

0.21

338

Gonarthrosis [arthrosis of knee](FG)

590

3021

1.15

2.70

1.4

34.28

34.87

u/l

0.15

460

2459

Chronic suppurative otitis media, including avohilmo

365

1.57

2.70

1.3

1.4

22.58

20.60

u/l

0.18

308

Achilles tendinitis

461

1.50

2.69

1.3

25.37

33.95

u/l

1.18

376

Nasal polyp

104

751

1.39

2.68

1.5

1.3

23.14

28.05

u/l

0.89

630

Early complications of trauma

168

1.86

2.68

1.7

1.4

12.46

22.37

u/l

1.75

138

!Aliquae complicationes praecoces traumatis

168

1.86

2.68

1.7

1.4

12.46

22.37

u/l

1.75

138

Type 2 diabetes, strict (exclude DM1)

836

4446

1.12

2.66

1.4

1.3

21.84

31.17

u/l

16.27

674

3653

Other disorders of Eustachian tube

155

1.90

2.63

1.4

18.96

25.62

u/l

0.66

130

Deep bite

101

637

1.40

2.61

1.3

1.4

17.67

19.95

u/l

0.37

548

Sequelae with surgical and medical care as external cause

110

806

1.37

2.61

1.4

1.3

33.29

29.33

u/l

0.53

661

Astigmatism

313

1.61

2.60

1.4

17.29

19.58

u/l

0.21

261

Asthma and allergy, excluding more controls

159

1216

1.30

2.60

1.5

1.4

19.20

22.56

u/l

0.78

137

1039

Pyoderma

2.22

2.59

1.5

37.56

25.53

u/l

0.55

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

214

1.74

2.59

1.3

41.38

43.35

u/l

0.12

151

Venous thromboembolism

293

2359

1.21

2.57

1.5

1.3

28.76

31.30

u/l

0.67

259

1909

Pustulosis palmaris et plantaris

200

1.77

2.57

1.2

1.4

30.18

30.84

u/l

0.04

166

Other disorders of bone

177

1392

1.28

2.56

1.4

24.90

25.25

u/l

0.05

148

1144

Other and unspecified rosacea

508

1.47

2.56

1.4

34.09

30.64

u/l

0.33

418

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

338

1.57

2.56

1.3

1.4

25.14

28.15

u/l

0.22

277

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

421

1.51

2.55

1.4

12.61

14.29

u/l

0.24

375

Chronic pancreatitis

307

1.60

2.55

1.3

1.4

28.51

24.92

u/l

0.28

249

Overjet

149

1.90

2.54

1.5

20.57

17.43

u/l

0.19

129

Carcinoma in situ of breast, intraductal

411

1.52

2.54

1.3

1.4

36.29

40.91

u/l

0.45

333

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

592

1.43

2.53

1.4

1.3

18.73

25.90

u/l

1.91

496

Asthma and allergy

159

1221

1.29

2.53

1.5

1.4

19.20

22.71

u/l

0.83

137

1043

Excessive vomiting in pregnancy

125

942

1.34

2.53

1.4

18.62

23.87

u/l

1.28

107

781

Keratitis

273

2256

1.21

2.52

1.4

28.68

26.13

u/l

0.61

229

1861

Arthropathies in other diseases classified elsewhere

143

1.91

2.52

1.3

1.4

21.07

26.41

u/l

0.46

122

Redundant prepuce, phimosis and paraphimosis

322

1.58

2.51

1.4

6.72

10.03

u/l

2.44

270

HSIL lesion of the cervix uteri

318

2672

1.20

2.51

1.4

20.94

24.70

u/l

1.42

240

2226

Oral leukoplakia and related diseases

136

1.92

2.50

1.3

1.4

46.79

33.59

u/l

0.80

109

Crohn's disease of small intestine

429

1.50

2.50

1.3

1.4

15.19

21.44

u/l

1.51

361

Impacted cerumen

255

1.65

2.48

1.5

1.4

25.31

26.46

u/l

0.07

209

Artificial joint operation, meniscal resection

444

3426

0.86

2.48

1.4

1.3

34.56

32.79

u/l

0.49

355

2782

Appendectomy

672

5742

1.13

2.48

1.4

27.82

25.64

u/l

0.95

561

4726

Acute nasopharyngitis (common cold)

467

1.47

2.48

1.4

1.3

20.12

18.06

u/l

0.24

390

Calcific tendinitis of shoulder

310

1.59

2.47

1.3

1.4

42.79

37.37

u/l

0.40

253

Inflammatory diseases of the central nervous system

414

1.51

2.46

1.5

1.4

22.82

25.02

u/l

0.24

337

Emotional disorders and disorders of social functioning with onset specific to childhood

417

1.50

2.46

1.5

1.4

5.63

9.81

u/l

4.60

375

Visual impairment including blindness (binocular or monocular)

218

1.71

2.45

1.6

1.3

25.45

26.73

u/l

0.07

179

Maternal care for known or suspected malpresentation of fetus

397

2534

1.18

2.44

1.3

1.4

22.63

24.50

u/l

0.60

332

2103

Lyme disease

165

1296

1.28

2.43

1.4

29.63

30.74

u/l

0.14

131

1063

Superficial injury of hip and thigh

505

1.45

2.42

1.3

1.4

16.46

24.43

u/l

1.85

423

Superficial injury of thorax

673

1.39

2.41

1.3

1.4

17.49

24.54

u/l

1.96

558

Systemic lupus erythematosus, unspecified

197

1.75

2.41

1.3

1.4

27.58

27.15

u/l

0.02

167

Benign neoplasm of urinary organs

131

1.92

2.41

1.2

1.4

31.89

29.55

u/l

0.09

107

Osteomyelitis

167

1.81

2.40

1.6

1.4

15.58

23.00

u/l

0.72

133

Acute pharyngitis

139

1063

1.30

2.39

1.4

14.95

17.12

u/l

0.45

114

906

Burns and corrosions

104

768

1.36

2.39

1.5

1.4

20.58

22.17

u/l

0.22

649

Open bite

434

1.49

2.39

1.5

1.4

17.56

17.01

u/l

0.06

377

Benign neoplasm: Skin of other and unspecified parts of face

393

1.51

2.38

1.3

1.4

29.04

29.02

u/l

0.00

323

Asthma (diagnoses ohter than nonallergic)

795

6103

1.12

2.37

1.4

1.3

22.62

25.58

u/l

2.06

650

5053

Pustular psoriasis

213

1.70

2.37

1.2

1.4

29.50

30.17

u/l

0.04

176

Crohn's disease NAS

386

1.51

2.36

1.3

1.4

25.63

21.77

u/l

0.42

325

Oesophageal varices

2.16

2.35

1.3

1.4

20.65

31.41

u/l

0.70

Aortic valve malfunction, age under 60 years

354

1.53

2.35

1.3

29.73

27.65

u/l

0.18

286

Presence of other devices

710

1.37

2.34

1.4

1.3

31.73

29.88

u/l

0.20

584

conjunctival haemorrhage

206

1.71

2.34

1.5

1.3

37.13

28.81

u/l

0.63

167

Hard cardiovascular diseases

291

2229

0.84

2.33

1.3

1.4

36.01

32.99

u/l

0.73

233

1804

Blood alcohol or alcohol intoxication level

126

1.93

2.32

1.4

32.72

19.20

u/l

0.69

105

Recurrent dislocation and subluxation of joint

528

1.43

2.31

1.3

17.88

25.35

u/l

1.94

444

Superficial injury of lower leg

207

1682

1.23

2.30

1.4

23.39

23.98

u/l

0.09

164

1395

Atopic dermatitis, strict definition

382

3218

1.17

2.29

1.4

20.16

21.30

u/l

0.31

307

2697

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

215

1.68

2.29

1.4

27.31

28.28

u/l

0.06

172

Congenital malformations of genital organs

133

1022

1.30

2.27

1.4

23.75

22.13

u/l

0.26

114

859

Recurring oral aphthae, including avohilmo

690

1.37

2.26

1.5

1.4

26.29

24.12

u/l

0.24

584

Chalazion

623

1.39

2.25

1.4

1.3

26.15

25.63

u/l

0.05

520

Exposure to other and unspecified inanimate mechanical forces

334

1.54

2.25

1.3

1.4

29.26

20.36

u/l

1.04

273

Other nonscarring hair loss

2.25

1.3

1.5

30.06

22.04

u/l

0.28

Persons with potential health hazards related to communicable diseases

361

4164

0.86

2.24

1.4

20.67

20.90

u/l

0.05

331

3439

HSIL lesion of the cervix uteri, vagina or vulva

332

2832

1.18

2.23

1.4

21.59

25.00

u/l

1.25

251

2344

Inflammatory disorders of breast

608

1.39

2.23

1.6

1.4

17.95

22.36

u/l

0.79

514

All dysplastic lesions of the vulva

392

1.50

2.23

1.4

37.59

29.92

u/l

0.89

316

Haemangioma, any site

391

1.49

2.23

1.2

1.4

28.25

26.92

u/l

0.10

294

Coeliac disease

101

752

1.35

2.23

1.3

1.4

25.78

26.02

u/l

0.02

625

Other (not insulin) diabetes medications

830

4509

1.11

2.23

1.4

1.3

20.85

30.85

u/l

19.67

662

3705

Lichen ruber planus, wide definition including periferal and oral lichen planus

114

864

1.32

2.22

1.4

37.12

32.75

u/l

0.61

693

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

441

1.46

2.22

1.4

21.20

20.82

u/l

0.04

377

Dental pulpitis 3

163

929

1.27

2.21

1.4

6.84

7.50

u/l

0.32

146

816

Hydrocele

128

1.88

2.20

1.1

1.3

5.52

12.39

u/l

4.28

104

LSIL lesion of the vulva

297

1.57

2.20

1.5

1.4

36.55

29.86

u/l

0.64

246

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

194

1574

1.24

2.19

1.3

1.4

24.66

25.33

u/l

0.10

160

1313

Superficial injury of forearm

601

1.39

2.19

1.4

19.40

20.15

u/l

0.08

513

Nonsuppurative otitis media

228

1625

1.22

2.17

1.4

14.73

14.32

u/l

0.09

185

1398

Adhesive capsulitis of shoulder

738

1.35

2.17

1.3

1.4

30.36

35.72

u/l

0.93

607

Other spirochaetal diseases

166

1327

1.25

2.15

1.4

29.63

30.63

u/l

0.13

131

1091

Explicit bacterial Sepsis

313

1.54

2.15

1.4

1.3

22.10

22.48

u/l

0.03

261

Bitten or struck by other mammals

121

931

1.31

2.15

1.4

1.3

23.67

23.56

u/l

0.01

780

Arthropod-borne viral fevers and viral haemorrhagic fevers

378

1.49

2.15

1.4

27.72

26.14

u/l

0.13

306

Congenital malformations of uterus and cervix

236

1.64

2.14

1.2

1.4

15.32

19.21

u/l

0.49

203

Other conjunctival vascular disorders and cysts

2.12

2.14

1.3

1.4

33.73

29.30

u/l

0.20

Mental retardation

189

1.71

2.14

1.6

1.4

13.55

19.81

u/l

0.93

163

Diabetic retinopathy

116

955

0.76

2.13

1.4

23.95

20.97

u/l

0.37

785

Monoarthritis, not elsewhere classified

197

1.69

2.13

1.2

1.4

26.28

26.39

u/l

0.01

172

Acute and subacute iridocyclitis

141

1108

1.28

2.12

1.4

1.3

27.93

26.72

u/l

0.17

121

911

Benign neoplasm: Adrenal gland

197

1.68

2.12

1.3

1.4

25.31

30.20

u/l

0.38

147

Striking against or struck by other objects

250

2088

1.20

2.12

1.3

1.4

20.89

20.69

u/l

0.04

203

1733

Carrier of infectious disease

138

1.84

2.11

1.4

18.22

19.50

u/l

0.07

117

Subacute thyroiditis

175

1.73

2.10

1.8

1.3

20.77

26.00

u/l

0.41

145

Polyarthropathies

475

3603

0.88

2.10

1.4

1.3

28.34

26.72

u/l

0.46

385

2984

Fracture of rib(s), sternum and thoracic spine

129

1004

1.29

2.09

1.3

1.4

25.59

27.20

u/l

0.22

813

Amblyopia ex anopsia

206

1.66

2.08

1.2

1.4

17.05

18.01

u/l

0.07

177

LeFortI or BSSRO operation

341

1.51

2.08

1.4

19.84

23.19

u/l

0.41

291

Fall on and from stairs and steps

173

1397

1.24

2.07

1.3

19.61

26.85

u/l

2.65

130

1154

Postmenopausal osteoporosis with pathological fracture

2.08

2.07

1.7

1.3

66.08

48.63

u/l

—

Other and unspecified injuries of lower leg

448

1.44

2.06

1.3

1.4

29.91

22.85

u/l

0.81

382

Pedal cyclist injured in other and unspecified transport accidents

557

1.39

2.06

1.5

1.4

18.47

23.44

u/l

0.97

463

Disorders of optic nerve, not elsewhere classified

2.35

2.05

2.2

1.3

31.76

31.23

u/l

—

Diabetes, varying definitions

979

5340

1.10

2.05

1.4

1.3

21.64

27.70

u/l

8.62

794

4421

Other benign neoplasms of connective and other soft tissue

440

1.44

2.05

1.3

26.83

26.20

u/l

0.05

339

Crossbite

400

1.45

2.04

1.6

1.5

13.90

16.99

u/l

0.51

348

Diseases of peritoneum

399

1.46

2.04

1.2

1.4

28.34

29.70

u/l

0.09

330

Benign leiomyoma with endometriosis

121

938

1.30

2.04

1.3

1.4

31.85

36.38

u/l

0.74

762

Other diseases of liver

120

929

1.30

2.04

1.3

23.18

31.33

u/l

1.71

749

Injuries to the hip and thigh

230

1750

1.20

2.04

1.5

1.3

25.27

26.40

u/l

0.18

178

1445

Desensitization to allergens

509

1.41

2.03

1.5

1.3

18.54

19.02

u/l

0.04

436

Benign neoplasm: Skin of eyelid, including canthus

576

1.38

2.02

1.4

1.3

32.58

33.78

u/l

0.10

475

Pregnancy examination and test

318

1696

1.18

2.01

1.5

1.4

21.10

26.18

u/l

2.12

270

1342

Panniculitis affecting regions of neck and back

170

1.72

2.01

1.7

1.4

26.80

30.33

u/l

0.19

140

Malignant neoplasm of other and unspecified parts of tongue

2.85

2.01

1.6

1.5

50.04

31.45

u/l

—

Carcinoma in situ of cervix uteri, exocervix

2.10

2.00

1.2

1.5

13.75

23.10

u/l

0.91

Certain conditions originating in the perinatal period

609

1.35

2.00

1.6

1.4

11.33

12.58

u/l

0.23

535

Benign neoplasm of eye and adnexa

360

1.48

2.00

1.3

1.4

37.07

30.70

u/l

0.56

295

Mucosal proctocolitis

860

0.71

1.99

1.4

24.93

22.78

u/l

0.21

726

Retained placenta and membranes, without haemorrhage

139

1102

1.27

1.99

1.5

1.4

31.11

31.37

u/l

0.03

121

898

Other neurotic disorders

148

1.77

1.98

1.7

1.3

28.45

24.41

u/l

0.23

125

MS-disease / Multiple Sclerosis

682

1.34

1.98

1.3

1.4

28.17

24.20

u/l

0.56

577

Benign neoplasm of ovary

123

960

1.29

1.98

1.3

1.4

40.06

36.34

u/l

0.59

112

777

Postpartum haemorrhage due to retained placenta

226

1889

1.20

1.98

1.3

24.07

26.46

u/l

0.51

181

1560

Disorders of choroid and retina

343

2891

0.86

1.97

1.4

1.3

31.53

29.96

u/l

0.33

266

2361

Diseases of appendix

710

5845

1.11

1.96

1.3

27.89

25.61

u/l

1.06

590

4805

Perforation of tympanic membrane

461

1.42

1.96

1.4

18.26

24.23

u/l

0.94

387

Nontoxic diffuse goitre

134

1.81

1.96

1.4

1.3

28.83

31.32

u/l

0.14

107

Viral haemorrhagic fevers, not elsewhere classified/unspecified

321

1.50

1.96

1.4

27.09

25.53

u/l

0.12

259

Benign neoplasm: Cerebral meninges

321

1.50

1.95

1.7

1.4

30.52

36.21

u/l

0.54

262

Other inflammatory liver diseases

273

1.55

1.95

1.2

1.3

27.08

27.36

u/l

0.02

225

Haemangioma and lymphangioma, any site

420

1.44

1.95

1.2

1.3

27.77

26.99

u/l

0.06

318

Benign neoplasm of meninges

354

1.48

1.94

1.7

1.4

32.39

36.19

u/l

0.34

288

All dysplastic lesions of the vagina

203

1.65

1.94

1.5

1.4

26.22

27.50

u/l

0.07

167

LSIL lesion of the vagina

113

1.89

1.94

1.1

1.4

26.17

25.56

u/l

0.02

Infective dermatitis

504

1.39

1.94

1.4

26.71

27.43

u/l

0.07

418

Bilateral sagittal split ramus osteotomy operation

282

1.54

1.94

1.4

20.62

24.40

u/l

0.39

241

Mental retardation, wide definition

195

1.65

1.93

1.6

1.4

13.55

19.92

u/l

0.96

168

Contusion of other and unspecified parts of foot

323

1.50

1.92

1.6

1.4

12.56

19.34

u/l

1.85

279

Corneal ulcer

138

1098

1.26

1.91

1.5

1.3

29.87

24.60

u/l

0.95

118

909

Contact with sharp glass

235

1.59

1.91

1.3

1.4

29.89

17.04

u/l

1.77

200

Benign neoplasm: Colon, unspecified

599

1.36

1.91

1.5

1.3

27.48

33.47

u/l

0.82

479

Alcohol-induced chronic pancreatitis

150

1.74

1.90

1.5

1.4

24.66

23.34

u/l

0.09

114

Fracture of foot, except ankle

204

1693

1.21

1.90

1.3

1.4

27.16

24.33

u/l

0.52

162

1404

Cholecystitis

405

1.44

1.90

1.2

1.4

23.17

30.18

u/l

1.09

333

Asthma mixed form (mode)

227

1.59

1.90

1.2

1.3

21.11

23.04

u/l

0.16

195

Asthma mixed form (mode), excluding more controls

227

1.59

1.90

1.2

1.3

21.11

22.87

u/l

0.14

195

Other infective otitis externa

275

1.54

1.90

1.4

27.92

25.96

u/l

0.14

225

Emotional disorders starting during childhood or adolescence

403

1.44

1.90

1.5

1.4

5.69

9.64

u/l

3.90

355

Defect, injury or illness of lumbar spine

2.98

1.90

1.4

1.6

19.40

26.27

u/l

—

Other obstetric trauma

697

1.33

1.89

1.4

24.28

24.92

u/l

0.06

574

Acute gastritis

251

1.56

1.89

1.4

26.29

30.68

u/l

0.32

207

Injuries to the head

1014

6069

1.09

1.89

1.4

1.3

22.71

25.10

u/l

1.65

823

5034

Atopic conjunctivitis

300

1.51

1.88

1.4

21.22

22.65

u/l

0.12

255

Ascites

181

1.66

1.88

1.1

1.3

28.53

35.26

u/l

0.61

146

Colitis, primary sclerosing, strict definition

0.00

1.88

0.0

1.5

—

21.23

—

Anogenital herpesviral [herpes simplex] infection

611

1.35

1.87

1.5

1.4

18.44

20.61

u/l

0.28

528

Other specified/unspecified systemic involvement of connective tissue

333

1.48

1.87

1.6

1.4

14.09

27.10

u/l

4.19

277

IBD (strict) with PSC

0.00

1.87

0.0

1.5

—

18.28

—

Biguanides

773

4325

1.10

1.86

1.4

1.3

20.16

31.13

u/l

24.01

618

3538

Other disorders of pigmentation

159

1.71

1.86

1.3

34.43

25.85

u/l

0.48

129

Bacterial, viral and other infectious agents

433

1.42

1.85

1.3

1.4

26.18

21.48

u/l

0.48

356

Ischemic heart diseases

279

2045

0.85

1.85

1.3

1.4

33.62

34.63

u/l

0.19

229

1644

Type of accident

207

1726

1.20

1.85

1.4

19.19

24.27

u/l

1.55

167

1429

Papulosquamous disorders

257

2184

1.18

1.84

1.3

1.4

29.24

30.62

u/l

0.28

213

1777

Demyelinating diseases of the central nervous system

103

795

1.30

1.84

1.3

1.4

27.26

24.74

u/l

0.34

669

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

3.57

1.84

1.3

1.2

36.50

27.06

u/l

—

Conjunctivitis

758

6010

1.10

1.84

1.5

1.3

24.07

25.31

u/l

0.51

619

4980

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

802

4577

1.10

1.83

1.3

25.08

26.23

u/l

0.48

658

3797

802

4577

1.10

1.83

1.3

25.08

26.23

u/l

0.48

658

3797

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

4.19

1.82

1.6

1.3

9.20

19.12

u/l

—

Anterior Iridocyclitis

144

1159

1.25

1.82

1.3

28.49

27.07

u/l

0.21

124

954

Lichen simplex chronicus and prurigo

230

1.57

1.82

1.3

33.76

30.04

u/l

0.25

187

Type 1 diabetes, strict definition, subgroup 1

631

0.68

1.80

1.2

1.4

15.40

17.71

u/l

0.25

540

Other specified disorders of external ear

1.97

1.80

1.6

1.4

18.29

24.24

u/l

0.22

Urethral stricture

2.01

1.80

1.4

18.89

19.44

u/l

0.03

Chronic suppurative otitis media

312

1.48

1.78

1.3

1.4

18.50

20.52

u/l

0.19

264

Other disorders starting during childhood or adolescence

359

1.45

1.77

1.4

9.28

10.85

u/l

0.32

321

COPD, hospital admissions 3, with asthma pneumonia sepsis

377

1.40

1.77

1.3

25.80

31.43

u/l

0.79

308

Bacterial intestinal infections, IBD co-morbidities

747

1.30

1.76

1.3

1.4

29.97

27.53

u/l

0.25

616

Rosacea

757

1.30

1.75

1.4

1.3

31.04

29.20

u/l

0.19

616

Fracture of lower leg, including ankle

389

3413

1.14

1.73

1.4

1.3

28.74

28.57

u/l

0.04

323

2795

Congenital malformations of the nervous system

163

1.68

1.73

1.4

16.85

19.26

u/l

0.17

142

Vitamin B12 deficiency anaemia

257

1.52

1.73

1.5

1.4

29.45

31.54

u/l

0.13

212

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

140

1.73

1.72

1.2

1.4

33.61

26.85

u/l

0.44

116

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

3.89

1.72

1.8

1.2

16.94

29.11

u/l

—

Non-allergic asthma (mode), excluding more controls

119

935

1.26

1.72

1.4

1.3

25.79

26.93

u/l

0.15

792

Ulcerative colitis (strict) with PSC

0.00

1.72

0.0

1.5

—

17.03

—

Pneumonia, organism unspecified

734

4836

1.10

1.72

1.4

24.36

26.32

u/l

0.98

601

3982

Type 1 diabetes, strict definition

659

0.69

1.72

1.2

1.4

16.76

18.31

u/l

0.15

565

Artificial joint re-operation

125

1.77

1.72

1.2

1.3

52.04

40.13

u/l

0.68

100

Appendicitis, broad definition

701

5835

1.10

1.71

1.3

27.89

25.61

u/l

1.05

582

4800

Basal cell carcinoma

115

1155

0.79

1.71

1.4

1.3

39.93

35.45

u/l

0.72

930

Hallux rigidus

440

1.39

1.71

1.3

1.4

48.36

38.43

u/l

1.00

368

Enterocolitis due to Clostridium difficile

308

1.47

1.67

1.6

1.4

33.92

24.93

u/l

0.76

252

Autoimmune hyperthyroidism

451

1.38

1.67

1.4

1.3

29.88

26.81

u/l

0.27

377

Other infectious diseases

276

1.49

1.66

1.2

1.4

28.43

24.03

u/l

0.32

223

Iridocyclitis

156

1282

1.22

1.65

1.3

1.4

27.37

26.89

u/l

0.07

135

1057

Secondary malignant neoplasm of other and unspecified sites

2.83

1.65

1.3

1.4

36.96

33.77

u/l

—

Other and unspecified injuries of shoulder and upper arm

142

1.71

1.65

1.5

1.4

22.55

20.26

u/l

0.15

118

Cluster headache, strict, including avohilmo

343

1.44

1.65

1.3

1.4

26.25

22.64

u/l

0.34

289

Non-allergic asthma (mode)

119

941

1.26

1.64

1.4

1.3

25.79

27.07

u/l

0.17

798

Diseases of spleen

2.27

1.64

1.6

1.3

24.76

28.38

u/l

0.11

Melanocytic naevi of other and unspecified parts of face

310

1.46

1.64

1.5

1.4

19.13

25.18

u/l

0.78

244

Deep bite that required surgery

1.87

1.64

1.3

1.4

21.64

24.37

u/l

—

Other blood glucose lowering drugs, excl. Insulins

393

1.40

1.63

1.3

1.4

23.80

37.09

u/l

2.29

324

Diabetic retinopathy, excluding more controls

112

795

0.79

1.63

1.4

23.95

20.38

u/l

0.47

651

Stroke, including SAH

175

1554

0.83

1.63

1.3

36.31

31.95

u/l

0.85

133

1265

Malignant neoplasm of prostate

341

0.67

1.62

1.4

1.3

9.93

13.30

u/l

1.06

277

Secondary hypertension

283

1.48

1.62

1.5

1.4

17.41

24.82

u/l

1.01

233

Pregnancy hypertension

616

5044

1.10

1.62

1.3

1.4

23.37

27.79

u/l

3.08

517

4145

Chronic tubulo-interstitial nephritis

166

1.64

1.62

1.5

1.4

44.40

30.10

u/l

1.21

135

Insulin, intermediate and long-acting

295

2517

1.15

1.60

1.3

1.4

22.19

25.22

u/l

0.99

231

2071

Crohn disease (strict definition, all UC cases excluded)

312

1.45

1.60

1.4

18.46

19.36

u/l

0.09

264

Alzheimer disease, including avohilmo

219

0.56

1.60

1.3

52.49

38.69

u/l

—

172

Intentional self-harm by sharp object

183

1.60

1.58

1.6

1.4

14.41

14.58

u/l

0.01

157

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

2.71

1.58

1.3

1.2

32.10

39.42

u/l

—

Type 1 diabetes, definitions combined

740

0.72

1.58

1.3

1.4

19.24

18.78

u/l

0.04

627

Schizotypal disorder

152

1.66

1.58

1.4

21.14

21.61

u/l

0.02

126

Contact with and exposure to communicable diseases

325

3680

0.88

1.57

1.4

20.68

20.05

u/l

0.15

300

3048

Hypotension

304

1.45

1.57

1.5

1.3

32.72

27.15

u/l

0.35

245

Carcinoma in situ of cervix uteri

124

1003

1.24

1.57

1.3

18.62

19.60

u/l

0.14

818

Ankylosing spondylitis, ICD10

508

1.34

1.57

1.3

1.4

22.60

25.99

u/l

0.46

419

Dislocation, sprain and strain of joints and ligaments of head

264

1.49

1.56

1.4

32.55

21.34

u/l

0.89

226

Open wound of abdomen, lower back and pelvis

145

1.67

1.55

1.7

1.4

21.55

17.65

u/l

0.32

123

Strabismus

229

1959

1.17

1.55

1.4

22.39

24.51

u/l

0.46

186

1621

Foreign body entering into or through eye or natural orifice

339

1.42

1.54

1.3

1.4

21.82

19.61

u/l

0.19

277

Combinations of oral blood glucose lowering drugs

100

789

1.27

1.54

1.3

1.4

25.86

31.10

u/l

1.02

632

Type 1 diabetes, strict (exclude DM2)

736

0.73

1.53

1.3

1.4

19.24

18.59

u/l

0.06

625

Infectious mononucleosis

100

791

1.27

1.53

1.3

1.4

15.63

16.41

u/l

0.11

683

Other arrhythmias

529

3658

1.11

1.53

1.4

1.3

28.43

28.58

u/l

0.03

429

2981

Pregnancy, childbirth and the puerperium

279

1263

1.16

1.52

1.3

1.4

20.09

19.43

u/l

0.13

243

1037

Symptoms and signs involving emotional state

177

1.60

1.52

1.4

26.86

19.40

u/l

0.50

155

Emergency coronary revascularization (for ACS)

761

0.77

1.51

1.2

1.3

30.50

27.18

u/l

0.37

610

Major coronary heart disease event

174

1384

0.84

1.51

1.3

36.11

32.25

u/l

0.71

143

1111

Benign neoplasm: Parathyroid gland

2.89

1.51

1.2

62.90

40.09

u/l

—

Malignant neoplasm of skin

218

1401

1.17

1.49

1.5

1.3

35.22

34.94

u/l

0.04

193

1120

Benign neoplasm of breast

102

812

1.26

1.49

1.3

1.4

28.58

31.21

u/l

0.33

673

Acute pancreatitis (for exclusion)

705

1.28

1.48

1.6

1.4

22.75

28.29

u/l

1.11

572

Basal cell carcinoma, including avohilmo

124

1197

0.81

1.48

1.4

1.3

37.99

35.74

u/l

0.31

107

961

Obstructive hydrocephalus

2.24

1.47

3.1

1.4

7.22

25.97

u/l

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.86

1.47

1.8

1.4

30.49

13.32

u/l

—

L04AD Calcineurin inhibitors

488

1.34

1.46

1.4

28.34

25.10

u/l

0.30

397

Cluster headache, wide,, including avohilmo

352

1.40

1.46

1.3

1.4

26.25

23.61

u/l

0.23

297

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

2.52

1.45

1.4

1.2

20.04

33.30

u/l

—

Hemiplegia

228

1.50

1.44

2.1

1.4

25.27

25.29

u/l

0.00

184

Hyperplasia of prostate

300

1.33

1.44

1.5

1.3

11.03

12.07

u/l

0.25

251

Other viral diseases

291

2549

1.14

1.43

1.4

21.57

22.18

u/l

0.13

239

2137

Degenerative diseases of the nervous system

276

0.63

1.43

1.3

56.73

35.97

u/l

0.80

221

Maternal care for known or suspected disproportion

748

0.74

1.42

1.3

1.4

31.48

28.61

u/l

0.30

618

Unspecified acute lower respiratory infection

719

1.27

1.42

1.5

1.4

20.58

21.87

u/l

0.15

598

Rash and other nonspecific skin eruption

491

1.33

1.42

1.5

1.4

26.75

28.67

u/l

0.20

407

Cramp and spasm

229

1.49

1.42

1.6

1.4

18.50

21.30

u/l

0.28

190

Diabetes medication

953

5384

1.08

1.42

1.4

1.3

20.88

27.74

u/l

11.01

764

4462

Disorders of muscles

474

1.33

1.41

1.4

28.51

27.36

u/l

0.10

399

Mixed connective tissue disease

397

1.37

1.41

1.5

1.4

16.66

28.97

u/l

2.89

329

Failed attempted abortion

190

1.56

1.41

1.8

1.4

21.63

23.32

u/l

0.12

162

Other Crohn's disease

440

1.35

1.41

1.3

1.4

23.33

22.07

u/l

0.13

376

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

2.43

1.39

1.3

1.2

32.10

37.44

u/l

—

Presence of other functional implants

152

1286

0.84

1.39

1.3

1.4

31.92

34.73

u/l

0.37

115

1043

Congenital malformations of heart and great arteries

681

1.27

1.39

1.5

1.4

22.21

20.47

u/l

0.22

577

Other CVD (FINNGEN)

245

1.42

1.38

1.5

1.4

32.72

24.62

u/l

0.56

201

Acute pancreatitis

713

1.26

1.38

1.6

1.3

22.75

28.12

u/l

1.06

582

Congenital deformities of hip

127

1.67

1.37

1.3

1.5

30.47

17.30

u/l

0.68

109

Disorders of vitreous body

218

1842

1.16

1.37

1.4

1.3

36.74

36.80

u/l

0.01

167

1498

Use of glatiramer acetate

167

1.58

1.36

1.5

1.4

28.68

23.03

u/l

0.37

139

Pneumonia due to other infectious organisms, not elsewhere classified

112

1.71

1.36

1.6

1.5

26.15

24.15

u/l

0.09

Molar incisor enamel hypoplasia

187

1.53

1.36

1.7

1.5

18.29

10.56

u/l

0.70

163

Cerebrovascular diseases

264

2159

0.88

1.35

1.3

32.56

32.23

u/l

0.05

200

1756

Bursitis of shoulder

1.77

1.35

1.3

1.4

27.95

32.02

u/l

—

Ulcer of oesophagus

143

1.61

1.35

1.3

1.4

35.80

28.36

u/l

0.35

114

Left hemicolectomy

0.00

1.34

0.0

1.3

—

31.75

—

Heterophoria

540

1.30

1.34

1.5

1.4

30.44

22.30

u/l

0.87

452

Other hearing loss

713

1.26

1.33

1.5

1.3

25.25

30.85

u/l

0.82

579

Vitreous haemorrhage

316

1.40

1.32

1.3

29.17

26.37

u/l

0.18

260

Other bacterial intestinal infections

754

1.25

1.31

1.4

1.3

30.56

27.69

u/l

0.30

624

Gonarthrosis,primary

549

3150

1.10

1.31

1.3

35.71

36.35

u/l

0.15

429

2538

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

836

5568

1.08

1.31

1.4

1.3

26.44

26.76

u/l

0.10

698

4571

Maternal care for other conditions predominantly related to pregnancy

349

3082

1.12

1.31

1.3

22.70

25.99

u/l

1.26

285

2522

Non-rheumatic valve diseases

180

1119

1.18

1.30

1.4

32.89

29.04

u/l

0.72

145

921

Dipeptidyl peptidase 4 (DPP-4) inhibitors

217

1.48

1.30

1.3

1.4

25.98

34.60

u/l

0.73

179

Use of dimethyl fumarate

1.76

1.30

1.5

1.4

22.05

21.03

u/l

0.05

Cholelithiasis

725

4701

1.08

1.29

1.4

1.3

26.94

30.28

u/l

2.08

582

3852

Other or unspecified ileus, impaction or obstruction

507

1.30

1.29

1.3

35.12

30.07

u/l

0.60

421

Follicular cysts of skin and subcutaneous tissue

115

945

1.22

1.29

1.4

1.3

25.97

27.90

u/l

0.30

776

Disorders of iron metabolism

2.11

1.28

1.4

44.10

29.12

u/l

—

Cardiac arrhythmias

671

4089

1.09

1.28

1.4

1.3

27.28

28.07

u/l

0.24

553

3388

Contact with heat and hot substances

243

1.45

1.28

1.3

1.4

24.03

20.91

u/l

0.21

204

Certain disorders involving the immune mechanism

123

1019

1.21

1.28

1.5

1.3

29.63

28.56

u/l

0.13

108

827

Leiomyoma of uterus

743

3911

1.08

1.27

1.3

1.4

32.19

33.58

u/l

0.50

618

3173

Other symptoms and signs involving general sensations and perceptions

130

1.62

1.27

1.6

1.4

20.69

20.08

u/l

0.03

111

Malignant neoplasm, without specification of site

2.29

1.27

2.0

1.4

47.76

35.59

u/l

—

Pervasive developmental disorders excl. Autism + Asperger

2.02

1.27

1.5

4.08

11.90

u/l

2.50

Urolithiasis

146

1230

1.19

1.26

1.4

25.81

26.26

u/l

0.06

113

1013

Injury of nerves at wrist and hand level

154

1.57

1.26

1.2

1.4

21.71

20.79

u/l

0.04

124

Impacted maxillary molar

537

1.29

1.26

1.4

1.3

14.03

12.14

u/l

0.30

475

Mandibular prognathia AND surgery (LeFortI or BSSRO)

2.28

1.26

2.3

1.5

10.53

21.57

u/l

—

Valvular heart disease excluding rheumatic fever

182

1138

1.17

1.25

1.4

32.70

28.76

u/l

0.75

146

940

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

261

1.43

1.25

1.5

1.4

10.08

13.46

u/l

0.56

221

Peptic ulcer

2.42

1.25

1.8

1.3

31.77

18.02

u/l

—

Injuries involving multiple body regions

195

1.50

1.25

1.4

27.59

20.31

u/l

0.61

169

Haemangioma, any site

441

1.32

1.24

1.2

1.4

28.25

28.31

u/l

0.00

364

Other demyelinating diseases of the central nervous system

321

1.38

1.24

1.1

1.4

25.72

23.11

u/l

0.25

266

Meningitis

253

1.43

1.24

1.4

20.89

23.57

u/l

0.27

206

Extreme obesity with alveolar hypoventilation

131

1.61

1.24

1.2

1.3

26.77

32.14

u/l

0.41

104

Sequelae of injuries of lower limb

503

1.30

1.23

1.5

1.4

24.00

26.33

u/l

0.22

414

Renal failure

127

967

1.20

1.23

1.5

1.3

30.08

26.93

u/l

0.38

104

777

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

119

767

1.21

1.23

1.4

1.3

33.12

33.42

u/l

0.03

560

Coronary revascularization (ANGIO or CABG)

693

0.79

1.23

1.2

1.3

29.32

27.33

u/l

0.22

554

COPD-related respiratory insufficiency

171

1.52

1.23

1.2

1.3

17.31

30.30

u/l

1.69

141

Other malignant neoplasms of skin (=non-melanoma skin cancer)

109

1043

0.82

1.22

1.4

1.3

39.68

35.66

u/l

0.60

831

Unspecific neurodegenerative disorder

300

0.69

1.21

1.4

1.3

37.28

34.71

u/l

0.13

247

Parodontitis or/and operation codes

665

3652

1.08

1.21

1.3

1.4

30.54

26.53

u/l

2.20

512

3008

Open wound of forearm

408

1.33

1.21

1.6

1.4

17.44

18.98

u/l

0.17

344

Antepartum haemorrhage, not elsewhere classified

155

1322

1.18

1.21

1.4

25.04

24.98

u/l

0.01

132

1090

Calculus of kidney and ureter

139

1172

1.19

1.21

1.4

25.25

26.41

u/l

0.17

108

960

Diverticular disease of intestine

382

2286

1.11

1.20

1.4

1.3

33.65

36.47

u/l

0.89

294

1863

Urethritis and urethral syndrome

109

1.67

1.19

1.3

1.4

33.95

24.40

u/l

0.50

Insulin, fast-acting

224

1961

1.14

1.19

1.3

1.4

19.89

22.72

u/l

0.76

174

1615

Benign neoplasm: Parathyroid gland

2.33

1.19

1.2

1.4

62.90

45.63

u/l

—

Fracture of femur

461

1.29

1.18

1.6

1.3

37.19

28.44

u/l

0.80

375

Heart failure and antihypertensive medication

490

1.24

1.18

1.3

1.4

32.99

32.23

u/l

0.07

401

Disorder of the sleep-wake schedule

1.72

1.18

1.7

1.5

11.78

20.41

u/l

0.66

Bicipital tendinitis

165

1.52

1.17

1.4

26.04

33.96

u/l

0.60

136

Psoriasis vulgaris

114

947

1.21

1.17

1.4

22.78

26.95

u/l

0.93

775

Other disorders of cornea

367

1.34

1.17

1.3

1.4

37.84

28.88

u/l

1.07

297

Infections of genitourinary tract in pregnancy

104

857

1.22

1.17

1.4

24.10

22.64

u/l

0.17

712

Sarcoidosis

623

1.26

1.16

1.4

1.3

29.91

30.07

u/l

0.01

503

Cardiodefibrillation

645

0.76

1.15

1.1

1.3

26.57

28.28

u/l

0.12

522

Abscess of anal and rectal regions

377

1.33

1.15

1.3

1.4

30.68

24.02

u/l

0.57

312

Bacterial meningitis

150

1.54

1.15

1.1

1.4

22.24

25.12

u/l

0.20

127

Diagnoses used for exclusion with ILD

118

987

1.20

1.13

1.4

1.3

31.06

29.50

u/l

0.17

102

798

Perioral dermatitis

167

1.51

1.13

1.6

1.4

22.33

23.14

u/l

0.04

136

Other orthopaedic follow-up care

250

1.41

1.12

1.4

1.3

27.68

26.00

u/l

0.09

203

Benign neoplasm: Liver

127

1.59

1.12

1.4

1.3

23.94

25.88

u/l

0.09

100

Fracture at wrist and hand level

221

1944

1.14

1.12

1.4

22.00

23.70

u/l

0.35

178

1607

Communicating hydrocephalus

1.97

1.11

1.8

1.4

30.35

29.02

u/l

—

Other specified/unspecified inflammatory spondylopathies

345

1.34

1.11

1.3

1.4

24.31

25.55

u/l

0.10

291

Coronary artery bypass grafting

324

0.70

1.11

1.2

1.3

23.26

22.98

u/l

0.02

251

Reactive arthropathies

450

1.29

1.10

1.4

1.3

30.20

28.48

u/l

0.13

373

Chondrocostal junction syndrome [Tietze]

201

1.45

1.10

1.4

18.92

23.51

u/l

0.47

168

Other/unspecified rheumatoid arthritis

424

1.30

1.09

1.2

1.3

39.15

33.11

u/l

0.50

346

Statin medication

764

3997

1.07

1.09

1.4

1.3

32.67

29.37

u/l

1.76

604

3282

Melanoma in situ of lower limb, including hip

2.42

1.09

1.6

1.2

51.16

42.38

u/l

—

Other benign neoplasm of uterus: Corpus uteri

2.41

1.09

1.0

1.5

38.08

47.72

u/l

—

Coronary atherosclerosis

181

1343

0.87

1.09

1.2

1.4

33.75

33.23

u/l

0.07

144

1083

Other benign neoplasms of connective and other soft tissue

495

1.28

1.09

1.3

1.4

26.83

28.28

u/l

0.13

413

Disorders of vitreous body and globe

221

1900

1.14

1.09

1.4

1.3

36.37

36.36

u/l

0.00

170

1542

Alcohol withdrawal state with delirium

160

1.50

1.09

1.4

1.3

24.26

25.30

u/l

0.04

121

Purpura and other haemorrhagic conditions

602

1.25

1.09

1.4

28.86

24.14

u/l

0.52

504

Other diseases of the respiratory system

460

1.28

1.08

1.3

1.4

25.05

28.98

u/l

0.40

382

Other respiratory disorders and diseases

460

1.28

1.08

1.3

1.4

25.05

28.98

u/l

0.40

382

Type 1 diabetes

185

1612

1.15

1.07

1.4

18.43

22.13

u/l

1.05

145

1340

Gout, unspecified

312

1.35

1.07

1.3

1.4

25.81

24.74

u/l

0.06

254

Asthma/COPD (KELA code 203)

877

5804

1.07

1.3

23.52

25.22

u/l

0.92

721

4802

Other and unspecified disorders of white blood cells

161

1.50

1.07

1.5

1.4

33.94

22.95

u/l

0.72

134

Contact with nonpowered hand tool

153

1.51

1.06

1.3

1.4

16.44

19.27

u/l

0.22

125

Stroke, excluding SAH

154

1327

0.86

1.06

1.3

35.22

31.22

u/l

0.68

115

1089

Other and unspecified disease of Bartholin gland

137

1.54

1.06

1.3

1.4

20.33

28.25

u/l

0.34

116

Disorders of gallbladder, biliary tract and pancreas

830

5014

1.07

1.06

1.4

1.3

27.25

28.89

u/l

0.76

668

4115

Pedal cyclist injured in transport accident

161

1393

1.16

1.06

1.4

18.88

23.64

u/l

1.35

128

1157

Other keratitis

668

1.23

1.05

1.4

22.44

22.88

u/l

0.04

553

Coronary angioplasty

593

0.79

1.05

1.1

1.3

31.07

27.20

u/l

0.36

476

Syphilis

1.72

1.05

1.5

1.3

29.07

24.60

u/l

—

Abnormal spermatozoa

137

1.54

1.05

1.4

22.23

13.34

u/l

0.43

113

Open wound of lower leg

641

1.24

1.05

1.4

23.21

22.12

u/l

0.11

550

Suggestive for eosinophilic asthma

331

1.33

1.05

1.5

1.3

23.32

27.50

u/l

0.35

270

Other/unspecified enthesopathies of lower limb, excluding foot

401

1.30

1.05

1.6

1.4

26.53

27.76

u/l

0.11

333

Primary coxarthrosis, bilateral

596

1.24

1.05

1.2

1.3

42.72

37.33

u/l

0.52

472

Any dementia

321

0.72

1.04

1.2

1.3

46.52

33.81

u/l

0.83

259

Psoriasis

183

1600

1.15

1.04

1.3

1.4

25.34

28.75

u/l

0.88

150

1316

Inflammatory bowel disease

259

2316

1.12

1.04

1.4

24.07

24.42

u/l

0.06

214

1915

Divergent concomitant strabismus

535

1.26

1.03

1.5

1.4

21.06

26.16

u/l

0.75

440

Carcinoma in situ of skin of trunk

2.28

1.03

1.8

1.3

48.78

28.14

u/l

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

680

1.23

1.03

1.4

29.93

23.89

u/l

0.91

571

Other disorders of bladder

306

1.34

1.03

1.3

22.88

24.50

u/l

0.10

255

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

280

1.36

1.03

1.4

1.3

39.50

34.92

u/l

0.30

192

Other cataract

171

1151

1.15

1.02

1.4

1.3

32.92

34.28

u/l

0.20

136

930

Benign neoplasm of major salivary glands

272

1.36

1.02

1.2

1.4

19.63

27.64

u/l

0.97

202

Acute appendicitis

654

5756

1.07

1.02

1.3

27.83

25.64

u/l

0.93

542

4733

Benign neoplasm of bone and articular cartilage

447

1.28

1.02

1.5

1.4

27.91

23.46

u/l

0.39

347

Haemangioma and lymphangioma, any site

474

1.27

1.01

1.2

1.4

27.77

27.94

u/l

0.01

386

Alzheimer disease

190

0.63

1.01

1.3

55.66

39.54

u/l

—

150

Varicose veins

345

2866

0.91

1.00

1.3

38.79

36.82

u/l

0.44

281

2304

Peripheral arterial reconstruction

205

1.42

1.00

1.4

1.3

34.54

27.10

u/l

0.47

167

Bronchitis, not specified as acute or chronic

343

1.32

0.99

1.2

1.3

16.49

23.81

u/l

1.22

284

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

136

1171

1.17

0.99

1.4

22.53

28.30

u/l

1.53

116

965

Recurring oral aphthae

189

1.44

0.99

1.3

1.4

22.76

23.49

u/l

0.04

154

Optic neuritis

344

1.32

0.99

1.3

1.4

24.88

23.37

u/l

0.14

293

Specific development disorders of speech and language

272

1.35

0.98

1.3

1.4

8.44

12.31

u/l

1.01

243

COPD, hospital admissions 1, only main diagnosis

580

1.22

0.98

1.2

1.3

28.73

31.02

u/l

0.26

466

Lesion of plantar nerve

223

1.40

0.98

1.4

33.45

41.53

u/l

0.56

185

Malignant neoplasm of tonsil

2.19

0.98

1.4

1.3

33.94

43.23

u/l

—

Primary gonarthrosis, bilateral

186

1430

1.14

0.98

1.3

35.22

38.70

u/l

0.67

152

1159

Major anomalies of jaw size

173

1.46

0.98

1.5

1.4

31.19

23.88

u/l

0.43

145

Insulin, fast-acting or short human

224

1993

1.12

0.98

1.3

1.4

19.89

22.90

u/l

0.83

174

1640

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.98

0.0

1.6

—

21.82

—

Caught, crushed, jammed or pinched in or between objects

249

1.37

0.98

1.2

1.4

21.77

19.67

u/l

0.12

210

Primary open-angle glaucoma, strict

446

0.74

0.97

1.2

1.3

31.16

36.96

u/l

0.38

360

ILD medications: immunosuppressive drugs

513

4562

1.08

0.96

1.3

28.09

26.47

u/l

0.51

427

3740

Dental pulpitis 3, only avohilmo

140

881

1.16

0.96

1.4

5.94

7.38

u/l

1.97

127

778

Other disorders of prostate

0.00

0.96

0.0

1.1

—

15.13

—

Gout, idiopatic and unspecified

407

1.28

0.95

1.3

25.08

24.66

u/l

0.03

334

Labour and delivery complicated by fetal stress [distress]

469

2892

1.09

0.95

1.3

1.4

17.34

23.00

u/l

5.28

412

2364

114

971

1.18

0.95

1.6

1.4

22.80

25.03

u/l

0.35

798

Villonodular synovitis (pigmented)

1.91

0.94

1.1

1.4

31.83

32.26

u/l

—

Exposure to unspecified factor

765

6306

0.94

1.4

1.3

24.22

24.88

u/l

0.23

623

5223

Benign neoplasm: Adrenal gland

242

1.37

0.94

1.3

1.4

25.31

33.11

u/l

0.72

197

Diabetic nephropathy, excluding more controls

559

0.79

0.94

1.3

1.4

21.33

18.33

u/l

0.25

456

Synovial cyst of popliteal space [Baker]

225

1.38

0.94

1.5

1.4

40.51

35.21

u/l

0.34

187

Reactive arthropathies, FINNGEN

364

1.30

0.94

1.4

29.42

23.73

u/l

0.43

297

Glaucoma secondary to other eye disorders

116

0.52

0.94

1.7

1.5

17.38

26.86

u/l

—

Atrial fibrillation and flutter

129

979

0.86

0.94

1.2

1.4

30.70

34.64

u/l

0.57

104

781

Crushed, pushed or stepped on by crowd or human stampede

444

1.27

0.94

1.5

1.4

18.32

16.91

u/l

0.14

381

Contact with other sharp object(s)

382

1.29

0.94

1.4

1.3

13.43

19.56

u/l

1.15

322

Other strabismus

196

1733

1.13

0.93

1.5

1.3

22.93

24.03

u/l

0.18

158

1434

Melanocytic naevi of other and unspecified parts of face

347

1.30

0.93

1.5

1.4

19.13

25.56

u/l

0.87

289

Barrett oesophagus

101

1.59

0.93

1.3

20.57

34.28

u/l

—

Chronic nephritic syndrome

144

0.55

0.93

1.1

1.4

33.76

25.84

u/l

—

118

Cholelithiasis, broad definition with cholecystitis

738

4754

1.06

0.92

1.4

1.3

26.95

30.07

u/l

1.90

595

3894

Adult respiratory distress syndrome

2.16

0.92

1.5

29.82

31.00

u/l

—

Follicular lymphoma

1.67

0.91

1.4

1.2

37.92

32.29

u/l

0.24

Pleural plaque

1.67

0.91

1.2

1.3

23.18

17.26

u/l

0.34

Delivery, wide proxy

324

1567

1.10

0.91

1.3

1.4

20.40

20.88

u/l

0.10

278

1292

Congenital malformations of the musculoskeletal system, not elsewhere classified

143

1.49

0.91

1.5

1.4

25.93

19.62

u/l

0.42

123

Granulomatous disorders of skin and subcutaneous tissue

151

1.47

0.91

1.4

24.08

21.79

u/l

0.14

127

Other and unspecified injuries of head

244

1.36

0.91

1.3

1.4

15.24

22.71

u/l

1.09

203

Transient ischemic attack

181

1324

1.13

0.91

1.4

1.3

33.89

33.25

u/l

0.09

143

1079

Bleeding

450

3026

1.08

0.90

1.4

1.3

25.29

29.30

u/l

1.91

365

2478

Other general symptoms and signs

276

1.33

0.90

1.5

1.3

29.22

21.99

u/l

0.50

226

Dislocation, sprain and strain of joints and ligaments of knee

569

4938

1.07

0.89

1.3

1.4

22.55

25.51

u/l

1.64

465

4077

Ischaemic Stroke, excluding all haemorrhages

137

1191

0.87

0.89

1.4

1.3

34.16

31.19

u/l

0.43

103

975

Insulin, combination of fast acting with intermediate-acting or long-acting

334

2817

1.09

0.88

1.3

1.4

21.56

24.97

u/l

1.32

263

2310

Heart failure and bmi 25plus

595

0.82

0.88

1.3

34.21

28.37

u/l

0.64

464

Viral warts

611

1.21

0.88

1.6

1.4

17.55

22.37

u/l

0.77

520

ILD medications: azathioprine

113

970

1.17

0.87

1.3

1.4

25.96

23.53

u/l

0.33

804

Complications of the puerperium, not elsewhere classified

548

0.78

0.86

1.4

20.31

24.66

u/l

0.52

469

Disorders of orbit

212

1.37

0.86

1.4

31.46

28.82

u/l

0.13

176

Calcaneal spur

1.83

0.86

1.1

1.4

15.84

35.07

u/l

—

Adverse effects, not elsewhere classified

181

1608

1.13

0.86

1.4

22.59

24.35

u/l

0.31

153

1329

Perichondritis of external ear

1.83

0.86

1.5

1.4

20.23

26.34

u/l

—

Senile cataract

189

1318

0.89

0.86

1.3

33.96

36.92

u/l

0.46

148

1061

Benign neoplasm: Skin, unspecified

153

1.44

0.86

1.4

28.48

25.43

u/l

0.15

114

Ischaemic heart disease, wide definition

279

1922

0.91

0.85

1.3

1.4

33.98

35.25

u/l

0.25

230

1538

Covid-19 confirmed case

194

1731

1.12

0.85

1.4

24.09

22.91

u/l

0.20

170

1435

Other degenerative diseases of the nervous system

121

791

1.16

0.85

1.3

30.40

28.48

u/l

0.22

661

Otosclerosis

273

1.32

0.85

1.2

1.4

30.69

31.22

u/l

0.04

228

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

335

1.29

0.85

1.3

1.4

27.81

28.73

u/l

0.06

266

Localized adiposity

1.97

0.85

1.7

1.5

10.18

37.14

u/l

—

Paralytic ileus and intestinal obstruction

824

1.18

0.84

1.3

32.68

30.89

u/l

0.22

671

Other congenital malformations of face and neck

196

1.39

0.84

1.3

1.4

22.34

20.47

u/l

0.11

164

Benign neoplasm: Liver/bile ducts

137

1.47

0.84

1.4

1.3

23.94

25.83

u/l

0.09

107

Allergic conjunctivitis

535

5627

0.93

0.84

1.5

1.3

23.62

26.30

u/l

1.20

432

4647

Respiratory and cardiovascular disorders specific to the perinatal period

101

0.53

0.84

1.2

1.5

5.45

9.98

u/l

—

Other specified/unspecified deforming dorsopathies

129

1.49

0.84

1.3

1.4

27.39

29.14

u/l

0.09

110

Multiple delivery

107

920

1.17

0.83

1.3

1.4

32.57

30.06

u/l

0.30

735

Neovascular glaucoma

115

0.52

0.82

1.7

1.5

17.38

25.42

u/l

—

Gout

428

1.24

0.82

1.3

24.88

27.42

u/l

0.19

356

Congenital malformations of the circulatory system

792

1.18

0.82

1.4

21.09

21.37

u/l

0.03

674

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

1.66

0.82

1.2

1.5

8.30

16.30

u/l

1.61

Mixed conductive and sensorineural hearing loss

381

1.26

0.82

1.4

23.79

29.61

u/l

0.70

314

Personal history of certain other diseases

155

1.43

0.82

1.5

1.4

12.79

12.76

u/l

0.00

136

Other heart diseases, wide

907

5343

1.05

0.81

1.4

1.3

27.32

26.46

u/l

0.33

750

4390

Other and unspecified disorders of vitreous body

166

1465

1.13

0.81

1.4

1.3

40.10

39.29

u/l

0.10

126

1185

Intermittent heterotropia

400

1.25

0.81

1.6

1.4

22.21

17.26

u/l

0.45

348

Abnormal findings on antenatal screening of mother

137

1203

1.14

0.81

1.5

1.4

18.05

17.72

u/l

0.05

120

1009

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

511

5364

0.94

0.80

1.5

1.3

23.78

26.32

u/l

1.06

411

4429

Other congenital malformations of the digestive system

197

1.37

0.79

1.4

21.72

16.92

u/l

0.40

168

Other and unspecified disorders of psychological development

1.69

0.79

1.3

1.5

6.72

12.16

u/l

—

Foreign body in ear

106

1.52

0.79

1.1

1.4

8.59

17.94

u/l

—

Benign neoplasm: Other and unspecified parts of small intestine

1.83

0.79

1.7

1.3

12.93

39.19

u/l

—

Short stature, not elsewhere classified

1.57

0.78

1.8

1.2

11.17

9.53

u/l

0.14

Carbimazole or st.post thyroidectomy, condition for graves disease

183

1639

1.12

0.78

1.3

1.4

28.55

29.52

u/l

0.14

150

1345

Injury of eye and orbit

730

1.18

0.78

1.4

25.39

22.17

u/l

0.42

623

Abnormalities of gait and mobility

314

1.28

0.76

1.5

1.4

30.45

25.66

u/l

0.42

259

Gout, FINNGEN

476

1.22

0.75

1.3

1.4

24.88

25.66

u/l

0.05

391

Chronic kidney disease

610

1.19

0.75

1.3

1.4

39.11

26.24

u/l

1.49

498

Prurigo nodularis

1.61

0.75

1.2

1.4

24.07

29.87

u/l

—

Acute appendicitis, no complications

541

5074

1.06

0.75

1.4

1.3

27.00

25.27

u/l

0.59

445

4171

Malignant neoplasm of oropharynx

2.09

0.74

1.4

1.3

33.94

42.27

u/l

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

496

1.21

0.74

1.3

38.97

33.41

u/l

0.50

350

Focal brain injury

141

1.42

0.74

1.5

1.4

11.41

24.06

u/l

1.89

120

Other complications of labour and delivery, not elsewhere classified

180

1559

1.12

0.74

1.4

13.72

16.03

u/l

0.83

165

1308

Glaucoma

176

1721

0.90

0.74

1.4

1.3

34.21

34.22

u/l

0.00

139

1403

Obstructed labour due to malposition and malpresentation of fetus

364

3184

1.08

0.74

1.4

26.68

27.76

u/l

0.25

312

2573

Other arthritis (FG)

215

1950

1.10

0.74

1.4

29.31

28.30

u/l

0.16

176

1615

Visual field defects

307

1.27

0.73

1.9

1.4

20.83

26.17

u/l

0.55

254

Dermatographic urticaria

534

1.20

0.72

1.6

1.4

18.89

24.72

u/l

0.83

457

Amputation

159

1.39

0.72

1.5

1.3

32.34

24.94

u/l

0.30

129

Other renal tubulo-interstitial diseases

168

1.38

0.72

1.2

1.4

25.94

24.64

u/l

0.06

135

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

117

1.46

0.71

1.3

41.17

32.55

u/l

0.24

Placenta praevia

637

1.18

0.71

1.4

25.70

23.09

u/l

0.26

536

Insulin medication

334

2645

1.08

0.71

1.3

21.56

26.29

u/l

2.17

263

2177

Allergic purpura

177

1.36

0.71

1.8

1.4

21.61

22.24

u/l

0.04

148

Toxic effect of ethanol

238

1.31

0.71

1.5

1.4

18.27

16.98

u/l

0.11

203

Gestational [pregnancy-induced] hypertension

351

3765

0.93

0.70

1.3

1.4

21.74

25.21

u/l

1.43

299

3085

Dental caries 3 and operation codes, only avohilmo

287

1568

0.92

0.70

1.4

22.36

24.01

u/l

0.42

246

1300

Childhood asthma (age<16), excluding more controls

152

1075

1.12

0.70

1.2

1.4

12.78

14.34

u/l

0.35

127

942

Phlebitis and thrombophlebitis (not including DVT)

134

1188

1.13

0.70

1.4

1.3

28.42

29.64

u/l

0.17

110

967

Childhood asthma (age<16)

152

1076

1.12

0.70

1.2

1.4

12.78

14.47

u/l

0.39

127

944

Other diseases of intestine

363

1.24

0.70

1.3

1.4

29.09

31.29

u/l

0.14

299

Voice disturbances

188

1700

1.11

0.70

1.4

33.88

31.28

u/l

0.39

147

1390

Atrial septal defect

185

1.35

0.69

1.5

1.4

17.19

19.88

u/l

0.20

157

Hydrocephalus

169

1.36

0.69

2.3

1.3

20.64

27.13

u/l

0.54

139

Non-ischemic cardiomyopathy

538

1.18

0.68

1.3

1.4

29.93

30.81

u/l

0.08

430

Aphakia

1.86

0.68

1.0

1.6

14.38

18.43

u/l

—

Coagulation defects, purpura and other haemorrhagic conditions

129

1144

1.13

0.68

1.5

1.4

24.06

24.54

u/l

0.06

105

953

Dislocation, sprain and strain of joints and ligaments of elbow

383

1.23

0.68

1.5

1.4

22.13

21.10

u/l

0.07

327

Glaucoma suspect

141

1257

1.12

0.68

1.4

35.26

33.48

u/l

0.22

114

1024

Fracture of lumbar spine and pelvis

611

1.18

0.67

1.4

31.11

26.79

u/l

0.36

508

STROKE

293

2199

0.92

0.67

1.3

1.4

35.12

33.20

u/l

0.42

231

1788

Mandibular prognathia

1.50

0.67

1.9

1.4

9.15

18.76

u/l

1.61

Endocrine disorders, other/unspecified

0.53

0.67

1.4

13.56

25.92

u/l

—

Dental caries 1 and operation codes, only avohilmo

235

1292

0.91

0.67

1.4

21.83

24.57

u/l

0.73

194

1071

Organic, including symptomatic, mental disorders

116

736

1.14

0.67

1.4

1.3

28.67

29.48

u/l

0.09

591

Other obstructed labour

743

1.16

0.67

1.3

1.4

30.13

30.24

u/l

0.01

607

Azathioprine

113

995

1.14

0.67

1.3

25.96

23.80

u/l

0.29

822

Type 1 diabetes, wide definition, subgroup 1

156

1400

1.11

0.66

1.3

1.4

17.74

22.01

u/l

1.15

123

1165

Hereditary ataxia

1.79

0.66

1.0

1.5

49.18

25.55

u/l

—

Discitis, unspecified

1.79

0.66

1.2

1.5

51.82

22.60

u/l

—

Congenital malformations of eye, ear, face and neck

448

1.21

0.66

1.3

1.4

17.88

18.29

u/l

0.04

386

Follicular lymphoma, hilmo

1.52

0.66

1.4

1.2

37.92

37.39

u/l

0.02

Dementia in other diseases classified elsewhere

1.52

0.66

1.2

1.4

29.46

29.22

u/l

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

321

1.25

0.66

1.3

30.47

33.82

u/l

0.24

229

Atrophic disorders of skin

781

1.15

0.66

1.3

24.63

31.49

u/l

1.64

637

Other necrotizing vasculopathies

197

1.32

0.65

1.9

1.4

33.20

27.30

u/l

0.35

156

Influenza and pneumonia

948

5970

1.04

0.65

1.3

1.4

24.62

25.14

u/l

0.20

785

4930

Injury of muscle and tendon at hip and thigh level

458

1.20

0.65

1.6

1.4

25.79

28.77

u/l

0.28

370

Respiratory insufficiency

111

1.44

0.65

1.4

1.3

14.78

29.45

u/l

—

Endovascular or surgical operations to intracerebral aneurysms

215

1.31

0.65

1.5

1.4

30.62

33.51

u/l

0.19

177

Antenatal screening

382

2010

1.07

0.64

1.4

22.93

29.02

u/l

3.25

339

1590

Benign neoplasm: Parotid gland

233

1.29

0.64

1.2

1.4

21.20

26.66

u/l

0.50

174

Primary open-angle glaucoma

523

0.82

0.64

1.3

34.21

35.93

u/l

0.10

422

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

1.73

0.64

1.0

1.2

30.88

22.98

u/l

—

Paroxysmal tachycardia

171

1308

1.11

0.63

1.4

23.71

27.93

u/l

1.08

139

1071

Any dementia, excluding more controls

289

0.79

0.63

1.2

1.3

46.52

34.64

u/l

0.75

240

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

109

931

1.13

0.63

1.4

19.35

21.04

u/l

0.25

786

Carcinoma in situ of cervix uteri

124

1105

1.13

0.63

1.3

1.4

18.62

21.05

u/l

0.44

937

Dementia

386

0.82

0.63

1.3

36.15

33.60

u/l

0.17

318

Diseases of arteries, arterioles and capillaries

223

1813

0.92

0.63

1.3

30.38

28.63

u/l

0.30

188

1478

Disorders of lens

273

1862

0.92

0.63

1.4

1.3

33.04

35.39

u/l

0.46

214

1493

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

1.55

0.62

1.2

1.3

30.78

31.60

u/l

0.03

Diffuse large B-cell lymphoma, helper endpoint

1.55

0.62

1.2

1.3

30.78

31.60

u/l

0.03

Ptosis of eyelid

297

1.25

0.62

1.4

1.3

18.05

31.28

u/l

2.56

247

Other benign neoplasm of uterus: Corpus uteri

1.68

0.61

1.0

1.6

38.08

39.68

u/l

—

Kyphosis

1.67

0.61

1.8

1.4

28.10

26.35

u/l

—

Gonarthrosis, primary, with knee surgery

176

1305

1.10

0.61

1.3

37.76

39.50

u/l

0.27

131

1060

Herpesviral [herpes simplex] infections

749

1.15

0.61

1.4

21.43

25.79

u/l

0.83

621

Other obstetric conditions, not elsewhere classified

610

4167

0.95

0.61

1.4

16.87

22.28

u/l

5.51

527

3459

Other disorders of the musculoskeletal system and connective tissue

600

1.17

0.61

1.5

1.3

32.98

30.11

u/l

0.29

483

Acute tubulo-interstitial nephritis

466

3901

1.06

0.61

1.3

1.4

24.30

25.74

u/l

0.45

386

3212

Interstitial lung disease

301

0.76

0.60

1.2

1.4

24.69

30.83

u/l

0.60

246

Interstitial lung disease endpoints

301

0.76

0.60

1.2

1.4

24.69

30.83

u/l

0.60

246

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

115

887

0.89

0.60

1.4

1.3

39.32

36.86

u/l

0.32

654

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1121

0.88

0.60

1.3

25.54

22.82

u/l

0.38

933

Complications predominantly related to the puerperium

339

3173

1.07

0.60

1.3

1.4

24.74

25.38

u/l

0.14

271

2615

Other specified/unspecified bacterial intestinal infections

245

1.27

0.59

1.1

1.4

27.43

26.27

u/l

0.06

199

Other interstitial pulmonary diseases

300

0.77

0.59

1.2

1.4

24.69

30.60

u/l

0.57

245

Burns and corrosions confined to eye and internal organs

157

1.34

0.59

1.6

1.3

21.34

22.90

u/l

0.09

133

Benign neoplasm: Lower jaw bone

0.00

0.59

0.0

1.3

—

26.19

—

Benign neoplasm: Skin of trunk

175

1.32

0.58

1.4

1.3

28.65

24.35

u/l

0.21

134

Myotonic disorders

1.73

0.58

1.3

1.5

29.48

26.15

u/l

—

Other hammer toe(s) (acquired)

461

1.18

0.58

1.3

1.4

39.50

43.38

u/l

0.37

385

Other acute skin changes due to ultraviolet radiation

123

1.39

0.58

1.2

1.4

45.89

26.64

u/l

0.87

Cerebral aneurysm, nonruptured

373

1.21

0.58

1.4

28.91

32.47

u/l

0.32

307

Nonhereditary hypogammaglobulinemia

1.49

0.57

1.4

1.5

35.40

23.76

u/l

—

Symptoms and signs involving speech and voice

216

1991

1.09

0.57

1.4

33.46

31.08

u/l

0.38

167

1635

Intestinal stricture

120

1074

1.12

0.57

1.4

33.17

30.90

u/l

0.32

104

866

ILD, hospital admissions

298

0.77

0.57

1.2

1.4

24.69

31.01

u/l

0.63

243

Viral pneumonia

493

1.18

0.57

1.2

1.4

27.66

22.98

u/l

0.51

411

Synovial hypertrophy, not elsewhere classified

1.46

0.56

1.1

1.4

20.46

24.55

u/l

—

Other and/or unspecified nontoxic goitre

338

1.22

0.56

1.3

34.18

35.97

u/l

0.13

277

Idiopathic gout

124

1.37

0.55

1.2

1.3

16.22

22.37

u/l

0.36

Other disorders of white blood cells

221

1.27

0.55

1.6

1.4

29.85

24.12

u/l

0.35

182

Maxillary prognathism

1.60

0.55

1.7

1.6

6.77

22.82

u/l

—

Chondropathies

116

1041

1.12

0.54

1.3

23.47

23.92

u/l

0.05

859

Sulfonylureas

454

1.16

0.54

1.3

22.73

34.48

u/l

2.66

365

Pilonidal cyst

552

1.16

0.54

1.3

1.4

18.90

19.17

u/l

0.03

465

Anomalies of pupillary function

125

1.37

0.54

1.3

1.4

19.55

20.72

u/l

0.07

109

Oral lichen ruber planus, hypothyreosis or thyroxin

1.48

0.54

1.7

1.5

32.60

36.62

u/l

—

malignant neoplasm of female genital organs

552

1.16

0.54

1.4

47.76

37.49

u/l

1.39

446

Other and unspecified hydrocephalus

1.48

0.54

3.3

1.4

9.37

29.33

u/l

—

Ulcerative proctitis

386

1.20

0.53

1.2

1.4

24.14

22.78

u/l

0.10

322

Twin gestation

150

1368

1.10

0.53

1.3

1.4

30.20

27.68

u/l

0.37

130

1125

Long labour

377

3107

1.06

0.53

1.4

23.76

26.10

u/l

0.75

325

2521

Alzheimer’s disease, wide definition

152

0.71

0.53

1.3

1.2

58.20

41.30

u/l

—

118

Skin changes due to chronic exposure to nonionizing radiation

567

1.15

0.52

1.3

42.98

35.99

u/l

0.74

461

Lung diseases due to external agents

304

1.22

0.52

1.2

1.4

27.05

25.67

u/l

0.07

250

Traumatic subdural haemorrhage

149

1.32

0.52

1.5

1.3

13.11

28.14

u/l

2.81

132

Melanocytic naevi of lower limb, including hip

223

1.26

0.52

2.0

1.3

35.18

24.44

u/l

0.64

174

Type 1 diabetes, wide definition

160

1462

1.09

0.52

1.3

1.4

18.13

22.13

u/l

1.04

126

1213

Multiple gestation

155

1418

1.10

0.52

1.3

1.4

30.87

27.76

u/l

0.49

134

1160

Other specified and unspecified strabismus

1.41

0.51

1.4

1.5

15.92

20.18

u/l

—

Sensorineural hearing loss

371

2449

1.06

0.51

1.3

30.99

32.80

u/l

0.44

299

1983

Other osteochondropathies

388

1.19

0.51

1.2

1.4

25.77

22.57

u/l

0.26

318

Varicose veins of other sites

188

1.28

0.51

1.4

33.34

24.13

u/l

0.43

151

Inguinal hernia

250

1808

0.93

0.51

1.4

23.35

21.85

u/l

0.33

201

1517

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

206

1.26

0.50

1.5

1.3

49.36

30.89

u/l

1.17

140

Complications of genitourinary prosthetic devices, implants and grafts

118

1.36

0.50

1.1

1.5

28.90

25.72

u/l

0.13

102

Hereditary deficiency of other clotting factors

1.51

0.50

2.4

1.5

15.19

23.50

u/l

—

Dementia, including avohilmo

427

0.86

0.50

1.3

34.53

32.84

u/l

0.13

352

Generalized epilepsy

279

1.22

0.50

1.4

1.3

15.20

19.39

u/l

0.47

242

Other appendicitis

482

1.16

0.50

1.4

28.08

27.24

u/l

0.07

406

Coxarthrosis, primary

192

1540

1.08

0.49

1.3

37.47

37.77

u/l

0.04

149

1236

Seropositive rheumatoid arthritis, wide

120

1324

0.91

0.49

1.4

1.3

31.31

32.18

u/l

0.10

1086

Rheumatoid arthritis, including avohilmo

196

2115

0.93

0.49

1.4

32.21

31.87

u/l

0.04

158

1721

Injuries to the shoulder and upper arm

536

4290

1.05

0.49

1.3

1.4

25.53

27.40

u/l

0.62

431

3534

Benign neoplasm: Liver

154

1.31

0.49

1.4

23.94

28.28

u/l

0.24

129

Actinic keratosis

520

1.15

0.49

1.3

45.36

36.40

u/l

0.97

423

Other congenital malformations

661

1.14

0.48

1.4

22.00

22.29

u/l

0.03

565

DVT of lower extremities

699

1.13

0.48

1.4

1.3

25.86

30.69

u/l

0.76

559

Mandibular retrognathia AND surgery (BSSRO)

217

1.25

0.48

1.4

14.74

24.13

u/l

1.45

184

Oral lichen ruber planus

1.45

0.48

1.8

1.3

40.13

34.76

u/l

0.21

Hallux valgus (acquired)

237

1600

1.07

0.48

1.4

1.3

38.29

36.92

u/l

0.22

181

1318

Respiratory conditions due to other external agents

1.49

0.47

1.1

1.5

39.89

33.19

u/l

—

Non-Hodgkin lymphoma, all

1.49

0.47

1.7

1.3

29.43

28.30

u/l

—

Fall on same level

1099

5949

1.03

0.46

1.4

1.3

25.94

24.41

u/l

0.77

864

4973

Sub-endpoint used in defining T1D endpoints

188

1715

1.08

0.46

1.4

18.57

21.64

u/l

0.82

148

1422

Other diseases of pericardium

120

1.34

0.46

1.8

1.3

35.08

25.89

u/l

0.47

Other/unspecified seropositive rheumatoid arthritis

119

1307

0.91

0.46

1.4

31.43

32.32

u/l

0.10

1072

Otitis media, unspecified

777

1.12

0.46

1.5

1.4

10.67

15.66

u/l

2.10

676

Volvulus

0.60

0.45

1.2

1.5

30.56

28.75

u/l

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

192

1.26

0.45

1.3

1.4

15.71

14.13

u/l

0.13

167

Poisoning by medicine, drug-induced

1.41

0.45

2.0

1.4

17.42

24.98

u/l

0.63

Secondary polycythaemia

1.45

0.44

1.1

1.4

11.18

26.47

u/l

—

Use of ropinirole

1.45

0.44

1.2

1.3

43.68

37.92

u/l

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

603

4072

0.96

0.44

1.4

1.3

15.91

21.84

u/l

7.28

520

3379

Hypertensive Heart Disease

307

1.17

0.43

1.4

1.3

35.10

31.29

u/l

0.27

254

Benign neoplasm of bone and articular cartilage

498

1.15

0.43

1.5

1.4

27.91

25.03

u/l

0.23

413

Fibrosis and cirrhosis of liver

220

1.23

0.43

1.3

38.56

31.49

u/l

0.31

178

Melanoma in situ of lower limb, including hip

1.63

0.43

1.6

1.5

51.16

42.07

u/l

—

Nonspecific lymphadenitis

433

1.16

0.43

1.4

29.96

28.59

u/l

0.11

351

Seropositive rheumatoid arthritis, strict definition

777

0.89

0.43

1.4

1.3

34.73

31.17

u/l

0.28

631

Meniscus derangement

367

2386

1.05

0.43

1.3

32.24

31.93

u/l

0.06

301

1964

Impetigo

285

1.20

0.42

1.5

1.4

16.40

20.11

u/l

0.38

236

Cerebrovascular diseases (FINNGEN)

192

1473

0.93

0.42

1.3

1.4

32.62

33.19

u/l

0.08

147

1186

Pneumocystosis

1.57

0.42

1.6

1.5

22.80

27.94

u/l

—

Superficial injuries involving multiple body regions

149

1.28

0.42

1.4

28.95

19.16

u/l

0.62

126

Congenital deformities of feet

158

1.27

0.42

1.6

1.4

21.84

18.89

u/l

0.16

139

Conductive and sensorineural hearing loss

428

2829

1.05

0.42

1.3

31.54

32.47

u/l

0.21

344

2305

Injuries to unspecified part of trunk, limb or body region

425

1.15

0.41

1.4

24.36

21.77

u/l

0.27

353

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

114

1246

0.91

0.41

1.3

1.4

25.69

23.73

u/l

0.28

1031

Benign neoplasm: Lower jaw bone

0.00

0.41

0.0

1.1

—

30.09

—

Carcinoma in situ of rectum

0.00

0.41

0.0

1.1

—

43.15

—

Contact with sharp object, undetermined intent

105

1.34

0.41

1.2

1.4

36.50

19.25

u/l

0.69

Myocardial infarction

110

865

0.91

0.41

1.2

1.4

38.25

29.64

u/l

1.57

685

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

398

1.16

0.40

1.8

1.4

33.26

28.13

u/l

0.41

305

Melanocytic naevi of eyelid, including canthus

1.48

0.40

1.0

1.3

43.58

30.29

u/l

—

Other coagulation defects

464

1.14

0.40

1.6

1.4

18.22

23.79

u/l

0.72

394

Congenital malformations of cardiac septa

331

1.17

0.40

1.6

1.4

15.42

19.04

u/l

0.44

283

Ectropion of eyelid

1.47

0.40

1.4

1.3

19.24

21.55

u/l

—

Other specified/unspecified arthritis

174

1622

1.07

0.40

1.4

1.3

30.03

28.72

u/l

0.18

142

1352

Injury of muscle and tendon at lower leg level

634

1.12

0.40

1.3

1.4

23.92

25.36

u/l

0.15

522

Other viral diseases, not elsewhere classified

150

1387

1.08

0.40

1.5

1.4

22.94

22.95

u/l

0.00

124

1152

Ulcerative colitis (strict definition, all Crohn cases excluded)

971

0.91

0.40

1.4

23.82

22.82

u/l

0.11

814

Distal bite

258

1.20

0.39

1.4

1.5

24.79

15.62

u/l

0.76

227

Unspecified lump in breast

107

1169

0.91

0.39

1.2

1.4

33.29

32.69

u/l

0.06

959

Neurofibromatosis, type 1

1.44

0.39

1.0

1.3

7.66

22.90

u/l

—

Septal defects

318

1.17

0.39

1.6

1.4

16.00

19.00

u/l

0.32

272

Coxarthrosis, primary, with hip surgery

119

1037

1.09

0.38

1.2

1.3

38.84

37.32

u/l

0.16

838

Pyoderma gangrenosum

1.40

0.38

2.2

1.4

23.28

21.39

u/l

—

Pedal cyclist injured in noncollision transport accidents

646

1.12

0.38

1.5

1.4

17.78

23.10

u/l

0.72

534

Rheumatic valve diseases

1.39

0.38

1.6

32.08

31.04

u/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

119

1291

0.92

0.38

1.4

31.43

32.35

u/l

0.10

1057

724

1.10

0.38

1.3

44.67

34.43

u/l

1.45

584

Benign neoplasm: Skin, unspecified

179

1.23

0.37

1.4

28.48

27.50

u/l

0.04

144

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

521

3179

1.04

0.37

1.4

32.27

30.03

u/l

0.75

430

2599

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

145

1.20

0.37

1.5

1.2

8.67

11.81

u/l

0.63

Ulcerative colitis (strict definition, require KELA)

106

1153

0.92

0.36

1.3

25.14

22.92

u/l

0.31

959

Other respiratory diseases principally affecting the interstitium

375

0.85

0.36

1.3

1.4

34.07

29.90

u/l

0.28

307

Secondary thrombocytopenia

1.47

0.36

1.3

1.6

67.47

28.07

u/l

—

Abnormal serum enzyme levels

697

1.11

0.36

1.4

1.3

28.54

21.45

u/l

0.89

575

Benign neoplasm: Long bones of lower limb

171

1.23

0.36

1.3

1.4

27.14

19.82

u/l

0.30

138

Congenital malformations of pulmonary and tricuspid valves

1.44

0.36

2.0

1.5

12.40

15.00

u/l

—

Benign neoplasm: Liver/bile ducts

162

1.24

0.35

1.4

23.94

27.43

u/l

0.19

135

Congenital malformations of eyelid, lacrimal apparatus and orbit

1.44

0.35

1.3

1.5

22.80

14.50

u/l

—

Sleep disorders, other/unspecified

245

1.19

0.35

1.7

1.4

31.14

21.77

u/l

0.59

204

Benign neoplasm: Other and unspecified parts of small intestine

1.40

0.35

1.7

1.5

12.93

38.63

u/l

—

Abnormal blood-pressure reading, without diagnosis

199

1.21

0.35

1.3

1.4

29.01

26.10

u/l

0.12

166

Other diseases of oesophagus

273

1.17

0.35

1.3

1.4

22.22

28.13

u/l

0.35

224

Other disorders of optic disc

1.38

0.35

2.5

1.5

16.50

23.17

u/l

—

severe traumatic brain injury, does not include concussion

546

1.12

0.34

1.5

1.4

10.59

25.17

u/l

8.47

450

Mental and behavioural disorders due to cannabinoids

172

1.22

0.34

1.3

1.4

9.98

12.03

u/l

0.23

147

Major coronary heart disease event excluding revascularizations

159

1172

0.94

0.34

1.3

34.35

31.97

u/l

0.35

131

942

Ulcerative colitis

180

1694

1.06

0.34

1.4

25.84

24.40

u/l

0.26

149

1412

Renal tubulo-interstitial diseases

633

5009

0.97

0.34

1.4

26.63

25.55

u/l

0.34

526

4119

Hernia

702

4618

1.03

0.33

1.4

1.3

28.46

28.01

u/l

0.13

568

3787

Myocardial infarction, strict

785

0.92

0.33

1.2

1.3

37.72

29.43

u/l

1.43

620

Other metabolic disorders

105

970

1.08

0.33

1.6

1.4

29.93

28.42

u/l

0.15

801

Transient global amnesia

182

1.21

0.33

1.1

1.3

27.94

41.82

u/l

0.78

144

Other disorders of kidney and ureter

378

1.14

0.33

1.4

21.97

28.14

u/l

0.66

311

Defects in the complement system

1.28

0.32

1.5

1.4

34.30

21.87

u/l

—

L04AA Selective immunosuppressants

150

1407

1.07

0.32

1.3

1.4

31.31

27.70

u/l

0.63

127

1154

Cardiomyopathy

455

0.88

0.32

1.4

24.09

27.52

u/l

0.33

368

Supervision of normal pregnancy

331

1975

0.96

0.32

1.4

24.78

29.09

u/l

1.65

285

1561

Malignant neoplasm of rectum

183

1.20

0.31

1.5

1.3

50.92

31.21

u/l

0.98

141

Atherosclerosis, excluding cerebral and coronary sclerosis

565

0.90

0.31

1.3

29.15

30.24

u/l

0.10

454

Mental disorders, not otherwise specified

664

0.90

0.31

1.3

1.4

29.39

22.86

u/l

0.63

565

Postprocedural endocrine and metabolic disorders, not elsewhere classified

100

925

1.08

0.31

1.6

1.4

30.86

28.64

u/l

0.23

765

Degenerative macular diseases

239

1.17

0.31

1.5

1.4

28.45

34.62

u/l

0.36

193

Glomerular disorders in diseases classified elsewhere

380

1.13

0.31

1.4

30.62

21.53

u/l

0.71

312

Tic and related disorders

1.33

0.31

1.0

1.2

26.96

13.06

u/l

—

Myeloproliferative diseases

230

1.18

0.31

1.1

1.4

19.92

28.77

u/l

1.14

186

Glucosamine medication

112

961

0.93

0.30

1.4

1.3

39.60

41.11

u/l

0.17

781

Faecal incontinence

305

1.15

0.30

1.4

26.96

36.52

u/l

0.65

247

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

111

824

0.93

0.30

1.5

1.3

40.59

37.19

u/l

0.47

604

Other heart diseases

488

3116

1.03

0.30

1.4

26.97

28.73

u/l

0.55

403

2554

Pedestrian injured in transport accident

296

1.15

0.30

1.2

1.3

16.53

23.73

u/l

0.82

242

Injuries to the elbow and forearm

515

4506

1.03

0.30

1.3

1.4

25.35

26.28

u/l

0.26

398

3728

Benign neoplasm: Pancreas

1.25

0.29

2.3

1.3

46.89

35.12

u/l

—

Nontraumatic intracranial haemmorrhage

482

0.89

0.29

1.1

1.4

41.99

31.95

u/l

1.04

389

Right hemicolectomy

112

1.25

0.28

1.1

1.3

27.59

30.23

u/l

0.14

Iridocyclitis in diseases classified elsewhere

1.32

0.28

1.2

1.4

20.25

21.64

u/l

—

Injury of muscle and tendon at forearm level

1.32

0.28

1.4

10.71

22.79

u/l

—

Eustachian salpingitis and obstruction

709

1.09

0.28

1.3

1.4

16.70

21.08

u/l

1.04

599

Diffuse large B-cell lymphoma

1.30

0.28

1.2

1.4

30.78

30.13

u/l

0.03

Budesonide

883

1.08

0.27

1.3

1.4

25.26

25.34

u/l

0.01

730

Cleft lip, lip and palate or palate

116

0.77

0.27

1.1

1.5

17.89

17.57

u/l

—

Other fall from one level to another

134

1261

1.06

0.27

1.4

1.3

18.28

19.64

u/l

0.23

111

1070

Disorders of lipoprotein metabolism and other lipidaemias

397

2582

0.97

0.27

1.3

30.86

33.80

u/l

0.90

310

2103

Disorders in reading

104

1.26

0.26

1.5

1.4

14.45

12.57

u/l

0.09

Systemic atrophies primarily affecting the central nervous system

104

1.25

0.26

1.1

1.4

28.05

27.79

u/l

0.01

All-cause Heart Failure

115

883

0.94

0.26

1.3

32.71

30.14

u/l

0.33

711

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

804

5519

1.02

0.26

1.3

1.4

24.57

25.92

u/l

0.61

660

4553

Sequelae of cerebrovascular disease

726

1.08

0.26

1.3

35.76

30.89

u/l

0.57

584

Congenital malformations of the urinary system

272

1.14

0.26

1.4

16.92

19.84

u/l

0.21

230

Heart failure, strict

118

902

0.94

0.25

1.4

1.3

32.11

30.10

u/l

0.25

725

Benign neoplasm: Skin of trunk

198

1.16

0.24

1.4

28.65

24.78

u/l

0.19

163

Helminthiases

0.70

0.24

1.3

1.5

22.77

22.21

u/l

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

607

0.93

0.23

1.3

1.4

32.10

31.13

u/l

0.09

489

Rheumatoid arthritis

170

1618

0.95

0.23

1.4

1.3

32.06

32.45

u/l

0.05

135

1335

Acute peritonitis

190

1.16

0.23

1.2

1.4

31.88

23.26

u/l

0.36

157

Diabetic nephropathy

570

0.92

0.23

1.3

1.4

21.33

18.36

u/l

0.24

466

Osteomalacia

1.25

0.22

1.4

1.6

56.58

18.43

u/l

—

Abscess of Bartholin gland

238

1.14

0.22

1.7

1.4

16.51

22.97

u/l

0.81

205

Fall on same level involving ice and snow

387

3760

1.03

0.22

1.4

1.3

25.44

28.37

u/l

1.01

322

3070

Melanocytic naevi of lower limb, including hip

248

1.13

0.21

2.0

1.4

35.18

24.19

u/l

0.67

209

Birth trauma

1.19

0.21

1.4

1.5

3.84

15.22

u/l

—

Fracture of shoulder and upper arm

147

1540

0.95

0.21

1.3

1.4

24.29

26.22

u/l

0.26

114

1283

Pre-eclampsia

241

2498

0.96

0.21

1.3

1.4

24.33

29.11

u/l

1.62

199

2035

Hypersensitivity angiitis

0.00

0.21

0.0

1.7

—

25.39

—

Surgical ablation of atrial fibrillation

0.00

0.21

0.0

1.4

—

18.36

—

Premature separation of placenta [abruptio placentae]

304

0.88

0.21

1.7

1.4

35.29

27.20

u/l

0.58

257

Accidental poisoning by and exposure to pesticides

0.00

0.21

0.0

1.9

—

22.84

—

Other congenital malformations of female genitalia

104

0.76

0.21

3.0

1.4

11.43

16.10

u/l

—

Bullous disorders

182

1.16

0.21

1.5

1.4

32.68

25.97

u/l

0.32

151

Other and unspecified medical devices associated with adverse incidents

0.00

0.21

0.0

1.8

—

33.17

—

Other and unspecified pemphigoid

0.00

0.21

0.0

1.8

—

28.82

—

Other/unspecified enthesopathies, not elsewhere classified

363

1.10

0.21

1.3

1.4

28.71

32.60

u/l

0.27

303

Sequelae of injuries of upper limb

450

1.09

0.21

1.2

1.4

31.49

26.31

u/l

0.43

371

Aortic aneurysm

357

1.10

0.21

1.3

28.19

22.19

u/l

0.49

290

Benign neoplasm of major salivary glands

335

1.11

0.20

1.2

1.4

19.63

30.13

u/l

1.47

273

Hypertensive heart and/or renal disease

341

1.09

0.20

1.3

34.47

31.10

u/l

0.25

278

Second line medication for Crohn's disease

413

4238

0.97

0.20

1.3

27.44

27.94

u/l

0.11

343

3461

Ankle and foot

1.25

0.20

1.3

1.5

39.07

24.28

u/l

—

Lumbosacral plexus disorders

0.00

0.20

0.0

1.6

—

34.01

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

829

5529

1.02

0.20

1.4

26.42

26.22

u/l

0.06

689

4547

Retinal detachments and breaks

120

1141

1.05

0.20

1.4

1.3

40.70

32.89

u/l

1.28

927

Alzheimer disease, excluding more controls

111

0.84

0.20

1.3

1.2

61.98

34.93

u/l

—

Childhood allergy (age < 16)

158

1246

1.05

0.20

1.3

1.4

7.25

7.67

u/l

0.19

133

1097

Hyperprolactinaemia, drug-induced

1.21

0.20

2.0

1.5

18.75

33.11

u/l

—

Chronic hepatitis NAS

1.18

0.19

1.3

1.6

24.28

28.13

u/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

104

987

1.06

0.19

1.4

25.84

24.24

u/l

0.19

824

Adjustment and management of implanted device

354

0.90

0.19

1.5

1.3

27.68

27.56

u/l

0.00

285

Disorders of eyelid in diseases classified elsewhere

165

1.15

0.19

1.2

1.4

34.65

23.83

u/l

0.65

133

Varus deformity, not elsewhere classified

1.13

0.18

1.7

1.5

32.23

27.40

u/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

107

1018

1.05

0.18

1.4

27.79

25.26

u/l

0.32

850

Delivery

366

1885

1.03

0.18

1.4

22.20

23.71

u/l

0.38

315

1562

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

120

865

0.95

0.18

1.4

1.3

38.55

36.96

u/l

0.19

104

639

Insulin, fast-acting (human)

107

1019

1.05

0.18

1.3

1.4

18.03

20.92

u/l

0.47

857

Pneumonias (Asthma/COPD co-morbidities)

833

5674

1.02

0.18

1.3

1.4

24.49

25.64

u/l

0.50

683

4683

Valvular operations

258

0.89

0.17

1.2

1.3

15.73

22.87

u/l

0.83

211

Benign neoplasm: Pancreas

1.15

0.17

2.3

1.4

46.89

33.86

u/l

—

Pyogenic granuloma

1.22

0.17

1.3

1.4

31.62

24.93

u/l

—

Gout, strict definition

243

1.11

0.17

1.1

1.3

21.96

23.82

u/l

0.10

197

Ulcer of lower limb, not elsewhere classified

291

1.10

0.17

1.5

1.4

28.59

28.09

u/l

0.03

239

Maternal care for cervical incompetence

272

1.11

0.17

1.5

1.4

23.48

21.81

u/l

0.09

232

Other and unspecified haemorrhagic conditions

0.74

0.17

1.6

9.30

24.97

u/l

—

Tic disorders

0.72

0.17

1.0

1.4

18.30

14.23

u/l

—

Malignant neoplasm of digestive organs

813

1.05

0.16

1.3

35.66

32.37

u/l

0.34

649

Sacrococcygeal disorders, not elsewhere classified

196

1.12

0.16

1.1

1.4

19.66

26.33

u/l

0.53

163

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

1.13

0.16

2.3

1.4

10.52

18.58

u/l

—

AV-block

300

1.09

0.16

1.5

1.3

24.94

26.61

u/l

0.09

246

Infections of breast associated with childbirth

428

1.08

0.16

1.4

18.98

21.36

u/l

0.20

364

Other (seronegative) rheumatoid arthritis, wide

887

1.05

0.15

1.3

35.31

30.99

u/l

0.51

720

Exclusion endpoint for supernumerary teeth

1.16

0.15

1.2

1.4

11.34

15.96

u/l

—

Tubulo-interstitial nephritis, not specified as acute or chronic

328

0.91

0.15

1.3

1.4

27.19

26.36

u/l

0.05

270

Other disorders of veins

277

2698

1.03

0.15

1.4

1.3

30.65

33.82

u/l

0.82

213

2185

Embedded teeth, including avohilmo

849

1.05

0.15

1.3

1.4

14.32

15.92

u/l

0.31

743

Adalimumab

624

1.06

0.15

1.3

1.4

24.44

23.77

u/l

0.06

522

Bronchiectasis

159

1.13

0.15

1.3

29.73

37.15

u/l

0.26

130

Other disorders of ear

641

4200

1.02

0.15

1.4

29.96

29.70

u/l

0.06

521

3426

Unspecified abortion

537

1.06

0.14

1.5

1.4

33.93

37.43

u/l

0.34

432

Burn and corrosion of shoulder and upper limb, except wrist and hand

1.09

0.14

1.4

1.5

20.74

23.64

u/l

—

Myocardial infarction, without ST-elevation

612

1.06

0.14

1.3

39.25

30.80

u/l

1.03

494

Hereditary corneal dystrophies

1.08

0.14

1.7

1.4

43.18

30.48

u/l

—

D07AA Corticosteroids, weak (group I)

130

1252

1.04

0.14

1.4

1.3

21.78

21.16

u/l

0.09

115

1057

Crowding of teeth, including avohilmo

653

1.05

0.14

1.4

9.93

13.51

u/l

1.32

578

Aneurysms, operations, SAH

626

1.05

0.14

1.3

34.79

33.34

u/l

0.13

501

Other diseases of biliary tract

208

1.11

0.14

1.4

26.71

31.38

u/l

0.28

169

Tumor necrosis factor alpha inhibitors

114

1097

1.04

0.14

1.3

1.4

23.70

23.57

u/l

0.02

100

906

Speech disturbances, not elsewhere classified

266

1.09

0.14

1.4

1.3

26.02

25.74

u/l

0.01

221

Fracture of forearm

344

3288

0.98

0.13

1.3

1.4

27.68

28.38

u/l

0.14

269

2724

Ulcerative enterocolitis

199

1.11

0.13

1.1

1.4

21.31

21.26

u/l

0.00

164

Overexertion and strenuous or repetitive movements

520

0.94

0.13

1.4

22.25

25.01

u/l

0.30

429

Colectomy operation

492

1.06

0.12

1.3

1.4

33.68

29.23

u/l

0.39

403

Intracerebral haemorrhage

210

0.90

0.12

1.1

1.3

46.07

28.53

u/l

1.11

169

Benign mammary dysplasia

763

0.96

0.12

1.4

1.3

29.37

34.61

u/l

0.74

611

Peripheral artery disease

672

1.04

0.12

1.3

34.24

29.41

u/l

0.59

537

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

307

1.08

0.12

1.6

1.4

35.99

28.44

u/l

0.45

240

IBD patients in KELA-register

178

1734

1.03

0.11

1.4

23.63

22.96

u/l

0.11

151

1440

Maternal care for known or suspected abnormality of pelvic organs

428

2905

1.02

0.11

1.4

23.04

26.71

u/l

1.60

363

2396

Other disorders of eyelid

166

1561

1.03

0.11

1.4

1.3

27.74

36.30

u/l

2.81

129

1278

264

1.07

0.11

1.4

1.3

42.39

39.15

u/l

0.23

212

Metabolic disorders

704

4319

1.01

0.11

1.4

1.3

29.34

29.71

u/l

0.10

567

3528

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

757

4568

1.01

0.11

1.4

1.3

23.78

30.40

u/l

7.62

601

3762

Sulfasalazine

194

1986

0.98

0.11

1.4

1.3

27.74

27.95

u/l

0.03

162

1620

Seronegative rheumatoid arthritis

516

0.95

0.11

1.3

36.35

31.94

u/l

0.32

418

Seropositive rheumatoid arthritis

120

1234

0.97

0.11

1.4

1.3

31.31

32.32

u/l

0.11

1020

Pacemaker

531

0.95

0.10

1.5

1.3

30.93

28.48

u/l

0.15

437

Coxarthrosis

212

1406

1.02

0.10

1.3

34.24

36.34

u/l

0.36

165

1143

Unstable angina pectoris

589

1.04

0.10

1.3

30.23

30.69

u/l

0.04

465

Pre-eclampsia or poor fetal growth

430

4350

0.99

0.10

1.3

1.4

22.32

25.58

u/l

1.52

359

3578

Other salmonella infections

154

1.11

0.10

1.0

1.4

55.58

25.82

u/l

1.50

125

Single spontaneous delivery

346

1872

0.98

0.10

1.4

24.63

23.83

u/l

0.16

294

1551

Melanocytic naevi of eyelid, including canthus

1.14

0.10

1.0

1.4

43.58

30.29

u/l

—

Right ventricular outflow tract obstruction

1.11

0.10

2.2

1.5

6.20

13.60

u/l

—

Acute renal failure

447

1.05

0.10

1.5

1.4

24.10

27.02

u/l

0.25

369

Disease of hard tissues of teeth, NOS

1.11

0.10

1.4

11.60

26.14

u/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

310

1.07

0.09

1.2

1.4

20.50

29.91

u/l

1.14

252

Normal-pressure hydrocephalus

1.11

0.09

1.8

1.3

21.28

32.22

u/l

—

All pneumoniae

839

5732

1.01

0.09

1.3

1.4

24.96

25.56

u/l

0.22

688

4732

Thoracic aortic aneurysm

252

1.07

0.09

1.2

1.3

32.47

23.01

u/l

0.56

206

L04AX Other immunosuppressants

402

4073

0.99

0.09

1.3

1.4

27.79

28.16

u/l

0.08

334

3326

Other secondary gonarthrosis

155

0.90

0.09

1.1

1.3

40.85

31.87

u/l

—

120

Pure hypercholesterolaemia

306

2020

1.02

0.09

1.3

32.70

34.05

u/l

0.26

242

1650

Impacted maxillary canine

1.11

0.09

1.2

1.6

9.88

9.62

u/l

—

Tibial collateral bursitis [Pellegrini-Stieda]

1.11

0.09

1.2

1.5

50.02

30.61

u/l

—

Myasthenia gravis

1.07

0.08

1.7

1.4

19.32

27.83

u/l

—

Complications specific to multiple gestation

0.81

0.08

1.2

1.5

6.96

24.47

u/l

—

Cyst of kidney

144

0.90

0.08

1.5

1.3

20.27

31.46

u/l

0.84

113

Psoriatic arthropathies

509

1.04

0.08

1.2

1.3

22.80

31.33

u/l

1.58

424

Benign neoplasm: Parotid gland

283

1.06

0.08

1.2

1.3

21.20

28.24

u/l

0.73

231

5-aminosalicylic acid

152

1552

0.98

0.08

1.4

24.61

23.93

u/l

0.10

132

1281

Cleft palate

1.05

0.07

1.1

1.5

19.85

17.07

u/l

—

Single delivery by forceps and vacuum extractor

241

1490

0.98

0.07

1.3

1.4

20.57

21.49

u/l

0.20

205

1233

Other puerperal infections

112

1094

1.02

0.07

1.2

1.4

17.28

19.00

u/l

0.27

928

Other condition

787

1.03

0.07

1.4

17.91

24.41

u/l

1.30

654

Pre-eclampsia or eclampsia

256

2597

0.99

0.07

1.3

1.4

25.17

29.36

u/l

1.37

212

2114

Acute appendicitis, with complications

113

1104

1.02

0.07

1.3

1.4

31.61

29.00

u/l

0.35

906

Motorcycle rider injured in other and unspecified transport accidents

294

1.06

0.07

1.4

10.61

15.47

u/l

0.81

247

Blepharochalasis

924

0.97

0.07

1.4

1.3

31.90

39.35

u/l

1.24

751

Benign neoplasm: Long bones of lower limb

196

1.07

0.07

1.3

1.4

27.14

20.97

u/l

0.24

169

Protozoal diseases

1.07

0.07

1.4

1.3

32.30

29.18

u/l

—

N06DA Anticholinesterases

223

0.94

0.07

1.4

1.3

32.74

37.98

u/l

0.31

177

Use of anticholinesterases

223

0.94

0.07

1.4

1.3

32.74

37.98

u/l

0.31

177

Glomerular diseases

709

1.03

0.07

1.4

30.14

24.23

u/l

0.62

593

Malignant neoplasm of thyroid gland

346

0.95

0.06

1.6

1.4

32.45

29.54

u/l

0.16

284

Dysplastic lesion of unknown severity of the cervix uteri

103

0.87

0.06

1.0

1.5

17.28

22.86

u/l

—

101

0.86

0.06

1.7

1.5

6.01

7.37

u/l

—

Ulcerative colitis, NAS

928

1.02

0.06

1.4

1.3

25.18

23.62

u/l

0.20

777

Sequelae of infectious and parasitic diseases

386

0.96

0.06

1.5

1.4

27.11

25.00

u/l

0.17

313

Diabetes, insulin treatment (Kela reimbursement)

764

4705

0.99

0.06

1.4

1.3

23.82

29.91

u/l

6.63

606

3871

Tooth eruption problems

135

1361

0.98

0.06

1.3

1.4

12.28

13.68

u/l

0.40

123

1188

Presence of cardiac and vascular implants and grafts

710

1.02

0.06

1.3

25.52

26.88

u/l

0.14

582

Sequelae of other and unspecified infectious and parasitic diseases

365

0.96

0.06

1.4

28.43

25.12

u/l

0.27

297

Dialysis, with operation codes

375

0.96

0.05

1.5

1.4

28.50

24.12

u/l

0.30

303

Unspecified fall

270

2708

0.99

0.05

1.4

26.31

25.13

u/l

0.23

214

2224

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

758

4904

1.01

0.05

1.3

1.4

31.47

28.90

u/l

1.20

615

4012

Cardiomyopathies, Primary/intrinsic

273

0.95

0.05

1.5

1.3

19.05

25.46

u/l

0.63

226

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

366

1.04

0.05

1.7

1.4

32.41

28.00

u/l

0.27

280

Inflammatory bowel disease, strict (require KELA)

178

1756

1.01

0.05

1.4

23.63

22.99

u/l

0.10

151

1454

Cardiomyopathy (excluding other)

293

0.96

0.05

1.5

1.3

18.04

25.11

u/l

0.80

242

Diabetic retinopathy, strict definition

806

0.98

0.04

1.3

1.4

21.19

19.33

u/l

0.19

670

Open wound of ankle and foot

466

1.03

0.04

1.3

1.4

23.19

20.38

u/l

0.26

396

Calcific aortic valvular stenosis, operated

379

1.03

0.04

1.4

1.3

22.78

30.51

u/l

0.98

308

Calcific aortic valvular stenosis

379

1.03

0.04

1.4

1.3

22.78

30.51

u/l

0.98

308

Other retinal disorders

247

2003

0.99

0.04

1.4

28.30

27.91

u/l

0.06

191

1651

Colorectal adenocarcinoma

368

1.03

0.04

1.4

1.3

39.50

32.93

u/l

0.48

297

Ulcerative rectosigmoiditis

517

1.03

0.04

1.3

1.4

27.84

23.87

u/l

0.36

426

Bacterial pneumonia (organism specified)

202

1821

1.01

0.04

1.4

23.19

26.04

u/l

0.73

174

1497

Generalized epilepsy, mode (most common among epilepsy diagnosis)

200

0.95

0.03

1.4

12.72

19.73

u/l

0.60

172

Complications following abortion and ectopic and molar pregnancy

200

1.05

0.03

1.3

1.4

48.38

36.66

u/l

0.52

169

Psoriatic and enteropathic arthropathies

633

0.98

0.03

1.2

1.3

22.79

28.06

u/l

0.91

520

Malignant neoplasm of endocrine gland

359

1.03

0.03

1.6

1.4

33.78

28.93

u/l

0.33

294

Bacterial pneumonia, not elsewhere classified

174

1524

1.01

0.03

1.4

24.42

26.59

u/l

0.44

150

1258

Personal history of other diseases and conditions

113

1140

0.99

0.03

1.3

1.4

22.11

20.68

u/l

0.20

961

Arthropathic psoriasis

568

1.02

0.03

1.2

1.4

24.12

29.09

u/l

0.74

463

Retinal breaks without detachment

582

0.98

0.03

1.6

1.3

42.72

33.05

u/l

0.97

466

Coxarthrosis [arthrosis of hip](FG)

216

1549

1.01

0.03

1.3

34.80

36.54

u/l

0.28

169

1256

Other embolism and thrombosis

521

0.98

0.03

1.3

1.4

22.48

29.95

u/l

0.79

424

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

104

1027

1.01

0.03

1.4

25.84

23.76

u/l

0.26

854

Reimbursement for rheumatic diseases

411

4081

1.00

0.02

1.3

27.97

29.35

u/l

0.35

333

3338

Total colectomy

198

0.96

0.02

1.3

1.4

22.81

21.92

u/l

0.05

165

Total colectomy operation

198

0.96

0.02

1.3

1.4

22.81

21.92

u/l

0.05

165

Retinal vascular occlusion

202

1.04

0.02

1.4

1.3

45.05

32.60

u/l

0.82

162

malignant neoplasm of male genital organs

362

1.02

0.02

1.4

1.3

11.93

12.76

u/l

0.19

294

Other superficial mycoses

113

1.06

0.02

1.3

1.4

16.83

22.39

u/l

—

Myeloproliferative diseases (CML excluded)

207

0.97

0.01

1.2

1.4

24.03

29.33

u/l

0.43

168

Colorectal cancer

493

1.01

0.01

1.4

42.08

32.81

u/l

0.84

401

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

107

1063

1.01

0.00

1.4

27.79

24.78

u/l

0.41

883

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

196

0.98

0.00

1.2

1.3

35.28

37.68

u/l

0.12

176

Atrial fibrillation and flutter with reimbursement

483

1.01

0.00

1.3

1.4

32.87

35.14

u/l

0.19

391

Heart failure,strict

117

846

1.00

0.00

1.4

1.3

32.11

30.35

u/l

0.22

683

Angina pectoris

163

1100

1.00

0.00

1.3

1.4

32.76

33.42

u/l

0.09

129

882

Bacterial pneumoniae

188

1664

1.00

0.00

1.3

1.4

23.31

26.28

u/l

0.73

163

1379

Methotrexate

833

1.00

0.00

1.4

1.3

31.38

29.57

u/l

0.19

681

Biological medication for rheuma

121

1207

1.00

0.00

1.3

1.4

24.58

23.92

u/l

0.09

106

999

Acute lymphadenitis

365

0.99

0.00

1.6

1.4

28.33

19.52

u/l

0.61

308

Diabetic neuropathy

373

0.99

0.00

1.3

1.4

20.88

22.25

u/l

0.09

310

Poor fetal growth

195

1952

1.00

0.00

1.3

1.4

18.55

21.24

u/l

0.75

164

1625

Degeneration of macula and posterior pole

718

1.00

0.00

1.5

1.3

39.30

34.30

u/l

0.56

585

Calcific aortic valvular stenosis, diagnosis (helper)

377

1.01

0.00

1.3

23.36

30.52

u/l

0.85

306

Operations 2 for CAVS

377

1.01

0.00

1.3

23.36

30.52

u/l

0.85

306

Mandibular retrognathia

518

1.00

0.00

1.5

1.4

21.04

21.69

u/l

0.05

442

Accidental poisoning by and exposure to alcohol

1.02

0.00

1.3

1.5

28.29

14.97

u/l

—

Other psoriatic arthropathies

514

0.99

0.00

1.2

1.4

21.68

29.01

u/l

1.24

423

Retinal detachment with retinal break

347

1.01

0.00

1.3

1.4

36.56

30.88

u/l

0.35

286

Subarachnoid haemorrhage

281

1.00

0.00

1.2

1.4

42.03

32.08

u/l

0.75

225

Unspecified privation

487

1.01

0.00

1.4

13.04

24.29

u/l

3.80

405

Myopia

112

1124

1.00

0.00

1.4

1.3

28.15

21.98

u/l

0.84

937

Psoriatic arthropathies, ICD10

529

1.00

0.00

1.2

1.4

22.80

28.75

u/l

0.94

433

Retinal vascular disorders

207

1.01

0.00

1.4

1.3

45.05

32.56

u/l

0.83

167

Artificial opening status

132

0.98

0.00

1.2

1.4

36.28

23.98

u/l

0.42

109

Calcific aortic valvular stenosis, including rheumatic fever

380

1.00

0.00

1.3

23.36

30.45

u/l

0.84

309

Other parasitologically confirmed or unspecified malaria

0.00

0.0

2.2

—

13.50

—

Other acute disseminated demyelination

0.95

0.00

1.3

1.5

20.02

22.88

u/l

—

Other immunodeficiencies

1.00

0.00

1.6

1.5

36.40

22.12

u/l

—

Intrauterine hypoxia

0.00

0.0

1.0

—

27.44

—

Other disorders following mastoidectomy

0.00

0.0

1.0

—

23.78

—

Dermatopolymyositis (FG)

1.02

0.00

1.4

31.30

31.78

u/l

—

Photocontact dermatitis [berloque dermatitis]

0.00

0.0

1.9

—

41.80

—

Other disorders originating in the perinatal period

0.92

0.00

1.2

1.5

36.88

21.28

u/l

—

Haemorrhagic disorder due to circulating anticoagulants

0.00

0.0

1.5

—

28.22

—

Acute epiglottitis

0.95

0.00

1.3

1.5

12.55

21.64

u/l

—

Intracranial laceration and haemorrhage due to birth injury

0.00

0.0

1.2

—

47.50

—

Accident to watercraft causing other injury

0.00

0.0

1.6

—

15.46

—

Diffuse (eosinophilic) fasciitis

0.00

0.0

2.0

—

32.16

—

Benign neoplasm: Scrotum

0.00

0.0

1.0

—

17.96

—

Dermatopolymyositis

0.98

0.00

1.4

1.5

31.30

30.29

u/l

—

Sequelae of hyperalimentation

0.00

0.0

1.8

—

59.04

—

Hirsprung

0.00

0.0

1.4

—

5.48

—

Other/unspecified crystal arthropathies

0.00

0.0

1.4

—

38.58

—

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

0.00

0.0

1.1

—

24.20

—

Iodine-deficiency-related goitre

0.00

0.0

1.2

—

32.32

—

Retinal haemorrhage

0.98

0.00

1.6

1.5

9.40

33.41

u/l

—

Combined immunodeficiencies

1.02

0.00

2.0

1.5

35.36

29.44

u/l

—

Foreign body in genitourinary tract

0.94

0.00

1.6

1.5

24.73

20.71

u/l

—

Migraine with aura, drug-induced

1.00

0.00

1.6

1.4

22.20

28.59

u/l

—

Juvenile dermatomyositis

0.00

0.0

1.7

—

21.74

—

Alpha thalassaemia

0.00

0.0

2.3

—

20.03

—

Arthropathy in hypersensitivity reactions classified elsewhere

0.00

0.0

2.0

—

17.34

—

Congenital malformation of biliary tract

0.00

0.0

1.2

—

25.32

—

Generalized epilepsy, strict definition

150

1.00

0.00

1.5

1.4

6.84

18.94

u/l

—

130

Other ill-defined and unspecified causes of mortality

0.92

0.00

1.4

28.49

23.76

u/l

—

Acne keloid

0.00

0.0

1.8

—

16.62

—

Acrodermatitis chronica atrophicans

0.00

0.0

2.4

—

5.40

—

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

0.00

0.0

1.6

—

45.28

—

Neuralgic amyotrophy

0.00

0.0

1.7

—

35.11

—

Cyst of Bartholin Gland

330

1.00

0.00

1.5

1.4

37.86

26.70

u/l

0.72

284

Loose body in joint

0.96

0.00

1.1

1.4

33.65

23.58

u/l

—

Drug-induced myopathy

0.00

0.0

1.1

—

31.04

—

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

24.82

—

Secondary lactase deficiency

0.00

0.0

1.4

—

11.42

—

Forearm

0.00

0.0

1.0

—

31.36

—

Tic and related disorders

0.92

0.00

1.0

1.5

26.96

13.95

u/l

—

Mucocutaneous lymph node syndrome [Kawasaki]

0.00

0.0

1.7

—

12.70

—

Disorders of hypoglossal nerve

0.00

0.0

1.6

—

26.87

—

Other changes in lacrimal passages

0.00

0.0

1.7

—

19.05

—

Toxic effect of pesticides

0.00

0.0

2.0

—

28.27

—

Pemphigus foliaceus

0.00

0.0

1.3

—

46.15

—

Hereditary factor IX deficiency

0.00

0.0

1.6

—

26.78

—

Use of trihexyphenidyl

0.00

0.0

1.5

—

43.62

—

Folliculitis decalvans

0.00

0.0

1.7

—

50.28

—

Genetic anomalies of leukocytes

0.00

0.0

1.9

—

43.36

—

Other congenital malformations of spinal cord

0.00

0.0

1.5

—

33.78

—

Sequelae of poliomyelitis

0.00

0.0

1.7

—

23.11

—

Disorders of muscle tone of newborn

0.00

0.0

1.3

—

6.67

—

Contact with lifting and transmission devices, not elsewhere classified

0.95

0.00

1.2

1.5

21.57

24.30

u/l

—

Carcinoma in situ of anus and anal canal

0.00

0.0

2.0

—

30.32

—

Maze procedure for atrial fibrillation

0.00

0.0

2.0

—

31.96

—

Profound mental retardation

0.00

0.0

1.2

—

38.80

—

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

0.00

0.0

2.0

—

4.94

—

Pemphigus vulgaris

0.00

0.0

2.0

—

44.26

—

Hereditary nephropathy, not elsewhere classified

0.00

0.0

2.3

—

29.77

—

Other birth injuries

0.00

0.0

1.0

—

18.64

—

Other and unspecified injuries of abdomen, lower back and pelvis

1.01

0.00

1.4

1.5

11.41

18.80

u/l

—

Benign neoplasm: Vertebral column

0.00

0.0

1.7

—

38.02

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Follitropin [Units/volume] in Serum or Plasma by Immunoassay

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS